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Monochorionic twins have a unique set of complications, due to vascular anastomoses 
allowing interfetal transfusion. This results in episodes of haemodynamic instability, 
and as a result, they are at risk of various co-morbidities including cardiovascular and 
neurodevelopmental sequelae. The pathophysiology behind increased neurological 
morbidity in monochorionic twins is not fully understood. Therefore, in this thesis I 
have explored the neurological and cardiovascular effects of monochorionic 
placentation. 
 
The impact of birthweight discordance on brain growth and brain volume was 
assessed in a cohort of twins (n = 96). Selective fetal growth restriction was associated 
with increased intertwin brain volume discordance and a trend towards a reduction 
in total brain tissue volume, after adjusting for birthweight. In both monochorionic 
and dichorionic twins, increasing birthweight discordance was associated with a 
reduction in absolute brain volume and an increase in brain volume discordance after 
controlling for various confounders including birthweight. 
 
Quantification of left ventricular strain was assessed in a cohort of twins (n = 144). 
There was an increase in intertwin strain discordance and a reduction in left 
ventricular strain, driven by reduced strain in the recipient twin, in twinsets affected 
by twin-to-twin transfusion syndrome. This resolved promptly following successful 
laser treatment.  
 
Prediction and early diagnosis of pathology remains a significant challenge in the 
management of monochorionic twins. This thesis provides evidence for the potential 
benefit of using left ventricular strain quantification to differentiate between and 
predict monochorionic pathologies, and evidence of a negative impact of intertwin 
growth discordance on brain growth and development.  
 
Continued investigation into adjuncts to enhance the prediction, diagnosis, and 
understanding of the complications of monochorionicity, will improve management 
and counselling in these high risk pregnancies. 
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Chapter 1 Introduction 
 
1.1  Background 
Twins account for around 3% of all pregnancies, and the incidence is increasing with 
the use of assisted reproductive technologies and increasing maternal age1,2. Perinatal 
morbidity and mortality in twin pregnancies is between three and seven times higher 
than in singleton pregnancies3,4. Twin pregnancies have a higher rate of antenatal 
complications, preterm birth and uteroplacental insufficiency compared to singleton 
pregnancies5. Approximately 20-30% of twin pregnancies will be monochorionic 6,7 
and these pregnancies have higher rates of preterm labour, low birth weight and 
perinatal mortality compared to dichorionic twin pregnancies. In addition, they have 
an increased incidence of developmental and acquired birth defects7. The risk of third 
trimester stillbirth in apparently uncomplicated monochorionic twin pregnancies is 
also significantly higher than in singleton or dichorionic twin pregnancies8. 
 
1.2  Mechanisms of Twinning 
Twins can be monozygotic or dizygotic, depending on whether one or two ova are 
fertilised at conception. Apart from rare cases,9,10 all dizygotic twins will be 
dichorionic, whereas traditionally it has been thought that the chorionicity and 
amnionicity of monozygotic twins depends on the timing of zygotic division. If division 
of the zygote occurs prior to day 3, this will result in a dichorionic diamniotic twin 
pregnancy11. Approximately 20-30% 12 of monozygotic twins will be dichorionic. If 
division occurs between day 3 and day 8 following fertilisation, the pregnancy will be 
monochorionic diamniotic, whereas if division occurs between day 8 and day 10 the 






Figure 1.1 The traditional theory of the formation of different types of twins. 
Reproduced with permission from McNamara et al, Copyright 201613. 
 
1.3 Diagnosis of Chorionicity  
Monochorionic twins have significantly higher rates of perinatal morbidity and 
mortality when compared to dichorionic twins6. Chorionicity is the biggest 
determinant of the outcome in twin pregnancies, regardless of zygosity14,15. This is due 
to the unique set of complications associated with a shared placenta, which are 
discussed in detail in Section 1.4. Early classification of chorionicity is therefore 
essential for risk stratification, optimal management and counselling. Routine 
assessment of chorionicity should be carried out at the first trimester dating scan, by 
examining the intertwin membrane at its insertion point to the placenta. In dichorionic 
twins, the interfetal membrane consists of two layers of amnion and two layers of 
chorion, whereas in monochorionic twins the membrane is composed of just two 
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layers of amnion16. This gives rise to characteristic ultrasound appearances: in 
monochorionic twins there is a characteristic ‘T’ sign, whereas a thicker wedge shaped 
‘lambda’ or ‘twin peak’ sign is seen in dichorionic twins, where the chorionic tissue 
extends into the intertwin membrane. Ultrasound visualisation of the ‘T sign’ has a 
100% sensitivity and 98% specificity in diagnosing monochorionic twins between 10-
14 weeks gestation16,17. 
 
 
Figure 1.2 T sign and lambda sign for diagnosis of chorionicity: a) lambda sign b) T sign. 
Taken from Khalil et al, Copyright 201518.   
 
Determination of chorionicity becomes less accurate after 14 weeks gestation 19 due 
to regression of the chorionic laeve20. The lambda sign becomes more difficult to 
visualise with advancing gestation, and disappears after 20 weeks in 7% of dichorionic 
pregnancies with a fused placenta, and in 26% of those with separate placental 
masses21. Monochorionic monoamniotic twins are diagnosed when no interfetal 
membrane can be seen on scan and further confirmed by the presence of cord 
entanglement22. This diagnosis should not be made before 8 weeks’ gestation, as the 
amnion cannot be reliably visualised prior to this23. 
 
1.4 The Shared Placenta – Complications Unique to Monochorionicity 
Monochorionic twins are associated with higher rates of morbidity and mortality than 
dichorionic twins, and this is largely due to the shared placenta and the presence of 
vascular anastomoses. Approximately 95% of monochorionic twins will have vascular 
anastomoses on the fetal surface of the placenta 24, which allow the blood to be 
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shared between the two circulations. In around 15% of monochorionic twins, the 
presence of vascular anastomoses will lead to the development of Twin-to-Twin 
Transfusion Syndrome (TTTS) 3,25 or more rarely Twin Anaemia Polycythaemia 
Sequence (TAPS) or Twin Reversed Arterial Perfusion (TRAP) sequence26. Vascular 




There are three different types of vascular anastomoses present in the monochorionic 
placenta: arterioarterial, venovenous and arteriovenous24. Arterioarterial and 
venovenous anastomoses are superficial and allow bidirectional blood flow,26 
depending on the relative hydrostatic pressure in each twin’s circulation. As 
arterioarterial anastomoses allow bidirectional blood flow, they are compensatory 
and can therefore prevent imbalance in the circulating blood volumes in each twin, 
and are therefore protective against developing TTTS27-29. Monochorionic 
monoamniotic twins have a much lower incidence of TTTS and this is thought to be 
due to the almost universal presence of an arterioarterial anastomosis27. An 
arterioarterial anastomosis is present in 84% of monochorionic twins who do not 
develop TTTS, whereas only 30% of cases of TTTS will have an arterioarterial 
anastomosis present27. In the absence of an arterioarterial anastomosis, 43-75% of 
monochorionic twins develop TTTS, whereas when an arterioarterial anastomosis is 
present, only 14% will develop TTTS25,31-33. Computer modelling has shown that 
arterioarterial anastomoses were able to compensate for unidirectional flow through 
an arteriovenous anastomosis more effectively than venoarterial anastomoses that 
allowed flow in the opposite direction28. In addition, in cases of TTTS where an 
arterioarterial anastomosis is detected on antenatal ultrasound, there is a milder 
phenotype and better survival in comparison to cases without an arterioarterial 
anastomosis29,30. The evidence that arterioarterial anastomoses are protective against 
TTTS is further substantiated by a report that thrombosis of an antenatally detected 




Arteriovenous anastomoses are connections deep within the placenta between a 
chorionic artery and the co-twin’s chorionic vein in a shared cotyledon. These are 
unidirectional anastomoses and therefore allow a net flow of blood from one twin to 
the other32. Monochorionic placentae usually have multiple arteriovenous 
anastomoses and so the net flow is often balanced by flow through arteriovenous 
anastomoses in the opposite direction. Arteriovenous anastomoses are found in 
around 90% of monochorionic placentae24,33. The majority of TTTS cases are 
characterised by the absence of an arterioarterial anastomosis and the presence of 
one or more arteriovenous anastomoses.  
 
Arteriovenous anastomoses have been shown to confer some benefit in cases of 
selective fetal growth restriction, as they enable the twin with the smaller share of the 
placenta to recruit oxygenated blood from the larger twin. One study showed that the 
more unequal the placental sharing, the greater the number of anastomoses and the 
greater the intertwin transfusion. There is a correlation between the degree of 
unequal placental sharing and the diameter of the anastomoses: the greater the 
placental territory discordance, the bigger the diameter of all anastomotic vessels34. 
Therefore, anastomoses appear to be beneficial in increasing the birthweight of the 
twin with the smaller placental share. 
 
Venovenous anastomoses are significantly rarer than arteriovenous or arterioarterial 
anastomoses and are present in only 20-30% of monochorionic placentae24,27. Some 
studies have shown an association with increased perinatal mortality, 24 although the 
mechanism behind this is not fully understood. 
 
1.4.2 Interfetal transfusion 
Several forms of interfetal transfusion have been identified: acute perimortem 
interfetal transfusion, acute perinatal interfetal transfusion, twin anaemia 
polycythaemia sequence (TAPS), twin reversed arterial perfusion (TRAP) sequence 




1.4.2.1 Acute Perimortem Interfetal Transfusion  
Acute perimortem interfetal transfusion occurs following a single intrauterine death. 
This is due to exsanguination of the surviving twin through passage of blood across 
large superficial anastomoses into the non-viable co-twin. This leads to hypotension 
and hypoxic-ischaemic damage or loss of the surviving twin35-37. The optimal 
treatment for acute perimortem interfetal transfusion is not known, treatment 
options include conservative management, emergency Caesarean section or rescue 
intrauterine blood transfusion. However, hypotension causing fetal brain injury 
happens at the time of the co-twin demise, therefore Caesarean section or rescue 
transfusion are unlikely to prevent harm. In practice, conservative management is 
usually the most appropriate option, as predicting the occurrence and exact timing of 
the single fetal demise is virtually impossible35.  
 
1.4.2.2 Acute Perinatal Interfetal Transfusion 
The incidence of acute perinatal interfetal transfusion occurring in labour in 
monochorionic twins ranges from 1.8-5.5%35,38. The spectrum of the disease ranges 
from severe hypovolaemic shock through to minor transfusion causing asymptomatic 
intertwin haemoglobin differences. The mechanism is thought to be passage of blood 
across large low resistance superficial anastomoses due to blood pressure alterations 
caused by uterine contractions or changing fetal position35. Treatment is aimed at 
correcting hypovolaemic shock through administration of blood and fluids. If the 
recipient twin is severely polycythaemic, then they may require a partial exchange 
transfusion35. Both acute perimortem and acute perinatal interfetal transfusion are 
caused by interfetal transfusion through large superficial arterioarterial anastomoses. 
 
1.4.2.3 Twin Anaemia Polycythaemia Sequence  
Twin Anaemia Polycythaemia Sequence (TAPS) was first described as a subtype of 
interfetal transfusion in 200739. It is a more gradual form of interfetal transfusion; 
characterised by large intertwin differences in haemoglobin in the absence of the 
oligohydramnios-polyhydramnios sequence seen classically in TTTS. TAPS can occur 
spontaneously (in 3-5% of monochorionic twin pregnancies) or can be iatrogenic, 
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occurring in 2-13% of TTTS cases following laser treatment40. A staging system for the 
severity of TAPS has been proposed, and is shown in Table 1.141. 
 
Table 1.1 Staging system for TAPS41 
Stage I MCA-PSV donor >1.5 MoM and MCA-PSV recipient <1.0 MoM, 
without other signs of fetal compromise 
Stage II MCA-PSV donor >1.7 MoM and MCA-PSV recipient <0.8 MoM, 
without other signs of fetal compromise 
Stage III As stage 1 or 2, with cardiac compromise of donor, defined as 
critically abnormal Doppler studies (defined as absent/reversed end-
diastolic flow in umbilical artery, pulsatile flow in the umbilical vein, 
increased pulsatility index or reversed flow in ductus venosus.) 
Stage IV Fetal hydrops 
Stage V Demise of one or both twins preceded by TAPS 
 
TAPS placentae are characterised by a few small (<1mm diameter) mostly 
unidirectional arteriovenous anastomoses and a paucity of arterioarterial or 
venovenous anastomoses39,40,42,43. Spontaneous TAPS placentae have more 
bidirectional arteriovenous anastomoses, whereas post-laser iatrogenic TAPS 
placentae tend to have only unidirectional anastomoses. Iatrogenic TAPS occurs due 
to one or two arteriovenous anastomoses being left patent following laser 
treatment43. In spontaneous and iatrogenic TAPS, the small calibre of the 
arteriovenous anastomoses means that the interfetal transfusion is very slow due to 
the increased vascular resistance. This allows both fetuses to compensate so that the 
haemodynamic compromise seen in TTTS is not present in TAPS. Antenatal diagnosis 
is based on a combination of increased middle cerebral artery peak systolic velocity 
(MCA-PSV) on Doppler ultrasound in the donor (>1.5 MoM) and decreased MCA-PSV 
in the recipient (<1.0 MoM). Increased velocity is suggestive of anaemia, whereas 
decreased velocity is suggestive of polycythaemia. Current guidance suggests 
fortnightly measurement of MCA-PSV in monochorionic twins, especially post-laser 
treatment, to facilitate timely diagnosis of TAPS. Postnatally, the diagnosis is made 
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using a combination of haematological abnormalities (chronic anaemia in the donor 
with a high reticulocyte count, and chronic polycythaemia in the recipient) and 
placental injection studies. There is no consensus regarding the best treatment for 
TAPS: options include delivery, intrauterine blood transfusion, or fetoscopic laser 
coagulation of the anastomotic vessels35. 
 
1.4.2.4 Twin Reversed Arterial Perfusion Sequence 
The most severe form of interfetal transfusion is the twin reversed arterial perfusion 
sequence (TRAP), which complicates 1 in 35,000 pregnancies, 1 in 100 monochorionic 
twins and 1 in 30 monochorionic triplets44. TRAP should be suspected when 
ultrasound examination of a monochorionic twin pregnancy shows one severely 
malformed twin. The main differential diagnosis is an early fetal demise of one twin, 
however in TRAP the non-viable fetus continues to grow and there is evidence of flow 
within45. TRAP is a serious complication of monochorionic twin pregnancies, and 
consists of reversed perfusion of an acardiac twin from a healthy ‘pump’ twin. The 
placenta in TRAP characteristically has one arterioarterial and one venovenous 
anastomosis that enable the passage of blood from the healthy twin to the affected 
twin45. The acardiac twin is completely dependent on blood pumped from the healthy 
twin, and its growth threatens the wellbeing of the ‘pump’ twin by causing high output 
cardiac failure. TRAP can also lead to preterm labour or miscarriage due to 
polyhydramnios44. The perinatal mortality rates for the healthy co-twin in a TRAP pair 
have been reported as 35-55%, 45-47 although more recent reports have reported 
survival rates of approximately 90% following occlusion of the acardiac twin’s 
umbilical cord48-50. 
 
1.4.2.5 Twin-to-twin transfusion syndrome (TTTS) 
The most common form of interfetal transfusion is TTTS, which occurs in around 15% 
of monochorionic twins. TTTS occurs when the interfetal transfusion via placental 
anastomoses result in the net flow of blood from one fetus (the donor) to the other 
(the recipient). The most widely accepted staging system for severity of TTTS is that 
proposed by Quintero et al 51 which comprises five clinical severities, or stages, of the 
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syndrome, as described in Table 1.2. However, criticisms of this staging system have 
been made, due to the fact that it does not accurately represent the natural 
progression of the disease, nor does the stage at presentation correlate with the 
clinical outcome52. 
 
Table 1.2 Quintero staging system for TTTS 
Stage I Presence of polyhydramnios (maximum vertical pocket of > or = 8 cm) 
and oligohydramnios (maximum vertical pocket of < or = 2 cm) 
Stage II Non-visualisation of the bladder in the donor twin 
Stage III Critically abnormal Doppler studies (defined as absent/reverse end-
diastolic flow in the umbilical artery, reverse flow in the ductus 
venosus, or pulsatile flow in the umbilical vein) 
Stage IV Fetal hydrops 
Stage V Demise of one or both twins 
 
The discordancy in amniotic fluid volumes is secondary to hypovolaemia in the donor 
and hypervolaemia in the recipient, which leads to oliguric oligohydramnios and 
polyuric polyhydramnios respectively.  Alterations in blood volume caused by 
interfetal transfusion cause an adaptive response via the cardiac, endocrine and renal 
systems that leads to discordant amniotic fluid volumes53. Studies have shown that 
recipient twins have higher levels of atrial natriuretic peptide (ANP) and brain 
natriuretic peptide (BNP) compared to donor fetuses or twins without TTTS54. This 
reflects the increased circulating volume resulting in fluid overload, which leads to 
cardiac dysfunction in the recipient twin54 55. Increased levels of ANP in the recipient 
fetus lead to an increase in the glomerular filtration rate and therefore polyuria. It has 
also been shown the level of anti-diuretic hormone (ADH) is lower in the recipient 
twin, which may be due to hypervolaemia directly causing down regulation, resulting 
in increased urine output and polyhydramnios53. Interestingly, hydropic recipient 
twins have been found to have higher circulating levels of ADH compared to non-
hydropic recipient twins. This may reflect the relative intravascular depletion as a 
result of fluid accumulating in interstitial spaces53. Conversely, interfetal transfusion 
leads to an intra-vascular depletion of volume in the donor twin leading to 
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upregulation and increased secretion of ADH and renin, hence reduced urine output 
and oligohydramnios53. However, high levels of renin and angiotensin have also 
paradoxically been demonstrated in the recipient. Therefore, it has been hypothesised 
that renin and angiotensin may be transferred from the donor to the recipient through 
the placental anastomoses, resulting in worsening hypervolaemia in the recipient56.  
 
If left untreated, TTTS will lead to the loss of one or both twins in approximately 80-
90% of pregnancies57,58. Untreated TTTS is associated with an increased risk of 
miscarriage, preterm birth and spontaneous rupture of membranes. Fetoscopic laser 
photocoagulation (FLP) of anastomotic vessels has been shown in two Cochrane 
reviews to be more effective than serial amnioreduction in the treatment for TTTS up 
to 26 weeks’ gestation and is now the preferred treatment modality57,59,60. FLP 
treatment is associated with a higher mean gestational age at delivery, greater chance 
of at least one fetus surviving and improved neurological outcomes in surviving 
fetuses when compared with serial amnioreduction59,61.  
 
1.5 Growth discordance in twin pregnancies 
Growth discordance is common in twin pregnancies, with the reported incidence 
ranging from 10-30%62. Birthweight discordance has been shown to be greater in 
monochorionic than dichorionic twins4. Studies suggest that growth discordance 
within a twinset is a marker of adverse outcomes,62-64 and has been associated with 
increased neurological morbidity64-66. Studies have demonstrated that, irrespective of 
chorionicity, the risk of neurodevelopmental morbidity is significantly higher in growth 
discordant twinsets, compared to growth concordant twinsets64,67.   However the 





1.5.1 Growth discordance in monochorionic twins 
In the past, many studies focussed on the impact of twin-to-twin transfusion 
syndrome on monochorionic pregnancies. More recently studies have begun to assess 
the impact of selective fetal growth restriction and birthweight discordance on 
outcomes in monochorionic twin pregnancies. Selective intrauterine fetal growth 
restriction (sFGR) occurs more commonly than twin-to-twin transfusion syndrome and 
is reported in up to 25% of monochorionic twin pregnancies68-70. 
 
The definition of selective fetal growth restriction in monochorionic twins varies 
widely63,67,71-73. In the UK, the RCOG has adopted a definition of an estimated fetal 
weight (EFW) difference of greater than 20% between fetuses, with or without the 
EFW of the smaller twin being less than the 10th centile72. The difference in estimated 
fetal weight is calculated as: the difference between EFW divided by the EFW of the 
heavier twin ([heavier EFW – lighter EFW]/heavier EFW × 100%). Fetal growth 
restriction in singletons is associated with increased perinatal morbidity and mortality, 
as well as complications such as cardiovascular disease and diabetes in future adult 
life74,75. Selective FGR has been reported to affect up to 25% of monochorionic twins 
but only 8% of dichorionic twin pregnancies68,76. The management of discordant 
growth in monochorionic twins is more complex than in dichorionic twin pregnancies 
due to the associated placental anastomoses linking the fetal circulations,72 and 
therefore the increased risk of harm to the larger “healthy” twin. 
 
Unequal placental sharing is the primary cause of sFGR, 77 although other factors such 
as the number and direction of anastomoses and the position of cord insertions may 
also play a part in the disease process. It has been suggested that unequal placental 
sharing causes selective fetal growth restriction but the clinical course is determined 
by the placental anastomoses78. Velamentous cord insertion is reported in 13-45% of 
twin pregnancies, and is associated with fetal growth restriction77,79. Studies have also 
shown that when one twin has a normal cord insertion and the co-twin has a 
velamentous cord insertion, the risk of growth restriction is 33-46%79,80. Lopriore et al 
found rates of velamentous cord insertion in monochorionic twins with and without 
sFGR of 30% and 16% respectively. Their work showed that in monochorionic twins 
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with sFGR, velamentous cord insertion was present in 57% of smaller twins and only 
2% of larger twins76. However, other work has suggested that it is the unequal 
placental sharing rather than the site of cord insertion that causes the discordance in 
fetal size, and that a peripheral cord insertion is a risk factor for unequal placental 
sharing77.  
 
The placenta in monochorionic twins with sFGR is characterised by larger diameter 
arterioarterial anastomoses76,81. Work from Denbow et al has shown that, in general, 
anastomoses are beneficial in monochorionic twins with unequal placental sharing. 
These anastomoses are thought to allow ‘rescue transfusion’ to allow oxygenated 
blood to be recruited from part of the larger twin’s placenta to help counteract the 
effects of unequal placental sharing and reduce the level of growth discordance24. The 
characteristics of umbilical artery Doppler waveforms in the smaller twin can vary 
considerably depending on the placental angioarchitecture. Monochorionic twins 
with sFGR can be classified into three categories based on their umbilical artery 
Doppler measurements: Type i) those with persistently positive end diastolic flow, 
Type ii) those with persistently absent/reversed end diastolic flow (AREDF) and Type 
iii) those with intermittent or periodic absent/reversed end diastolic flow (AREDF)75. 
The latter category is strongly associated with the presence of an arterioarterial 
anastomosis, which allows transmission of waveforms from the larger twin down the 
smaller twin’s umbilical cord, leading to periodic changes in the Doppler waveform.  
 
1.5.2 Growth discordance in dichorionic twins  
Growth discordance in dichorionic twins is harder to define, as the majority will be 
dizygotic and therefore birthweight discordance may reflect different genetic 
potentials. In addition, up to 10% birthweight discordance can be considered 
normal63,82,83. Studies looking at outcomes of growth discordant dichorionic twins 
have varied. The majority conclude that there is an increase in adverse outcome seen 
in growth discordant twinsets, especially when the smaller twin is small for gestational 
age,64,67,84-86 whereas others conclude that appropriately grown discordant 
dichorionic twins have no increased risk of poor outcomes66,87. All studies agreed that 
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discordant growth is more significant in monochorionic twin pregnancies. The main 
quandary in dichorionic pregnancies affected by discordant growth is the optimum 
gestation for delivery, as iatrogenic preterm delivery exposes the “healthy” 
appropriately grown twin to significant risks of prematurity, whereas expectant 
management is associated with a risk of intrauterine death for the smaller twin. 
 
1.6 Perinatal outcomes in twin pregnancies 
1.6.1 Effects of prematurity 
Around 60% of twins are born preterm88, and this is thought to be secondary to 
uterine overdistension due to a multiple pregnancy89. Monochorionic twins have a 
higher rate of iatrogenic early preterm delivery when compared with dichorionic 
twins. A recent review article compared outcomes in monochorionic and dichorionic 
twin pregnancies. They reported that the rate of preterm birth <37 weeks was 48.6% 
for dichorionic twins and 88.5% for monochorionic diamniotic twins, and preterm 
birth <32 weeks was 7.4% and 14.2%90.  The risk of neonatal morbidity and mortality 
decreases with increasing gestational age at birth91. Preterm birth is associated with a 
wide array of both immediate and long term complications affecting the brain, lungs, 
immune system, kidneys, skin, eyes, and gastrointestinal system.  
1.6.2 Perinatal outcomes in relation to chorionicity  
Studies have consistently shown higher rates of neurological morbidity and cerebral 
palsy in twin pregnancies compared with singleton pregnancies65,92,93. The background 
prevalence of cerebral palsy in term born singletons is 0.2%94, and  the rate of 
neurodevelopmental impairment is 1.2%95. This is largely due to a lower gestational 
age at delivery and lower birthweight in twins when compared to singleton births. 
Cerebral injury can be due to haemodynamic instability antenatally, or due to 
postnatal injury secondary to prematurity or low birth weight. However several 
studies have shown that when matched for birthweight, the rates of cerebral palsy 
are higher in twins and seem to be specifically associated with monochorionicity4. A 
literature review found significantly higher rates of cerebral palsy in monochorionic 
twins compared to dichorionic twins96. In addition, monochorionic twins have higher 
rates of fetal loss <24 weeks when compared to dichorionic twins (7.7% in MCDA 
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compared to 2.3% in DCDA) and higher rates of perinatal mortality >24 weeks (1.0% 
and 2.5%)96. 
 
The association between TTTS, TAPS and single intrauterine fetal death and an 
increased incidence of neurological morbidity is well documented, 97-99 and there is 
increasing evidence that discordant fetal growth in monochorionic twins is associated 
with significantly increased morbidity64. However even in the absence of any of these 
criteria, monochorionic twins have been shown to have higher rates of neurological 
morbidity than dichorionic twins65.  Ortibus et al investigated the long-term outcome 
in monochorionic twins in a large prospective multicentre study, and found 
neurodevelopmental impairment in 7% of apparently uncomplicated monochorionic 
twins. Therefore the authors suggested that all monochorionic twins may benefit from 
postnatal brain imaging and neurodevelopmental follow up given this significant 
increase in neurodevelopmental morbidity in the absence of monochorionic specific 
complications100. Interestingly, the rates reported by Ortibus et al are similar to the 
prevalence of neurological morbidity reported in a systematic review and meta-
analysis of monochorionic twins treated for twin-to-twin transfusion syndrome101. 
This suggests that a significant proportion of neurodevelopmental impairment seen in 
monochorionic twins is due to the effect of monochorionicity itself.  
 
1.6.2.1 Outcomes in TTTS with fetoscopic laser photocoagulation  
Fetoscopic laser photocoagulation (FLP) has been shown to be treatment of choice for 
TTTS prior to 26 weeks. A randomised controlled trial demonstrated higher survival 
rates and lower rates of neurological complications in FLP compared to serial 
amnioreduction59. In approximately 85% of cases of twin-to-twin transfusion 
syndrome treated with FLP at least one twin will survive, in approximately 40% cases 
both twins will survive and in 45% cases one twin will survive. Neurological 
impairment is present in approximately 10% of survivors102,103. Surviving twins have 
high rates of neonatal morbidity, largely due to prematurity and low birth weight. 
However, survivors also have cardiovascular and neurological complications, as well 




1.6.2.2 Neurodevelopmental outcomes in TTTS 
Fetoscopic laser photocoagulation treatment for TTTS has been shown to significantly 
reduce the risk of severe cerebral injury in surviving infants, when compared to serial 
amnioreduction. A systematic review found that liveborn children in whom TTTS had 
been treated with amnioreduction had a seven fold increased risk of cerebral injury 
compared to those who had received laser treatment104. The reported incidence of 
cerebral injury in surviving children following laser treatment ranges from 8-
18%59,104,105. A recent systematic review and meta-analysis reported the prevalence of 
neurologic morbidity in survivors of laser treatment to be 6% at birth, increasing to 
11% neurodevelopmental impairment at follow-up101. Cerebral injury in survivors is 
largely secondary to prematurity, but can also be a result of preterm ruptured 
membranes causing chorioamnionitis or reduced brain perfusion secondary to 
haemodynamic imbalance prior to laser treatment106.  Brain lesions seen in survivors 
of twin-to-twin transfusion syndrome include severe ventriculomegaly, 
intraventricular haemorrhage, leucomalacia, microgyria and schizencephaly106. The 
neurological impairment seen in survivors includes cerebral palsy (hemiplegia, 
quadriplegia or diplegia), severe mental or psychomotor developmental delay, 
sensory deficits and deafness101. No difference in neurological outcome has been 
demonstrated between surviving donor and recipient twins105,107. 
 
1.6.2.3 Hypoxic – Ischaemic sequelae 
There have been case reports of ischaemic lesions in the limbs, gastrointestinal tract 
and liver in monochorionic twins affected by TTTS108-111. All lesions reported were 
identified in the recipient twin; two reports followed intrauterine death of the donor 
and two occurred when both twins survived. The proposed mechanisms for these 
lesions include polycythaemia in the recipient leading to hyperviscosity and thrombus 





1.6.2.4 Outcomes in TAPS 
Outcomes following TAPS can vary from isolated differences in haemoglobin to more 
severe neurodevelopmental impairment or death.  One study assessed long term 
neurological outcome in TAPS pregnancies and reported the incidence of 
neurodevelopmental impairment was 9%, with mild to moderate cognitive delay 
present in 17% of surviving children98. Another recent study looked at long term 
outcomes in pregnancies complicated by spontaneous TAPS, and reported an overall 
incidence of neurodevelopmental impairment of 30%, with a significantly higher 
incidence in donor compared to recipient twins (44% and 18% for donors and 
recipients respectively). Interestingly, they also found a high rate of deafness in TAPS 
donors (15%) with no cases observed in recipients113.  
1.6.3 Neurodevelopmental morbidity in twins with discordant growth 
Prematurity and monochorionic specific complications have been clearly implicated in 
the increased neurological morbidity seen in twins. However, discordant fetal growth 
is increasingly being recognised as a risk factor for adverse outcomes in both 
monochorionic and dichorionic twins. Discordant growth in monochorionic twin 
pregnancies is associated with increased morbidity and neurodevelopmental 
impairment compared to in dichorionic pregnancies14,62-64,66-69,84-86,114-117. A recent 
systematic review and meta-analysis examined the literature to quantify the 
association between birthweight discordance and neonatal morbidity in twin 
pregnancies. Different thresholds for birthweight discordance were assessed in all 
twins and then stratified according to chorionicity. The review concluded that in 
monochorionic twins, the risk of neurological morbidity was increased if the 
birthweight discordance reached a threshold of 20%67. One study identified 
discordant fetal growth as a bigger risk factor than twin-to-twin transfusion syndrome 
for adverse neurological outcome in monochorionic twins. The reported rates of 
cerebral palsy in surviving infants from monochorionic pregnancies affected by 
discordant growth were five times higher than those seen in survivors from 
pregnancies affected by TTTS64. Gratacos et al investigated the prevalence of brain 
lesions depending on the type of selective fetal growth restriction (type I, II or III) in 
the monochorionic twin pair using neonatal ultrasound scans. They identified 
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parenchymal brain lesions in the larger twin in 19.7% of pregnancies complicated by 
type III sFGR, compared with 0% in type I and 3.3% in type II. In the smaller twin, the 
prevalence of lesions was 0%, 14.3% and 2.0% for type 1,2 and 3 sFGR respectively75.  
Some studies have shown that it is the larger twin in growth discordant pairs who has 
increased neurological morbidity,63,68,69,117 whereas others have shown that it is the 
smaller twin86,115,116. Schushan-Eisen at al evaluated risk factors for brain damage 
among (preterm) twins. They investigated twinsets who were discordant for neonatal 
cranial ultrasound abnormality and were unable to identify a specific risk factor for 
the development of brain pathology. However, interestingly within a subset of twins 
with discordant growth (birthweight discordance >20%), they identified that severe 
brain pathologies were more common in the larger co-twin117. Different pathologic 
mechanisms have been proposed to account for this, including an increased incidence 
of respiratory complications in the larger twin postnatally (32% respiratory distress 
syndrome (RDS) in larger twin vs 6% in smaller twin)117. In singleton pregnancies, fetal 
growth restriction is known to enhance lung maturation due to the increased 
production of endogenous steroids as a stress response, which may explain why RDS 
is increased in the larger twin of a discordant birthweight pair. Several studies have 
shown an increased incidence RDS in the larger twin,69,118 and RDS is known to be 
associated with an increased incidence of brain pathology119. However, the 
pathophysiology of increased neurological morbidity in discordant twin pairs remains 
unclear64.  
 
1.7 Current Surveillance for Twin Pregnancies 
1.7.1 Ultrasound assessment in monochorionic pregnancies 
Current guidance is that all monochorionic twin pregnancies have intensive 
surveillance, with fortnightly ultrasound scans from 16 weeks. This is to allow early 
detection of pathology such as TTTS or selective fetal growth restriction. Ultrasound 
between 16 and 26 weeks primarily aims to detect TTTS, whereas after 26 weeks the 




1.7.2 Ultrasound assessment in monochorionic twins with discordant growth  
In singleton and dichorionic pregnancies complicated by growth restriction, Doppler 
assessment (umbilical artery +/- ductus venosus) is used to monitor fetal wellbeing 
and time delivery. In these pregnancies, there is clear guidance regarding frequency 
of surveillance and intervention when deterioration in the Doppler parameters is 
identified120,121. However, interpretation of umbilical artery Doppler measurements in 
monochorionic twin pregnancies is more complex as they represent both placental 
insufficiency and the effect of interfetal transfusion, as discussed in Section 1.5.2. 
Monochorionic pregnancies with similar levels of EFW discordance can have vastly 
different outcomes depending on the placental angioarchitecture,75 hence the need 
for antenatal classification of the pattern of selective fetal growth restriction.  
  
1.7.2.1  Type I Selective Fetal Growth Restriction 
The placental anastomoses in Type I sFGR work in a compensatory fashion to reduce 
the effect of unequal placental sharing, and usually the discordancy in fetal weight is 
significantly lower than the discordancy in placental share122. The outcomes in Type I 
sFGR are generally good, with intrauterine mortality rates reported at 2-4%75,122. 
Delivery is recommended by 34-36 weeks72. 
 
1.7.2.2 Type II Selective Fetal Growth Restriction 
Type II sFGR is characterised by persistently AREDF in the umbilical artery of the 
smaller twin. The placental angioarchitecture in type II is similar to that of type I and 
of uncomplicated monochorionic twins, but with a much greater discordance in 
placental sharing. As in type I, the fetal weight discordance is much lower than the 
placental territory discordance75. However, the degree of placental insufficiency in the 
smaller twin is so severe that it cannot be fully compensated by ‘rescue transfusion’ 
via anastomotic vessels122. In the majority (90%) of type II cases there is deterioration 
in the clinical condition of the smaller twin, necessitating active management to 
prevent intrauterine fetal death75. Gratacos et al reported a mean gestational age of 
30 weeks at delivery, with a rate of 14.4% for brain damage in the smaller twin75. Other 
studies reported an intrauterine fetal death rate of 30-40% in the growth restricted 
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twin, when managed expectantly123,124. Treatment options for type II sFGR depend on 
the gestational age at diagnosis, and the clinical condition of the growth restricted 
fetus. If there are signs of imminent fetal demise, then active management should be 
considered to protect the larger co-twin. There are three options for active 
management: i) elective delivery ii) cord occlusion – with an expected survival rate of 
80-90% in the larger co-twin iii) fetoscopic laser coagulation to dichorionise the 
placenta – with reported survival rates of 40% in the growth restricted twin and 69% 
in the larger co-twin125. Delivery is recommended by 32 weeks at the latest72. 
 
1.7.2.3 Type III Selective Fetal Growth Restriction 
Type III sFGR is characterised by periodic AREDF in the umbilical artery. Periodic AREDF 
is significantly more common in monochorionic twins with sFGR (45%) than 
uncomplicated monochorionic twins (5%) or those with twin-to-twin transfusion 
syndrome (2%)126. This pattern represents the presence of a large arterioarterial 
anastomosis allowing transmission of waveforms from one twin to the other75. Twins 
with type III sFGR are the most unpredictable subtypes and have a higher rate of 
unexpected intrauterine death or antenatal brain injury127. The reported incidence of 
unexpected intrauterine fetal death in type III sFGR is 15.4%75,123. This is thought to be 
secondary to the high risk of acute transfusion across the arterioarterial anastomosis 
causing profound hypotension and exsanguination122. Interestingly, twins with 
intermittently AREDF have been shown to have much larger diameter arterioarterial 
anastomoses than those without, with mean diameters of 4.3mm and 2.1mm 
respectively122. These large diameter vessels allow a rapid passage of blood from one 
twin to the other. The reported incidence of neurological impairment in survivors 
ranges from 19.7-38.5% in the larger twin and 2-23.1% in the smaller twin75,123. 
Gratacos et al reported the incidence of neurological damage as 37% in the larger 
twin, even when the smaller co-twin survives128. The mechanism is thought to be 
increased flow across an arterioarterial anastomosis to the smaller twin causing 
cardiac overload and at the same time, reduced flow to the bigger twin causing 




1.7.3 Ultrasound assessment in twin to twin transfusion syndrome 
The majority of monochorionic twins will not develop TTTS, therefore research has 
been focussed on identifying predictive factors to identify those pregnancies at 
increased risk and therefore allow tailored surveillance schedules.  
 
1.7.3.1 Prediction of twin-to-twin transfusion syndrome 
Ultrasonographic features that are associated with TTTS may be present at the 10-14 
week dating scan130. Some studies have shown that discordancy in crown rump length, 
discordancy in nuchal translucency measurements or nuchal translucency >95th 
centile are predictive of TTTS25,130,131. Increased nuchal translucency can be associated 
with chromosomal abnormalities, genetic syndromes or cardiac defects and has also 
been linked to the development of TTTS. One study demonstrated that a discordance 
of >20% in the nuchal translucency measurements was associated with a 30% risk of 
either developing severe TTTS needing laser treatment, or of early fetal death130. 
However, a recent systematic review showed that using discordancy in crown rump 
length or nuchal translucency as parameters to predict TTTS had a low sensitivity132. 
The review found that the strongest predictive factor for the development of TTTS 
was reversed flow in the ductus venosus at the first trimester scan132. Second 
trimester sonographic features suggested as predictors for development of TTTS 
include membrane folding and the absence of arterioarterial anastomoses. The 
presence of membrane folding in an early second trimester scan has been suggested 
as a predictive marker for TTTS 133 with a likelihood ratio of 4.2 for subsequent 
development the disease25. Identification of an arterioarterial anastomoses confers a 
nine fold reduction in the risk of developing TTTS29,30,134. However, currently there is 
no identifiable ultrasound parameter that is strongly predictive enough of the 
development of TTTS to warrant a change in the current ultrasound surveillance 
schedule for these pregnancies132. 
 
1.7.3.2 Ultrasound features of twin-to-twin transfusion syndrome 
The diagnosis of TTTS is based on strict sonographic criteria. Monochorionic twins with 
TTTS should be distinguished from those with selective fetal growth restriction or an 
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anomaly in one twin causing reduced amniotic fluid production. Often a growth 
restricted fetus can have similar ultrasound findings to the donor fetus in TTTS, but 
the co-twin of a growth restricted twin does not have polyhydramnios, as is seen in 
TTTS135. The characteristic oligohydramnios-polyhydramnios sequence is 
pathognomic of TTTS. The following criteria are needed to make a diagnosis of TTTS: 
a diagnosis of a monochorionic twin pregnancy (ideally diagnosed in the first 
trimester), and polyhydramnios in the recipient (with a deepest vertical pool (DVP) of 
>8cm (or >10cm >20 weeks’ gestation)) combined with oligohydramnios in the donor 
(with a DVP of <2cm)40,51,136. A subjective discordancy in amniotic fluid volume that 
does not meet the threshold for diagnosis of TTTS, has been shown to progress to 
severe TTTS in <15% of cases136. Growth discordance and intrauterine growth 
restriction (EFW < 10th centile) are often seen in association with TTTS, but these are 
not diagnostic criteria136. TTTS may develop at any time during the pregnancy, but the 
majority of cases present in the second trimester136.  
 
In TTTS, absent or reversed end diastolic flow in the umbilical artery is seen in 19-47% 
of donor fetuses137,138. Donor fetuses have upregulation of the renin-angiotensin 
system, which causes vasoconstriction thereby decreasing renal and placental blood 
flow32. This reduction in blood flow results in oliguria and abnormal umbilical artery 
Doppler measurements. The abnormal Doppler measurements in donor twins reflect 
their hypovolaemic state leading to decreased venous return, with an increase in 
afterload secondary to increased placental resistance.  In contrast, the Doppler 
abnormalities characteristically seen in recipient fetuses are those of cardiac overload. 
Reports suggest that only 1-6% of recipient twins complicated by TTTS have absent or 
reversed end diastolic flow in the umbilical artery, 137-139 and it has been suggested 
that this is due to cord compression secondary to polyhydramnios140. However, 27-
37% of recipient twins have absent or reversed flow in the A wave of the ductus 
venosus and 31% have pulsatile flow in the umbilical vein137-139. The decreased 
diastolic flow seen in venous Dopplers is due to increased end-diastolic ventricular 
pressure due to hypervolaemia and increased preload141. Absent or reversed end 
diastolic flow in umbilical artery in the donor and reversed flow in the ductus venosus 
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of the recipient have been shown to correlate with survival rates following laser 
treatment for TTTS and can therefore be used as predictive factors for outcome137. 
 
1.7.3.3 Differentiation between early Twin-to-Twin Transfusion Syndrome and 
Selective Fetal Growth Restriction 
Selective fetal growth restriction (sFGR) and twin-to-twin transfusion syndrome can 
present with a very similar clinical picture in the early stages. Discordance in amniotic 
fluid volume is associated with an increased risk of subsequent development of either 
twin-to-twin transfusion syndrome or selective FGR142. However, it is often impossible 
to differentiate which pathology is responsible for the discordance in amniotic fluid 
volume, and distinguishing between these two pathologies is essential to enable 
accurate counselling and management of the pregnancy. Currently the only way to 
differentiate the two is by repeated ultrasound assessment to assess for progression, 
but the diagnostic uncertainty can lead to additional anxiety for the patient as well as 
the need for repeated scans. 
 
The extensive evidence of cardiac dysfunction even in early pre-stage twin-to-twin 
transfusion syndrome58,143,144 (as discussed in Section 1.7.4) has led to the suggestion 
of incorporating functional cardiac assessment into routine monochorionic twin 
surveillance to improve risk stratification and differentiation between pathologies. 
Left ventricular strain has been postulated as an early marker for cardiac dysfunction 
in twin-to-twin transfusion syndrome, with evidence of reduced strain earlier in the 
disease process145. Therefore, addition of left ventricular strain to routine 
monochorionic twin surveillance may help to differentiate between twin-to-twin 
transfusion syndrome and selective fetal growth restriction in very early stage disease. 
However, this technique remains a research tool at present, rather than being an 
accepted tool for clinical assessment and therefore further research is needed to 
validate it for clinical use.  
 
In addition, a recent study looked at the association between cardiac dysfunction and 
brain injury in monochorionic twins with twin-to-twin transfusion syndrome. They 
found that cardiac dysfunction immediately after birth is independently associated 
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with brain injury, regardless of whether donor or recipient. Quintero stage and 
gestational age at diagnosis were not associated with brain injury107. This further 
supports the need for functional cardiac assessment in monochorionic twins to aid 
counselling and risk stratification both for differentiation between pathologies and for 
prediction of outcome. 
 
1.7.4 Fetal cardiac assessment in twin-to-twin transfusion syndrome 
A wide range of cardiac findings can be seen in cases of TTTS. Cardiac dysfunction is a 
significant cause of death and morbidity secondary to TTTS146. Donor fetuses do not 
usually exhibit significant abnormalities in cardiac function, apart from umbilical 
Doppler anomalies; whereas up to 70% of recipient fetuses show significant 
abnormalities in systolic and diastolic ventricular function58,147,148. 
 
1.7.4.1 Echocardiography in in twin-to-twin transfusion syndrome 
Cardiac abnormalities in recipient twins include: cardiomegaly, ventricular 
hypertrophy, right ventricular outflow tract obstruction, and atrioventricular valve 
regurgitation. Approximately half of recipient fetuses will have cardiomegaly,149 which 
is secondary to hypertrophy of the myocardium, rather than ventricular dilatation147. 
Diastolic dysfunction is more common and usually precedes systolic dysfunction in 
recipient fetuses148. Monophasic ventricular filling, demonstrated by fusion of the E 
and A waves across the atrioventricular valves is seen in 20-30% of recipients148. This 
monophasic filling pattern is often combined with a shortened ventricular filling time 
secondary to increased ventricular pressure. In addition a prolonged isovolumetric 
relaxation time is seen, which increases the myocardial performance index (MPI)148. 
Abnormal fractional shortening secondary to poor systolic function is seen in 
approximately 30% of recipients147. Tricuspid regurgitation is present in 30-50% of 
recipients147. Various scoring systems have been developed to grade the 
cardiovascular involvement and degree of dysfunction146. Rychik et al describe a 
cardiovascular score that reflects the underlying physiological processes in TTTS. The 
score parameters include: Umbilical artery Dopplers, ventricular hypertrophy, cardiac 
dilatation, ventricular dysfunction, tricuspid valve regurgitation, mitral valve 
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regurgitation, tricuspid valve inflow, mitral valve inflow, ductus venosus Dopplers, 
umbilical vein pulsations, right-sided outflow tract and pulmonary regurgitation146. 
 
Whilst the Quintero staging system provides a basic framework to help aid treatment 
decisions, it does not assess the cardiovascular dysfunction seen in TTTS. Interestingly, 
significant cardiac dysfunction is seen in up to 55% of recipients in stage 1 TTTS58. One 
study has shown that recipient twin cardiovascular function correlates with postnatal 
survival 52 and the authors have recommended the addition of echocardiographic 
assessment of the recipient twin to the Quintero staging system to improve decision 
making regarding treatment52. 
 
The most comprehensive cardiovascular staging system has been developed by 
Children’s Hospital Of Philadelphia (CHOP), and constitutes detailed 
echocardiographic assessment of twelve parameters146. However, the examination 
time for each fetus is significant and therefore this has rendered the staging system 
impractical for routine clinical assessment. Therefore efforts have focussed on 
identifying a more clinically practical way to assess cardiac function in monochorionic 
twins147. Until recently, the cardiovascular scores proposed in TTTS reflected the 
theory that abnormal right heart function as a result of increased preload is the 
earliest sign of TTTS in the recipient twin150. However, more recent studies have 
shown that there is increased afterload due to reduced aortic distensibility, causing 
reduced left ventricular function in the recipient twin before abnormalities in right 
heart function become apparent151,152. Table 1.3 summarises the cardiac parameters 
that have been examined in TTTS and the key findings from these studies. 
Table 1.3 Cardiovascular parameters studied in TTTS 
Authors Parameters  Participants Findings 
Wohlmuth 2019145 Global 
longitudinal 
strain (LV & RV) 
n = 150 MCDA 
twins 
No differences in within twin 
pair strain discordance 
between pre-TTTS and 
uncomplicated MCDA twins 
Henry 2018153 MPI  n = 100 
“complicated 
MCDA” 52 
MPI in TTTS pairs had no 
correlation with Quintero 





In pregnancies with 
growth/liquor discordance not 
meeting threshold for 
TTTS/sFGR, some evidence 
that MPI values may predict 
which pregnancies would 
become TTTS versus sFGR 
Wohlmuth 2018154 MAPSE, TAPSE, 
MPI, TDI 
n = 145 (26 
uncomplicated 
MCDA, 61 stage 
1/2 TTTS, 58 
stage 3/4 TTTS) 
Left ventricular function is 
decreased in the recipient 
before abnormalities in the 
right heart become apparent. 
Wohlmuth 2016152 AFAC (aortic 
fractional area 
change) 
n = 51 
pregnancies (14 
uncomplicated 
MCDA, 37 TTTS) 
Higher AFAC in recipients than 
in donors of TTTS pairs, no 
intertwin differences in 
uncomplicated MCDA 




RV‐MPI, LV‐MPI and LV‐MPI ′ 
are predictive in identifying 
recipient to be in TTTS 
Taylor-Clarke 2013151 Global 
longitudinal 
strain (LV & RV) 




Reduced LV strain in recipients 
even in early stage TTTS 




n = 100 stage 1 
and 2 TTTS 
cases 
Poor correlation between 
Cincinnati stage and CVPS / 
CHOP score in early‐stage TTTS 




n = 123 stage 1 
and 2 TTTS 
cases 
Recipient cardiomyopathy 
present in 65% cases of stage 1 
and 2 TTTS at presentation 
Stirnemann 201058 CTR, FS, MPI, CI, 
E/A ratio 




Significant cardiac dysfunction 
in 55% cases of stage 1 
recipients 
Van Mieghem 2010158 Strain and strain 
rate (LV & RV) 




Only feasible in 61% of 
recipients TTTS. Decreased RV 
strain in TTTS recipients 
compared with controls 




Inverse relationship between 
MPI and FS. Normal LV 
function in stage 1 TTTS, but 
reduced in stage 2-4 
Van Mieghem 2009159 MPI, DV, UV, E / 
A inflow pattern 




Resolution of recipient cardiac 
dysfunction within 1 month 
after laser. Transient 
impairment of cardiac function 
in donor fetuses post laser. 
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Habli 2008160 Ventricular 
hypertrophy, 
TR, MR, FS, MPI  
n = 144 TTTS 
recipient twins 
Improvement in MPI after FLP 
is associated with 
improvement in recipient 
survival. 
Shah 200852 CVPS n = 62 
pregnancies 
A normal CVPS in the recipient 
is predictive of improved 
survival compared with an 
abnormal CVPS 
Michelfelder 2007161 DV, UV, 
ventricular 
hypertrophy, 
CTR, AVVR, FS, 
MPI 
n = 42 cases 
TTTS 
Increased ventricular 
hypertrophy, AVVR and 
elevations in both RV‐ and LV‐
MPI in recipients 
Rychik 2007146 CHOP score n = 105 TTTS 
pregnancies 
Increased risk of IUD if CHOP 
score > 3 and MPI z-score > 
1.645 
Raboisson 2004143 MPI, CTR, FS n = 34 
pregnancies (23 
TTTS, 11 sFGR) 
Increased MPI in recipient twin 
MPI = myocardial performance index, FS = fractional shortening, CTR = cardiothoracic ratio, CCO = 
combined cardiac output, LV strain = left ventricular strain, CI = cardiac index, DV = ductus venosus, 
UV = umbilical vein, TR = tricuspid regurgitation, MR = mitral regurgitation, AVVR = atrioventricular 
valve regurgitation, CHOP score = composite score (0-20, comprising: ventricular hypertrophy, CTR, FS, 
tricuspid or mitral regurgitation, fused E and A inflows, abnormal DV, pulsatile UV, right ventricular 
outflow tract size and pulmonary regurgitation), CVPS (cardiovascular profile score) = composite 
score (10 point scale comprising: presence or absence of hydrops, DV and UV findings, cardiomegaly, 
AVVR, and cardiac dysfunction (FS +/- MR or TR)).  
 
1.7.4.2 Left ventricular strain in twin-to-twin transfusion syndrome 
Twin-to-twin transfusion syndrome is associated with cardiac dysfunction especially 
in the recipient twin, and there is emerging evidence that altered left ventricular strain 
may be an earlier indicator of twin-to-twin transfusion syndrome, before the 
traditional diagnostic criteria have been met145,151. Using speckle tracking to enable 
calculation of ventricular strain has been investigated in recent years as a potential 
method for the early prediction of twin-to-twin transfusion syndrome145.  
 
Speckle tracking uses greyscale imaging and the speckles within the myocardial wall 
are recognised and traced through each frame of a cineloop sequence. The speckles 
are referenced back to their positions in the original frame. This allows tracking of the 
myocardium and calculation of deformation (strain)151,158. One of the main advantages 
of speckle tracking over traditional methods of fetal cardiac assessment is the fact that 
it is relatively angle independent. In addition, it is straightforward to obtain a cine loop 
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sequence of a four chamber view, which means that it would be a straightforward 
addition to routine clinical assesment158. However, although speckle tracking has been 
repeatedly shown to be feasible in healthy singleton fetuses,162-166 there have been 
varying rates of success and reproducibility in performing speckle tracking in fetuses 
with twin-to-twin transfusion syndrome151,158. One study investigated whether the 
addition of speckle tracking into routine clinical assessment could aid with risk 
stratification in early twin-to-twin transfusion syndrome which has not met the 
diagnostic threshold based on traditional staging criteria51. Their work demonstrated 
a reduction in left ventricular strain in the recipient twin in TTTS pairs, and increased 
intertwin strain discordance in TTTS pairs compared to uncomplicated monochorionic 
twins151. Further work looked at whether interpair left ventricular strain discordance 
predicted the development of twin-to-twin transfusion syndrome. They found no 
significant intertwin strain discordance in uncomplicated monochorionic twins or 
those with selective fetal growth restriction, but some evidence of increased intertwin 
strain discordance in those with early twin-to-twin transfusion syndrome145. The 
findings from these studies support the possibility of strain being a useful adjunct in 
differentiating early twin-to-twin transfusion syndrome from selective fetal growth 
restriction in monochorionic twins.  
 
1.8 Neonatal predictors of neurological outcome 
Small head size in fetal life and infancy is a strong predictor for poorer 
neurodevelopmental outcome167,168. Fetal growth restriction is associated with a 
reduction in brain volume, with one study demonstrating a 10% reduction in neonatal 
brain volume in infants who were growth restricted compared to appropriately grown 
controls. The reduction in brain volume in growth restricted infants was also shown 
to correlate with a reduction in neurodevelopmental performance169. 
 
1.8.1 Brain size 
A number of studies in singletons have shown evidence of an association between 
head circumference at birth and neurodevelopmental outcome170,171. In addition, 
several studies have shown that preterm infants have altered brain volumes at term 
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corrected gestational age, compared to control infants172,173. Brain volume at term 
corrected gestational age has been shown to correlate with neurodevelopmental 
outcomes including motor skills and cognition172-174. In addition, a decrease in growth 
velocity of head circumference has been shown to be associated with an increased in 
long term cognitive deficits175. Studies have shown that larger brain volumes are 
associated with better neurodevelopmental outcomes172,174,176. Total brain tissue 
volume has been shown to account for up to 20-40% of the variations in cognitive 
performance between ex-preterm children and their term peers177. 
 
Fetal growth restriction causes redistribution of fetal cardiac output to protect brain 
growth relative to other organs, resulting in brain sparing. Neonates with asymmetric 
intrauterine growth restriction have been shown to have better neurodevelopmental 
outcomes compared to those with symmetric growth restriction, possibly due to the 
effect of brain sparing175. However despite this protective mechanism, brain sparing 
does not guarantee normal brain development168. A number of studies have shown a 
reduction in brain volume in intrauterine growth restricted infants compared to age 
matched appropriately grown infants, and infants who were growth restricted in utero 
have evidence of neurodevelopmental impairment169,178. Magnetic Resonance 
Imaging (MRI) studies have shown that intrauterine growth restriction is associated 
with a reduction in total brain volume,169 and interestingly this decreased brain 
volume is first evident in utero179. 
 
1.8.2 Magnetic Resonance Imaging   
1.8.2.1 Magnetic Resonance Imaging of the neonatal brain 
Magnetic resonance imaging (MRI) is an increasingly important neonatal imaging tool 
and has led to improved diagnosis of brain lesions and therefore improved counselling 
regarding likely prognosis. Neonatal MRI is established for use clinically to assess both 
acquired and congenital brain abnormalities. However, the technique remains 
challenging for various reasons such as movement, small brain size and differences in 
brain composition compared to adult brains. Therefore, there has been considerable 
research into MRI sequence optimisation to allow faster imaging and improve the 
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quality of images acquired. Various different MRI modalities are now possible, 
including volumetric MRI to allow quantification of both whole brain and regional 
tissue volumes180. This has prompted research into the possible association between 
brain volume and poor neurodevelopmental outcomes173. Advanced MRI techniques 
(for example volumetric MRI) are better able to assess more subtle differences in brain 
structure compared to conventional MRI, and allow better prediction of 
neurodevelopmental outcome. Studies using neonatal MRI have consistently 
demonstrated that smaller brain volumes are associated with poorer 
neurodevelopmental outcomes in singletons irrespective of the presence of overt 
brain injury181,182. 
 
To date, there have been no studies looking at volumetric brain MRI in twins and the 
association with neurodevelopmental outcome. However, given the significant 
associations between intrauterine growth restriction, brain volume and 
neurodevelopmental outcomes in singletons, it would seem logical that a similar 
reduction in brain volume may be present in twins with selective fetal growth 
restriction. If so, this may help explain the pathophysiology behind the increased 
neurodevelopmental impairment seen in these infants. 
 
In monochorionic twins, severe brain pathology is increased in the larger 
twin63,68,69,117. Some of this is can be attributed to increased postnatal pathology, such 
as respiratory distress syndrome. However research has shown that over half of brain 
injuries seen in twin-to-twin transfusion syndrome are antenatally acquired183 and 
therefore the increased postnatal morbidity in recipient twins does not account for 
these. Therefore, it would be beneficial to image the brain antenatally to see whether, 
if there are differences in brain volume, these are present antenatally or whether they 
are acquired postnatally. 
 
1.8.2.2 MRI imaging of the fetal brain 
The use of fetal MRI is increasing, and the introduction of ultrafast MRI sequences, 
which minimise fetal movement artefact and improve image quality has meant that 
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MRI is now an accepted tool for fetal brain imaging. Studies have shown that fetal 
brain MRI is feasible and clinically useful, and can identify abnormalities that are not 
easily detectable on ultrasound, such as neuronal migration disorders, callosal and 
posterior fossa abnormalities173-175. MRI scans are increasingly recognised as a useful 
adjunct to ultrasound imaging to detect brain injury in high risk pregnancies, for 
example in monochorionic twins treated for twin-to-twin transfusion syndrome or in 
cases of single intrauterine fetal death184. 
 
MRI has been used to quantify fetal brain volume in fetuses with congenital heart 
defects. One study found that fetuses with congenital heart disease had smaller brain 
tissue volumes and a reduction in third trimester brain growth compared to control 
fetuses, after correcting for gestational age and fetal weight185. MRI has also been 
used to quantify brain volume in fetal growth restriction, with evidence that growth 
restricted fetuses had significantly smaller total brain volume compared to controls. 
In addition, growth restricted fetuses with abnormal umbilical artery Doppler 
measurements had significantly smaller brain volumes compared to those with 
normal Dopplers. Middle cerebral artery Doppler abnormalities were not associated 
with differences in total brain volume186. There have been no studies to date 
investigating fetal brain volume in twin pregnancies and the impact of growth 
restriction on brain volume and brain growth. 
 
1.8.2.3 MRI imaging in twins 
There have only been three studies to date that have used MRI imaging to investigate 
neonatal brain volumes in twins. Knickmeyer et al compared singletons to 
monozygotic and dizygotic twins, but did not adjust for chorionicity within the 
monozygotic group. They compared total brain tissue volumes across the groups and 
found no intergroup differences in brain volume187. Mukherjee et al compared fetal 
and neonatal head size and brain volume discordance in monozygotic-monochorionic, 
monozygotic-dichorionic and gender concordant dizygotic twins. They identified no 
group differences in head circumference discordance either antenatally or at birth. In 
addition, they did not find an association between birthweight discordance and head 
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circumference discordance in any group. However, they demonstrated a significant 
increase in neonatal brain volume discordance (on MRI scan) in dizygotic twins 
compared to monozygotic-monochorionic or monozygotic-dichorionic twins188.  
 
Gilmore et al compared regional brain volumes on neonatal MRI scans between 
monozygotic and dizygotic twins (not stratified according to chorionicity). They found 
no significant differences in overall or regional brain volumes between monozygotic 
and dizygotic twins, nor any difference in brain volume discordance at birth between 
the two groups. Interestingly, they showed that brain volumes in monozygotic twin 
pairs become less discordant in the first few weeks of life, as they have a period of 
catch up “normalisation”189. This is in keeping with previous studies demonstrating 
similar discordance in head circumference at birth in monozygotic and dizygotic twins, 
but a reduction in intertwin discordance postnatally in monozygotic twins, with no 
corresponding reduction in dizyotic twins. This suggests that genetic potential 
becomes the most influential factor in determining brain growth postnatally in 
monochorionic twins, whereas antenatally factors such as unequal placental sharing 
have a greater influence188,189. Monochorionic twins are genetically identical, 
therefore should have less intertwin brain volume discordance than dichorionic twins, 
therefore these results may reflect the pathological effect of a shared placenta. 
Neurological morbidity is higher in monochorionic twins compared to dichorionic 
twins, even in the absence of twin-to-twin transfusion syndrome or single intrauterine 
death,64,65 with one study reporting 7% incidence of neurodevelopmental impairment 
in uncomplicated monochorionic twins. The mechanism behind this increase in 
neurodevelopmental morbidity in apparently uncomplicated monochorionic twins is 
not fully understood and therefore warrants further research. 
 
1.9 Study hypotheses and aims 
Risk stratification and outcome prediction in monochorionic twins are the two areas 
where there is the biggest uncertainty and where more research is clearly needed. 
Firstly, there is a clear need for more detailed assessment to enable earlier diagnosis 
and differentiation between pathologies such as twin-to-twin transfusion syndrome 
Chapter 1 
 32 
and selective fetal growth restriction. Left ventricular strain is emerging as a promising 
clinical assessment tool that may aid in earlier diagnosis and risk stratification. At 
present, the research on quantification of left ventricular strain in monochorionic 
twins is inconsistent, and therefore more studies are needed to establish whether this 
could be a useful adjunct in surveillance for these high risk pregnancies.  
 
Secondly, there is clear evidence of a poorer neurological outcome in monochorionic 
twins (especially those with twin-to-twin transfusion syndrome) as well as in twins 
with discordant birthweight (both monochorionic and dichorionic). There is emerging 
evidence that brain volume correlates with neurodevelopmental outcomes and that 
growth restricted singletons have smaller brain volumes. However, there are very few 
studies investigating brain volume in monochorionic twins and whether there is any 
association between birthweight discordance and brain volume.  
 
Therefore, the aims of this thesis were to: 
1. Compare neonatal total brain tissue volume and relative intertwin brain 
volume discordance between monochorionic and dichorionic twins, and 
between uncomplicated twins and those with pathology (twin-to-twin 
transfusion syndrome or selective fetal growth restriction).  
2. Compare third trimester brain growth (between 32 weeks gestational age and 
term corrected gestational age) in dichorionic twins, uncomplicated 
monochorionic twins, those with twin-to-twin transfusion syndrome and those 
with selective fetal growth restriction. 
3. Assess the association between (i) birthweight discordance and (ii) growth 
discordance (EFW discordance at 20 weeks compared to birthweight 
discordance) and total brain tissue volume, relative intertwin brain volume 
discordance and brain growth. 
4. Compare longitudinal left ventricular strain values throughout the second 
trimester (16-28 weeks) between dichorionic twins, uncomplicated 
monochorionic twins, those with twin-to-twin transfusion syndrome and those 
with selective fetal growth restriction. 
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5. Assess the relationship between left ventricular strain at 21 weeks’ gestation 




Chapter 2 Methods and study design 
 
2.1 Study Aims 
1. Compare neonatal total brain tissue volume and relative intertwin brain volume 
discordance between monochorionic and dichorionic twins, and between 
uncomplicated twins and those with pathology (twin-to-twin transfusion 
syndrome or selective fetal growth restriction).  
2. Compare brain growth between dichorionic twins, uncomplicated monochorionic 
twins, those with twin-to-twin transfusion syndrome and those with selective fetal 
growth restriction. 
3. Assess the association between growth discordance and both total brain tissue 
volume and relative intertwin brain volume discordance. 
4. Compare left ventricular strain between dichorionic twins, uncomplicated 
monochorionic twins, those with twin-to-twin transfusion syndrome and those 
with selective fetal growth restriction. 
5. Assess the relationship between left ventricular strain and neonatal brain volume. 
 
Table 2.1 Timetable of participation in BRIT Study 
Gestation BRIT Study component 
11-14 weeks Written study information given 
15-16 weeks Written consent obtained 
19-20 weeks Extended cardiac scan at each visit. 







30-32weeks Fetal MRI scan performed at CRIC Bristol 
Early neonatal period 
(37-42 weeks cGA) 





In order to achieve the thesis aims, women were recruited prior to 16 weeks’ 
gestation and followed at set points through their pregnancy (see Table 3.1 above) 
until after delivery, at term corrected gestational age. 
 
2.2 Study Design and Population 
2.2.1 Study Design 
The Bristol Twin Study (BRIT Study) was a prospective cohort study conducted over 
an 18 month period. Full ethical approval was granted on 7th October 2015. (See 
Appendix 2 for documentation regarding ethical approval and sponsorship).  
 
A sample size calculation was not performed as the techniques investigated in this 
thesis are exploratory and therefore there are no data to allow calculation of an 
expected effect size. Therefore, after discussion with the research team, a 
pragmatic decision was taken to recruit 50 monochorionic twins and 20 dichorionic 
twins as a control group. This was based on the number of monochorionic twins 
expected to attend the Fetal Medicine Unit over a two year period.  
 
Dichorionic twins were chosen as a control group as opposed to singletons, as a 
recent study showed no differences in brain volume between singletons and 
dizygotic twins187. In addition, using dichorionic twins as a control group allowed 
comparison of intertwin brain volume discordance.  
 
2.2.2 Study Setting 
Women were recruited from St Michael’s Hospital, University Hospitals Bristol NHS 
Foundation Trust and a secondary site, Southmead Hospital, North Bristol NHS 
Trust from October 2015 until April 2017. The primary site was St Michael’s 
Hospital, which is a tertiary referral centre for fetal medicine for South West 
England and South Wales. All pregnant women with monochorionic twins or 
higher order multiple pregnancies, in both Bath and South Bristol are seen in the 






2.2.3.1 Screening and eligibility 
During the recruitment period, I approached all women with monochorionic 
diamniotic (MCDA) twins who were seen in the Fetal Medicine Unit at St. Michael’s 
Hospital prior to 16 weeks’ gestation. The start date for the study was determined 
by full ethical approval being granted, which was 7th October 2015. The endpoint 
for recruitment was determined by the participant being able to undergo a fetal 
MRI scan (at 30-32 weeks’ gestation) prior to 1st August 2017, which meant that 
recruitment period ended on 1st April 2017. Therefore, the recruitment period for 
the study was 18 months. A control group of dichorionic twins were recruited from 
July 2016. Consecutive dichorionic twin pregnancies seen in St Michael’s Hospital, 
Bristol by the ultrasound department, the Early Pregnancy Clinic or the Fetal 
Medicine Unit, were invited to participate in the study.  
 
In addition, Southmead Hospital (North Bristol NHS Trust) was established as a 
secondary study site, and full ethical approval was granted on 1st April 2016. All 
monochorionic twins who were seen at Southmead Hospital were invited to 
participate in the study. 
 
All spontaneously conceived twins were dated using the crown rump length of the 
larger twin, measured at 11-14 weeks’ gestation as per established guidelines190. 
Pregnancies conceived through in vitro fertilization (IVF) or intracytoplasmic sperm 
injection (ICSI) were dated based on their IVF or ICSI dates. Chorionicity was 
confirmed based on ultrasound appearance (T sign of lambda sign) at the first 
trimester scan. 
 
The estimated fetal weight was calculated using Hadlock formula B (HC-AC-FL), and 
formula A (AC-FL) where there was no head circumference measurement 
available191. The estimated fetal weight was plotted onto an established twin 
specific chart192.  
 




twinsets, but zygosity testing was not performed and therefore they were not 
stratified by zygosity. This decision was made due to the fact that chorionicity is 
the biggest determinant of neonatal outcome, rather than zygosity14,15. In 
addition, when women are being counselled antenatally the zygosity of (gender 
concordant) DCDA twinsets is not usually known, therefore DCDA twins are 
considered as a single group. 
 
Twins were labelled as “twin 1” and “twin 2” antenatally based on their site in the 
uterus (left or right side). This was clearly documented in the handheld notes and 
the importance of consistent labelling during all follow up scans and after birth 
was emphasised to participants. All routine surveillance scans were performed by 
the same two operators (SN or MLD) and where possible I delivered the twins to 
ensure correct labelling postnatally. All twins were scanned immediately prior to 
delivery (in labour or prior to Caesarean section) to establish whether twin 1 or 
twin 2 would be born first, to avoid confusion due to the “perinatal switch 
phenomenon” 190.  
 
2.3 Inclusion criteria  
• Women who were willing and able to give informed consent. 
• Ability to communicate in written and spoken English. 
• Women with ultrasonically confirmed viable intrauterine monochorionic or 
dichorionic twin pregnancies  
 
2.4 Exclusion criteria 
2.4.1 Maternal exclusion criteria 
• Any contraindication to MRI scans: 
• Maternal health conditions that were incompatible with MRI (metal 
implants, pacemaker) 
• Maternal obesity not suitable for MRI scanner facilities 





If women were unable to undergo an MRI scan, they were still invited to 
participate in the cardiac imaging study but advised that they would be excluded 
from the MRI study. This was to enable recruitment of as many women as possible 
to assess the effect of chorionicity and monochorionic pathology on cardiac 
function.  
2.4.2 Fetal exclusion criteria 
• Chromosomal abnormalities 
• Presence of other fetal anomalies 
• Significant structural abnormality identified on MRI scan 
 
These exclusion criteria were chosen as they are known to have an effect on 





2.5 Assessment of the impact of chorionicity, birthweight discordance and twin-
to-twin transfusion syndrome on brain volumes in twins  
2.5.1 Safety 
Prior to starting data collection, I attended a mandatory MRI safety training course 
run by CRIC Bristol, which covered all safety issues surrounding using the MRI 
scanner.  MRI is a safe imaging technique for fetuses and there is no published 
evidence of harm as a result of undergoing a fetal MRI in the third trimester.193 
According to the literature, potential adverse effects are secondary to tissue 
heating due to radiofrequency energy deposition (which is quantified as the 
Specific Absorption Rate of Energy (SAR)). Stringent calculation of SAR is a routine 
procedure in every MRI examination and as a safety precaution the scanner would 
not perform the examination if the SAR was exceeded. Different modes of 
operation allow for different SAR limits. For pregnant women, the MHRA 
recommends that patients are scanned in ‘normal mode’, which limits SAR to 
2W/kg and is not expected to raise core temperature by more than 0.5°C194. All 
mothers were screened for MRI contraindications by two separate members of the 
study team (researcher and radiographer) and the scan protocol was delivered in 
normal operating mode. These actions minimised potential safety issues with the 
MRI protocol described below.  
 
2.5.2 Outcomes 
1. Total brain tissue volume: total grey matter and total white matter were 
measured (in cm3) and combined to give a total brain tissue volume (TBT). TBT 
was chosen as this has been shown to be an important marker for 
neurodevelopmental deficits in children195. 
2. The intertwin relative discordance in total brain tissue volume in each twinset: 
this was calculated as 100 × ([brain volume of larger twin − brain volume of 
smaller twin]/brain volume of larger twin) and expressed as a %. This was 
chosen to allow within twinset comparison that would not be affected by the 
absolute brain volume.  





2.5.3 Variables of interest 
1. Category  
Antenatally, mothers were categorised into one of four categories, depending on 
ultrasound findings. Each twinset was only assigned to one category. 
(i) Dichorionic twins were classed as one category (DCDA), regardless of growth 
pattern and gender discordance or concordance; 
(ii) Uncomplicated monochorionic twins (uMCDA) if there was no diagnosis of 
twin to twin transfusion syndrome or selective fetal growth restriction;  
(iii) Twin to twin transfusion syndrome (TTTS) if established diagnostic ultrasound 
criteria51 had been met; 
(iv) Selective fetal growth restriction (sFGR) if there was consistently greater than 
or equal to 20% discordance in the estimated fetal weight (EFW), and the EFW 
of the smaller twin was below the 10th centile for gestational age72. 
 
2. Birth weight discordance 
I aimed to assess the association between birthweight discordance and brain 
volume, to determine whether there was a linear, non-linear or no relationship 
between the two variables. In order to assess this, the intertwin birth weight 
discordance was calculated as per accepted practice,72 as 100 × [(birth weight of 
heavier twin − birth weight of lighter twin]/birth weight of heavier twin) and 
expressed as a %. 
 
  Subgroup analysis 
i) Twins were classed as “heavier” or “lighter” twin in the twinset to assess 
whether any association between birthweight discordance and outcome 
measures was different in heavier and lighter twins 
ii) Twins were stratified according to chorionicity, to assess the effect of the 
outcome measures in monochorionic and dichorionic twin subgroups 
iii) Dichorionic twins were stratified into gender concordant and gender 
discordant pairs, to assess whether there was any difference in the 
association between birthweight discordance and the outcome measures 




3. Change in weight discordance over time 
I aimed to determine whether twins with an EFW discordance that diverged had 
different brain volumes to those who had a stable EFW discordance over time. 
Therefore, the change in weight discordance was calculated as: (birth weight 
discordance – EFW discordance at 20 week scan)/time interval (in weeks) between 
these two weights. This measure gave a linear estimate of the pattern of growth 
discordance over time, whereas in reality growth patterns are rarely linear. 
However, a pragmatic decision was taken to use this approximation of the pattern 
of growth discordance within the twinset with acknowledgement of the limitation 
of this measurement. 
 
4. Weight discordance < or > 20% 
I categorised birth weight discordance into those with greater than 20% 
discordance and those with less than 20%, to assess whether there was a threshold 
effect for weight discordance on brain volume. I chose 20% based on a threshold 
that has been shown to be clinically significant in the literature64,66,67. 
 
5. Cardiac function - as measured by left ventricular strain at 21 weeks’ gestation 
I used left ventricular strain as a measure of cardiac function, to determine 
whether there was a relationship between cardiac function and brain volume. I 
chose to take the strain measurement at this gestation to limit the additional 
commitment for participants. This is the time frame in normal clinical practice 
during which the anomaly scan is completed and the heart structure is assessed in 
detail.  
 
2.5.4 Data collection 
MRI protocols for fetal and neonatal MRI imaging were agreed and are described 
in more detail below. For the fetal imaging, this was based on the normal clinical 
fetal protocol in use at UH Bristol NHS Foundation Trust. For neonatal imaging, I 
utilised an optimised neonatal protocol developed by members of the research 




a fetal MRI study performed at 30-32 weeks’ gestation. Each twin underwent a 
postnatal MRI scan, at a corrected gestational age of approximately 37-41 weeks. 
The MRI examinations all took place at the CRICBristol using a Siemens 3T 
Magnetom Skyra MRI scanner.  This scanner had a wider (70cm) and shorter 
(173cm) bore, therefore was less likely to cause the participants to feel 
uncomfortable or claustrophobic. 
 
2.5.4.1 Fetal MRI protocol 
The fetal MRI scans were performed at approximately 30-32 weeks’ gestation. 
Participants were screened and completed a safety checklist whilst in the Fetal 
Medicine Unit prior to the MRI. Immediately prior to entering the MRI scanner, 
they completed a second safety screening form, which was countersigned by the 
Lead Radiographer for CRIC who performed all of the MRI scans (AW). See 
Appendix 4 for the CRIC MRI Screening Forms.   
 
Participants were scanned immediately prior to the MRI scan to ascertain the 
position of each twin and ensure correct labelling for the MRI scan. Participants 
were asked to remove all metal containing clothing, and were offered the choice 
of changing into a hospital gown or staying in their own clothes. They were asked 
to empty their bladder prior to the scan, to minimise discomfort. They were 
provided with standard ear protection (noise cancelling headphones +/- earplugs 
to wear with the headphones), and were offered the option of listening to music 
through the headphones whilst the scan was being performed. Participants were 
carefully positioned to ensure they were as comfortable as possible during the 
scan. They were asked to lie on their side in a left lateral position to avoid aorto-
caval compression from the gravid uterus, with pillows between their legs and 
memory foam padding under their hips and bump. Two body coils were fitted 
around their abdomen to maximise the MRI signal over the uterus. They were 
transferred feet first into the MRI scanner. 
 




the scan. They were advised that they should use the call bell if they wished to stop 
the scan or speak to us at any point. Each participant was informed via intercom 
during the scan when the brain imaging for each twin had been completed, so that 
they had an idea of how far through the scan they were.  The MRI acquisition time 
was limited to a maximum duration of sixty minutes and SAR calculated 
throughout.  
2.5.4.2 Fetal MRI sequence 
A T2 HASTE (single shot fast spin echo) sequence was used in the sagittal, coronal 
and axial directions. Thirty slices of 3mm thickness (no interslice gap) were 
acquired (TR = 1100ms, TE = 80ms, FOV 310mm, flip 180), to give whole brain 
coverage.   
2.5.4.3 Neonatal MRI protocol 
Each set of twins was invited to come for a neonatal MRI scan between 37-42 
weeks corrected gestational age. This gestational age was chosen as this is classed 
as “term”. Where possible, the scan was arranged prior to the mother being 
discharged from the postnatal ward, to minimise disruption and travelling time 
with young babies. The parents completed a safety screening questionnaire for 
each participant immediately prior to the MRI scan. Neonates were changed into 
an MRI safe sleepsuit, fed and swaddled in an adjacent room, prior to being taken 
through to the MRI scanner. Parents were asked to wait in the preparation room, 
which was immediately next door, for the duration of the MRI scan. Neonates had 
mouldable ear putty inserted and MiniMuffs® (Kettering Surgical Appliances 
Limited) applied, to provide maximum ear protection. They had an oxygen 
saturation probe attached to their foot to monitor pulseoximetry throughout the 
scan, and were placed in a vacuum immobilisation device to reduce movement in 
the scanner. Finally, where possible, I ensured that each neonate was asleep prior 
to being placed in the scanner. If the neonate began moving or crying during the 
scan, or the pulseoximeter stopped recording, the scan was immediately stopped 
and I went in to assess them. If the pulseoximeter could be adjusted, or they could 
easily be settled then the scan was restarted, if not then the attempt was stopped 





Figure 2.1 MiniMuffs® ear protection on a swaddled neonate 
 
 





2.5.4.4 Neonatal MRI sequence 
Optimal sequences were used for the fetal and neonatal scans. Both T1 and T2 
weighted sequences were acquired in infants. For volumetric determination the 
T1 sequence was used as it allows higher resolution, better differentiation 
between grey and white matter, and optimised the quality of volumetric data to 
be extracted. This differed from the approach in the fetal scans where T1-weighted 
sequences, acquired over multiple repeated volumes would have been too 
severely degraded by fetal movement artefact to allow for accurate volumetric 
determination, hence only T2-weighted sequences were acquired for fetal scans, 
using a single-shot approach to provide rapid acquisition at lower resolution. 
 
A T1 sequence was used in the sagittal, coronal and axial directions. 120 slices of 
0.9mm thickness (no interslice gap) were acquired (TR = 700ms, TE = 12ms, FOV 
200mm).  
 
2.5.5 Data processing 
2.5.5.1 Structural MRI Data 
I received training from my supervisor (Dr Adam Smith-Collins) to enable me to 
independently clean the data, extract the brain tissue and run automatic 
segmentation analysis. 
 
The structural MRI data for both fetal and neonatal scans, were uploaded to a 
secure system - the University Hospitals Bristol Picture Archive and 
Communication System (PACS). These data were assessed for macroscopic 
pathology by a consultant neuroradiologist (ML) with extensive experience in fetal 
imaging. Participants were informed that each scan would be examined by a 
radiologist, and if any significant abnormality was identified then they were 
contacted by myself to inform them and arrange further follow up with either the 
St Michael’s neonatal team, or their local neonatal team (if the booking hospital 
was not St Michael’s) as needed. If there was a significant abnormality identified, 





2.5.5.2 Volumetric MRI Data 
All fetal and neonatal files were anonymised to participant number and 
downloaded from the CRIC server in DICOM format and stored on an encrypted 
external hard drive. The DICOM files were converted to NIfTI files and manually 
imported using SPM12 in Matlab, which is a software package that has been 
designed for the analysis of brain imaging data sequences. 
 
2.5.5.3 Fetal scan processing 
The fetal 2D images were initially reconstructed into 3D images, but due to 
problems with fetal movement during the scan, this technique produced 
suboptimal diagnostic images. This led to me using 2D images acquired in the axial 
plane for analysis, as these provided the clearest picture allowing brain 
segmentation and volumetric analysis. 
 
I used SPM12 to view the NIfTI files, if multiple T2 axial sequences had been 
acquired then I reviewed all images and chose the optimal image sequence for 
processing. I optimised and standardised all the images by cleaning the data prior 
to analysis. I manually adjusted the signal intensity to optimise image clarity, and 
did this by identifying the lowest and highest intensity areas of signal within the 
image, and then altering the manual window by inputting these values as the 
range. I ensured that the image was orientated correctly by adjusting the pitch, 
roll and yaw such that the anterior and posterior commissures aligned along the Y 
axis, and the interhemispheric fissure was centred on the Z axis. I centred the 
image by positioning the crosshair in the centre of the fetal brain (mid thalamus), 
and noting the right, forward and up values in mm. The reverse of these were then 
entered into the boxes to recentre the crosshair and the new position was saved 
by clicking on “reorient image”. 
 
I used an established brain mask198 (based on a normal neonatal brain template, 




image, and checked manually to ensure that no areas of the fetal brain were 
outside of the mask. I used the Image Calculator in SPM12 to automatically 
subtract the remaining tissue outside of the mask. To perform automatic brain 
extraction, I input two images into the calculator: the T2 weighted axial image for 
the participant, and the established brain mask. I then eliminated tissue from each 
participant which had a low probability of sitting within the fetal brain mask. By 
repeated iterations, I determined that a fairly conservative likelihood threshold of 
0.2 that a voxel sat within the brain mask provided effective automatic subtraction 
of maternal tissue without losing fetal brain voxels. The higher the value the more 
maternal tissue is subtracted but there is a greater chance of removing fetal brain 
tissue, whereas the lower the value the more conservative the software is, 
meaning that less maternal tissue is subtracted and there is less chance of fetal 
brain tissue being removed. Each subtracted image was subsequently opened in 
FSL view, and carefully examined to ensure that no brain tissue had been 
inadvertently removed during brain extraction. If fetal brain tissue had been 
removed, the image calculator could be re-run with a lower number in the 
equation for expression. No fetal scans required a lower threshold than 0.2. 
 
Using FSL View (a computer software system to view brain volumes), I examined 
each slice and digitally removed maternal tissue and fetal skull tissue. The images 
were examined in axial, coronal and sagittal planes to ensure that only the fetal 
brain was left in the image, and then this image was saved.  This was very time 
consuming, as in each brain every slice, in all three planes, had to be examined 
manually. I performed the digital removal of excess soft tissue for all fetal and 
neonatal scans, therefore this reduced the risk of bias between operators.  
 
To perform segmentation, I initially used FSL FAST segmentation, FMRIB’s 
automated segmentation tool. The number of input channels was set to 1, and the 
input image was the fetal image that I had manually cleaned using FSL. With 
guidance from my supervisor (Dr Adam Smith-Collins), I experimented with the 
number of output classes, and tried either three (grey matter, white matter and 




tissue). I experimented with using partial volume maps, or doing binary 
segmentation.  We also tried altering the advanced options, and the values for the 
main MRF parameter and bias field smoothing, and finally adding in tissue type 
means, where each input image was inspected and a text file created with the 
mean intensity for each of: grey matter, white matter, CSF and excess tissue. 
Unfortunately, despite experimentation with each of these parameters, the 
resulting segmentation was poor quality. 
 
To improve the segmentation process, I used the segmentation tool within SPM12. 
Using the segmentation tool within SPM meant using tissue probability maps, 
therefore potentially increasing the risk of bias, but from careful experimentation 
and inspection (by myself and Dr Adam Smith-Collins), this segmentation tool gave 
a much more reliable estimation of each of the brain tissue types. The input image 
was the fetal image that had been manually cleaned using FSL. Bias regularisation 
was set to light regularisation (0.001), and bias FWHM was set to 0.60mm cut off. 
SPM requires six different tissue probability maps, therefore established tissue 
probability maps were used for combined grey matter, white matter, 
cerebrospinal fluid, 198 and the final three were all set to tissue class 4 to pick up 
excess tissue. The MRF parameter was set to 1, and the tool was set to “don’t do 






Figure 2.3 Processing of fetal MRI scan images 
(1) Images were orientated and intensity adjusted in SPM12; (2) Brain was extracted in SPM12; (3) Fragments 
of maternal tissue were removed manually in FSL view; (4) Automatic segmentation was performed in SPM 12 
and each tissue class checked (image depicting fetal grey matter) 
 
2.5.5.4 Neonatal scan processing 
I reviewed the T1 structural image sequences in SPM12 and if multiple sequences 
had been taken, then I chose the best quality one for analysis. I reoriented the 
image using pitch, roll and yaw adjustments in SPM12 to ensure that the axial, 
coronal and sagittal views were correctly aligned, as described for the fetal scans 
previously. I positioned the crosshair in the centre of the brain (mid-thalamus) to 
centre the image. I experimented with running the brain segmentation software 
without first performing brain extraction, but found that this consistently 
overestimated the grey matter as the skull was assigned as grey matter. Therefore, 
I ran each neonatal image through brain extraction prior to segmentation. I used 
FSL 5.0.11 BET version 2.1 to perform brain extraction. The fractional intensity 
threshold was set to 0.25 and the software was set to output a brain extracted 
image. I experimented with different values for this (the default setting is 0.5), and 
again the higher the value the smaller the brain estimate, so the more artefactual 




estimate – giving a more conservative brain extraction. I found that when the data 
was good quality, a value of 0.25 produced the best result. After running the brain 
extraction tool, I inspected each image to ensure that brain tissue had not been 
removed. In cases where there had been some neonatal movement and the brain 
extraction tool had removed brain tissue, I re-ran the extraction with a lower 
fractional intensity threshold (set to 0.15). A total of 13/96 (13.5%) of neonatal 
scans required a lower threshold of 0.15.  
 
 
Figure 2.4 Processing of neonatal MRI images 
(1) The MRI images are orientated and the brain is extracted in FSL view; automatic segmentation is performed 
into the three tissue classes: (2) grey matter, (3) white matter and (4) cerebrospinal fluid, each image is checked 
manually to ensure quality 
 
As with the fetal segmentation, I used the segmentation tool within SPM12, and 




segmented brain volumes.  
 
2.5.6 Statistical Analysis 
I provided descriptive statistics for the demographic and clinical characteristics of 
the participants by group. I reported continuous normally distributed measures 
using the mean and standard deviation, and categorical or non-parametric 
measures using the median and range.  
 
Potential confounders 
A confounder is an influence that may modify the association between the 
outcome and the exposure without being an experimental parameter of interest. 
Potential confounders which could affect neonatal brain volume include: maternal 
age, ethnicity, parity, BMI, smoking status, and the presence or absence of 
Diabetes Mellitus or pre-eclampsia. The association of these confounders with the 
outcome was assessed using statistical modelling, and if an effect on brain volume 
or intertwin brain volume discordance was identified, they were included in the 
final adjusted model. 
 
Covariates 
I reviewed the literature to identify which factors may have an effect on fetal and 
neonatal brain volume and included these as potential covariates in the initial 
regression model: gender of the fetus or neonate, whether the twinsets were 
gender discordant (in some DCDA twins) or concordant (some DCDA and all MCDA 
twins), the gestational age at MRI scan, birthweight and birth gestation. A recent 
large study examined factors affecting neonatal brain volume and identified 
gestational age, birthweight and gender as having a significant effect on brain 
volume195. Brain volumes were larger in male than female neonates and there was 
a positive correlation between brain volume and both gestational age at MRI scan 
and birthweight. Therefore, these factors were included as covariates in my study. 
 
As I used complex statistical modelling, I received guidance from a University of 




understanding of these methods and ensure that I processed my data correctly. I 
performed exploratory analyses by creating scatter plots for each of my outcome 
measures with each of the variables of interest (as detailed previously). The 
association between the outcome and covariates was investigated by fitting linear 
and non-linear smoother lines to assess whether the relationship was linear or 
polynomial. I assessed these graphs and identified that the relationships were 
linear. This was confirmed by a statistician (CP), which meant that I was able to use 
a linear regression model for analysis. 
 
A regression model was the optimum choice for data analysis, as ANOVA testing 
would have only assessed the difference between groups without taking into 
consideration other factors and confounders, whereas regression models allow 
adjustment for these. When assessing total brain tissue volume, I used a multilevel 
regression model to account for the clustering within my twinsets. In a normal 
twinset the brain volumes should be very similar, therefore there will inevitably be 
correlation between the twins. A linear regression model assumes independence, 
and does not allow for the clustering seen in twinsets.  By using a multilevel 
regression model, with random effects at the level of the twinset this adjusts for 
the clustering and assesses how much the twinset differs from the overall average.  
When I assessed the intertwin % brain volume discordance, I was able to use a 
normal linear regression model, as each twinset was treated as one data point and 
therefore there was no clustering, as each twinset was independent of each other.  
 
I identified clinically plausible interactions, for example birth gestation and 
birthweight, as birthweight is known increase with increasing gestational age at 
birth. (See Appendix 6 for the full list of interactions examined.) I conducted 
likelihood ratio tests to assess whether a significant interaction existed. If the p 
value for the likelihood ratio test was ≤0.05 then the interaction was deemed 
significant, and was included in the initial multivariable regression model.  
 
I assessed the influence of each characteristic and covariate on the initial 




testing. Variables were retained in the final multivariable models if their p-value 
was ≤0.2. Heteroskedasticity is when the standard errors of a variable in a 
regression model are not constant when plotted against a second variable. 
Therefore, robust standard errors (using Huber-White sandwich estimator) were 
used for all the regressions to account for any heteroskedasticity. I assessed the 
residuals (linear and mixed models) and random effects (mixed models) for each 
model to ensure they were normally distributed. 
 
I used Stata version 15.1 for Mac (StataCorp, Texas, USA) and Microsoft® Excel for 





2.6 The use of speckle tracking to assess the impact of chorionicity and 
monochorionic pathology on fetal cardiac function 
2.6.1 Outcomes 
The outcome for this study was left ventricular global longitudinal strain (%). Left 
ventricular GLS was measured at repeated points throughout the second 
trimester. Each twin was looked at as an individual, and also compared to its co-
twin to assess group differences and within twinset differences in left ventricular 
strain. 
 
2.6.2 Variables of interest 
1. Time 
There are inconsistencies in the literature regarding the relationship between left 
ventricular strain and gestational age, with some studies showing no effect of 
gestation, and others demonstrating a reduction in left ventricular strain with 
advancing gestation. In order to assess this in my cohort, gestational age in days 
was recorded for each clip captured, and time was included as a covariate to assess 
whether there was a relationship between left ventricular strain and advancing 
gestation in each of the twin groups. 
  
2. Category (DCDA, uMCDA, TTTS, sFGR) 
Twins were placed the same antenatal categories as described in the MRI section 
above. 
 
3.  Within twin pair differences in strain  
Within twin pair differences in strain were assessed and twins were classified as 
“donor” or “recipient” in TTTS pairs, and “heavier” or “lighter” in DCDA, uMCDA and 
sFGR pairs.  
 
2.6.3 Data Collection 
As part of routine monochorionic twin surveillance, each participant underwent a 




umbilical artery Doppler and middle cerebral artery Doppler measurements (all 
scans performed by SN or MLD). Each participant underwent a full fetal 
echocardiogram by either an experienced fetal cardiac sonographer (JJ), or myself 
(supervised by JJ) at 18-20 weeks’ gestation, to exclude any cardiac structural 
abnormality. Any participants with pre-existing structural cardiac abnormalities 
were excluded from the study. 
 
In order to become competent in performing a conventional fetal echocardiogram, 
I spent six months with an experienced fetal cardiac sonographer at University 
Hospitals Bristol NHS Foundation Trust (JJ). At the end of six months of hands on 
training, I was competent in performing functional fetal cardiac assessment. At 
each visit up to 28 weeks, a functional fetal cardiac scan was performed. Two 
operators (either JJ or myself) performed all of the fetal echocardiograms. 
 
In the original study protocol, I planned to use a GE® Vivid E9 XDclear ultrasound 
machine (GE® Healthcare, Illinois USA) which was located on the Neonatal Intensive 
Care Unit in St Michael’s Hospital. This machine was chosen as GE EchoPAC® software 
(GE® Healthcare, Illinois USA) was already in use in the cardiology department, and 
the fetal cardiology team were familiar with the software. However, it became 
obvious that this approach was impractical as the machine on NICU was not readily 
available for use. After discussion with my supervisors, an experienced fetal 
cardiologist (Dr Jonathan Forsey) and CRICBristol, I decided to use a Toshiba Aplio500® 
machine to acquire the scans. TomTec® 2D Cardiac Performance Analysis (CPA) 
software (Tomtec® Imaging Systems GMBH Munich, Germany) was used to perform 
speckle tracking analysis. Due to these constraints, the first five twinsets were not 
scanned as there was no available ultrasound machine. 
 
2.6.3.1 Functional Cardiac Protocol 
All clips were obtained on an Aplio 500 or Aplio 400 ultrasound machine (Toshiba® 
Medical Systems Europe) using a 674 curved array probe (frequency 4-MHz – 8-




the pregnancy starting from around 19 weeks’ gestation. Where there was a 
suspicion of complications (for example twin to twin transfusion syndrome) prior 
to 19 weeks, functional cardiac assessment was opportunistically performed at 
this earlier gestation, where feasible.  
 
2.6.3.1.1 Speckle Tracking 
A fetal four chamber view was obtained and the image was magnified as much as 
possible to include only the fetal thorax.  A cine loop sequence capturing a 
minimum of three cardiac cycles was recorded in the absence of fetal or maternal 
movements. Acquisition time varied depending on factors such as fetal position, 
fetal movement and maternal habitus but was usually no more than ten minutes 
per twin. The clips were exported from the ultrasound machine in DICOM format 
for offline analysis. 
 
 
Figure 2.5 Four chamber view acquired for performing speckle tracking 
 
2.6.4 Data processing 
The clips were analysed on a workstation running TomTec® 2D Cardiac 
Performance Analysis (CPA) software (Tomtec® Imaging Systems GMBH Munich, 




become competent in performing data analysis using 2D CPA software, I received 
face-to-face training sessions and remote access training sessions by an 
applications specialist from TomTec®.  
 
I generated an M-mode tracing to identify the end systole and end diastole points. 
I selected a single cardiac cycle, determined by closure of the mitral valve, for 
analysis (see figure 2.6). Points just below the atrioventricular valve annulus on the 
intraventricular septum and on the left ventricular free wall, and at the cardiac 
apex were plotted, and the algorithm automatically detected the endocardium of 
the left ventricle (see figure 2.7).  
 
 
Figure 2.6 Generation of M mode tracing to identify end systole and end diastole 
 (1) Generation of M mode trace (2) Line drawn perpendicular to ventricular septum across both walls of the 
left ventricle (3) Identification of end systole (4) Identification of end diastole  
 
Following automatic detection, I subjectively reviewed this trace and manually 
adjusted it if necessary. The algorithm automatically tracked the endocardium 
through the cardiac cycle to end diastole. I subjectively verified the accuracy of 




despite adjustment, then as per previous research199,200 cases in which satisfactory 
tracking could not be obtained after several attempts and a maximum of ten 
minutes, were classified as inadequate and excluded from data analysis. The time 
taken to perform this analysis varied, but was usually around 10 to 15 minutes per 




Figure 2.7 Calculation of left ventricular strain using speckle tracking  
(1) Points selected just below the atrioventricular valve annulus on the intraventricular septum, on the left 
ventricular free wall, and at the cardiac apex, the software automatically detects the endocardial border in (2) 
end systole, and (3) end diastole (4) The endocardial border is followed through the cardiac cycle to calculate 
strain 
 
2.6.5 Statistical Analysis 
The need to make adjustments for multiple covariates meant that complex 
statistical models needed to be used. Therefore, University of Bristol statistician 






The outcome measure was global left ventricular strain. Strain is defined as the 
relative (%) shortening of the ventricle during systole and is therefore a negative 




I identified potential confounders that could affect the cardiac function including 
maternal age, BMI, smoking, ethnicity, pre-eclampsia, or Diabetes Mellitus. These 
confounders were all assessed using statistical modelling, and if found to have an 
effect on brain volume or intertwin brain volume discordance, were included in 
the final model to adjust for their effect.  
2.6.5.1 Intra- and Inter-observer Variability 
The intra- and inter-observer variability was assessed to ensure reproducibility of 
strain measurements, as although the literature suggests good reproducibility and 
feasibility, there are large variations in published fetal strain data.201  Intra-
observer (the amount one observer varies between observations when reporting 
more than once on the same set of results) and inter-observer (the amount two 
observers vary from one another when reporting on the same set of results) 
variability for strain values were analysed with repeated measurements by the 
same observer (SDN) and by a second independent observer (MLD).  Offline 
analysis was performed in 30 randomly selected subjects to provide a value for 
longitudinal strain, and each of the 30 clips was analysed three times by each 
observer. Both observers were blinded to previous strain measurements, and 
started the analysis from tracing of the endocardium in end systole onwards. 30 
subjects (20% of the study population) were chosen as this is in-keeping with 
previous sampling in the literature158,199,201,202. 
 
The agreement between these three measurements within each observer was 




measurement, one-way random effects model as previously described was used 
for analysis.203 Based on the 95% confidence interval of the estimated ICC, the 
values below 0.5 were considered as “poor”; between 0.5 and 0.75 as “moderate”; 
between 0.75 and 0.9 as “good”; and ≥ 0.90 as “excellent” agreement204.  
 
The inter-observer variability was assessed by the means of the three 
measurements made by the two observers on the same fetus. A two-way mixed 
effect model with average as the unit of measurement was used to obtain the ICC 
of absolute agreement. Bland-Altman analysis was also used to study the mean 
differences between two observers and to obtain limits of agreements for inter-
observer agreement. 
 
2.6.5.2 Statistical Models 
Exploratory analyses were performed to assess the relationship between each of 
my outcome measures with each of the variables of interest (as detailed 
previously). Lines of best fit and lowess lines were fitted to explore the relationship 
between the outcome and covariates and assess whether it was linear or 
polynomial. This showed that the relationships were linear, therefore a linear 
regression model was used for analysis. A multilevel regression model was used to 
account for the clustering within the twinsets, as in my MRI data analysis.  
 
Possible interactions were identified, and likelihood ratio tests conducted to assess 
whether a significant interaction existed. If the p value for the likelihood ratio test 
was ≤0.05 then the interaction was deemed significant, and was included in the 
initial multivariable regression model.  As described in Section 2.5.6, the influence 
of each characteristic and covariate on the initial multivariable regression model 
was assessed using backwards elimination and likelihood ratio testing. Variables 
were retained in the final multivariable models if their p-value was ≤0.2. Robust 
standard errors (using Huber-White sandwich estimator) were used for all the 





For the outcome measure (left ventricular global longitudinal strain) a comparison 
was made within each twin group over gestation, to ascertain whether values 
changed with advancing gestation. The mean values at three different time points 
were assessed to see whether there were differences between groups at different, 
clinically significant, time points.  
 
All the analyses were performed in R statistical software (R Core Team® 2017).  
 
Different statistical software packages were used for analysis of the MRI and 
cardiac data. I chose to use Stata as I had received extensive training in this 
software package, whereas Chetan Prajapati opted to use R software as he was 
more familiar with this software package. Regression models were used to analyse 
all data and therefore the results were comparable. 
 
2.7 Ethical Issues 
This study was granted R&D approval by University Hospitals Bristol NHS 
Foundation Trust on 7th October 2015 (ref: CH/2015/4927) and ethical approval (by 
NRES Committee South West - Central Bristol) on 17th September 2015 (ref: 
15/SW/0230). A substantial amendment (to include Southmead Hospital as a 
secondary site for recruitment) was granted ethical approval on 1st April 2016. 
Additional approval from the University of Bristol Clinical Research and Imaging 
Centre (CRIC Bristol) was applied for, and granted on 10th August 2015 for the MRI 
study.  
 
Participants’ confidentiality was maintained throughout. All documents were 
stored securely and were only accessible by study staff and authorised personnel. 
Clinical notes were only be used by NHS staff on NHS premises. 
 
The study complied with the Data Protection Act, and data was anonymised as 
soon as it was practical to do so.  Participants were not recognisable in the 





Parents were asked to consent on behalf of their fetus/child. All consent processes 
were in line with GMC guidance on ‘Good Medical Practice in Research’205 and the 
Declaration of Helsinki. 
 
2.8 Financing and Insurance 
The study was funded by The Capella Foundation. In addition, I was successfully 
awarded an additional grant by the David Telling Charitable Foundation, which was 
used to cover the costs of performing the neonatal MRI scans. Insurance for the 




Chapter 3 Assessment of the impact of chorionicity and 
monochorionic pathology on neonatal brain volume in twins 
 
3.1 Introduction 
Previous comparisons between singletons, dichorionic twins and uncomplicated 
monochorionic twins showed no inter-group differences in brain volume187,189. Studies 
have compared monozygotic and dizygotic twins, and whilst monozygotic twins would 
be expected to have more similar brain volumes as they are genetically identical, the 
discordance is similar in the two groups. This suggests that variation in placental blood 
flow and other factors may have an effect on the size of the developing brain188. 
Interestingly, studies have shown that monozygotic twin brain volumes become less 
discordant in the first few months of life, suggesting a period of catch up 
normalisation188. 
 
Discordance in birthweight has been associated with increased neurologic morbidity 
in twins188. The prevalence of cerebral palsy is higher in monochorionic twins even in 
the absence of twin-to-twin transfusion syndrome or single intrauterine death.64,65 
One study found that surviving monochorionic twins who had discordant growth 
antenatally had five times the risk of cerebral palsy compared to those who had twin-
to-twin transfusion syndrome64. However, the cause of underlying neuromorbidity in 
discordant twins is unclear.  
 
The aim of this study was to assess  
(i) Whether there are differences in brain volume between uncomplicated 
monochorionic twins and dichorionic twins. 
(ii) Whether having a diagnosis of selective growth restriction or twin-to-twin 






This was a multicentre prospective cohort study over a 2 year period. Consecutive 
referrals of monochorionic and dichorionic twin pregnancies were invited to 
participate in the study.  Participants had a neonatal MRI scan performed at term 
corrected gestational age. The MRI sequence performed is described in detail in 
Chapter 2. Scan images were processed and volumetric data extracted, as described 
previously.  Regression analyses were performed to compare brain volumes and 
correct for potential confounders, to assess the intergroup differences in mean brain 
volume and intertwin brain volume discordance.  
 
3.3 Results 
3.3.1 Intergroup differences in mean total brain tissue volume 
3.3.1.1 Recruitment 
Figure 3.1 outlines the study recruitment. Of the total number of twins recruited to 
the study (n=162), a total of 96 (59.2%) were scanned. A total of 30 twins (18.5%) did 
not undergo a neonatal MRI scan as the parents/guardians declined, 18 (11.1%) had a 
fetal or neonatal death, 15 (9.3%) were lost to follow up, and 3 (1.9%) were not 
scanned for technical reasons. Of the 96 MRI scans performed, 6 scans (6.3%) were 
unable to be analysed due to poor quality images from movement artefact and 1 scan 
(1.0%) was excluded due to significant structural abnormalities (as per protocol). This 






Figure 3.1 Recruitment flowchart 
 
Table 3.1 and Figure 3.2 outline the participant characteristics and the breakdown 
of twins in each subgroup. There were 48 twin pregnancies included, and 89 
individual twins. There were 31 DCDA twins (34.8%) and 58 MCDA twins (65.2%), 
of whom 40 (44.9%) were uncomplicated monochorionic twins (uMCDA), 9 
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(10.1%) had selective fetal growth restriction (sFGR). Dichorionic twins were 
treated as a control group and not separated into uncomplicated and sFGR 
subgroups, as the impact of growth discordance in DCDA is less significant than in 
monochorionic twins. In addition, only three dichorionic twins had a birthweight 
discordance above the accepted threshold of 25% 73. 
 
The median gestational age at delivery was lower in the TTTS and sFGR subgroups 
(33+3 and 33+4 weeks respectively) compared to the DCDA and uMCDA subgroups 
(36+4 and 36+1 respectively). Indications for preterm delivery in these subgroups 
included preterm ruptured membranes, spontaneous preterm labour and 
deterioration in fetal condition on ultrasound. (See Appendix for table of 
indications for preterm delivery). The median corrected gestational age at MRI 
scan overall was 38+3 (range 36+1 – 45+3 weeks). One participant was excluded due 
to significant abnormalities detected on MRI scan (bilateral ventriculomegaly and 
periventricular white matter injury), which were also suspected on antenatal USS. 
 
 
Figure 3.2 Bar chart showing distribution of cohort in each category 
DCDA (dichorionic twins), uMCDA (uncomplicated monochorionic twins), TTTS (monochorionic twins 
treated for twin-to-twin transfusion syndrome), and sFGR (monochorionic twins with an antenatal 





Table 3.1 Baseline characteristics and numbers of twin in each category  
Maternal characteristics 
Twin pregnancies (n = 48) DCDA (n=16) uMCDA(n=21) TTTS (n = 5) sFGR (n = 6) 
Age, mean (SD) 31.9 (5.0) 31.2 (6.2) 31.4 (1.8) 35.2 (8.3) 
BMI, mean (SD) 23.4 (3.2) 25.9 (5.3) 23.9 (3.2) 24.8 (2.5) 
Ethnicity, n (%)     
White 15 (93.8) 19 (90.5) 4 (80.0) 4 (66.7) 
Non white 1 (6.2) 2 (9.5) 1 (20.0) 2 (33.3) 
Parity, n (%)     
0 11 (68.8) 7 (33.3) 3 (60.0) 4 (66.7) 
1 4 (25.0) 9 (42.9) 2 (40.0) 2 (33.3) 
2+ 1 (6.2) 5 (23.8) 0 (0.0) 0 (0.0) 
Smoking status, n (%)     
Non-smoker 16 (100.0) 16 (76.2) 5 (100.0) 6 (100.0) 
Smoker 0 (0.0) 1 (4.8) 0 (0.0) 0 (0.0) 
Missing 0 (0.0) 4 (19.0) 0 (0.0) 0 (0.0) 
Infant characteristics 
Twin fetuses (n = 89) DCDA (n=31) uMCDA (n=40) TTTS (n=9) sFGR (n=9) 









Birthweight (g), mean (SD) 2279 (554) 2302 (310) 1782 (544) 1799 (390) 
Gender, n (%)     
Female 14 (45.2) 19 (47.5) 5 (55.6) 4 (44.4) 
Male 17 (54.8) 21 (52.5) 4 (44.4) 5 (55.6) 
% BWT discordance, mean 
(SD) 15.6 (6.7) 9.4 (6.7) 14 (9.6) 24.3 (8.0) 









Gender disc, n (%)  N/A N/A N/A 
Discordant 7 (24.1)    
Concordant 22 (75.9)    
* One set of twins out of five (20%) in the TTTS category also had sFGR with an EFW 
and birthweight discordance of >20%, but as the predominant antenatal diagnosis was 






3.3.1.2 Observed values for mean total brain tissue volume 
Table 3.2 and Figure 3.3 (below) show the raw unadjusted data for brain volume in 
each category. The median brain volume for each category is given, along with the 
minimum and maximum brain volume measured in each category. The central line in 
the box represents the median value, the box represents the interquartile range (IQR), 
the whiskers represent the upper and lower adjacent values (1.5*the IQR) and the 
individual dots are data points that are outliers. 
 
Table 3.2 Observed values for total brain tissue volume (cm3) by group 
TBT (cm3) Mean Min Max 
DCDA 310 220 410 
uMCDA 350 260 450 
TTTS 380 360 430 
sFGR 320 270 400 
Overall 340 220 450 
 
 





3.3.1.3 Model adjusted values for predicted total brain tissue volume 
Mixed multiple regression analysis was performed with the following parameters 
included in the model: 
Exposure variable – category of twin 
Outcome variable – neonatal total brain tissue volume (cm3) 
Covariates – birth weight (ß = 0.03, p 0.017), birth gestation (ß =-8.3, p 0.011), male 
gender (ß = 20.7, p <0.001), corrected gestational age at MRI scan (ß = 18.5, p <0.001) 
 
Table 3.3 Model adjusted values for total brain tissue volume (cm3) by group 
TBT (cm3) Mean Robust SE CI (lower) CI (upper) 
DCDA 336.0 5.7 324.8 347.2 
uMCDA 341.7 4.4 333.0 350.3 
TTTS 343.2 10.3 323.1 363.4 
sFGR 328.0 8.4 311.5 344.4 
 
 





Figure 3.4 demonstrates that monochorionic twins with selective growth restriction 
appear to have a lower predicted mean total brain tissue volume (cm3) compared to 
dichorionic twins, uncomplicated monochorionic twins or those with twin-to-twin 
transfusion syndrome.  Table 3.4 shows the between group comparisons, there was 
some evidence that monochorionic twins with selective growth restriction had a 
reduction in predicted brain volume compared to the twins in other categories 
(8.0cm3, 13.7cm3 and 15.3cm3 compared to DCDA, uMCDA and TTTS respectively) 
however this did not reach statistical significance (p values 0.461, 0.140 and 0.200 
respectively). However, the confidence intervals for the predicted mean total brain 
tissue volume for both sFGR and TTTS twins were very wide reflecting the small 
numbers in these categories.  
 
Table 3.4 Between group comparisons for total brain tissue volume (cm3) for sFGR 
compared to DCDA, uMCDA and TTTS twins  
Category TBT difference (cm3)  SE p value CI (lower) CI (upper) 
DCDA vs sFGR 8.0 10.9 0.461 -13.3 29.3 
uMCDA vs sFGR 13.7 9.3 0.140 -4.5 31.8 
TTTS vs sFGR 15.3 11.9 0.200 -8.1 38.6 
DCDA vs uMCDA -5.7 7.5 0.452 -20.4 9.1 
TTTS vs uMCDA 1.6 11.0 0.886 -20.0 23.2 
DCDA vs TTTS -7.2 12.9 0.575 -32.5 18.0 
 
3.3.2 Intergroup differences in relative intertwin brain volume discordance (%)  
3.3.2.1 Recruitment 
Figure 3.5 outlines the study recruitment. Of the total number of twins with MRI scans 
available for analysis (n=89, 48 twinsets), 6 monochorionic twins were excluded and 1 
dichorionic twin was excluded as there were no scans available for their co-twin. This 





Figure 3.5 Recruitment flowchart 
 
Table 3.5 and Figure 3.6 show the breakdown of twinsets in each category. 
Approximately a third (37%) of the twinsets were dichorionic and two thirds (63%) 
were monochorionic. Of the monochorionic twins, 73% were uncomplicated, 15% had 
been treated for twin-to-twin transfusion syndrome and 12% had an antenatal 
diagnosis of selective fetal growth restriction. 
 
Table 3.5 Breakdown of twins into assigned categories 
Category Frequency Percent 
DCDA 15 36.59 
uMCDA 19 46.34 
TTTS 4 9.76 
sFGR 3 7.32 







Figure 3.6 Bar chart showing distribution of cohort in each category 
 
3.3.2.2 Observed values for mean intertwin % total brain tissue volume discordance 
Table 3.6 and Figure 3.7 (below) show the raw unadjusted data for relative intertwin 
brain volume discordance (%) in each category. The median brain volume discordance 
(%) for each category is given, along with minimum and maximum brain volume 
measured in each category. The central line in the box represents the median value, 
the box represents the interquartile range (IQR), the whiskers represent the upper 







Figure 3.7 Observed values for intertwin total brain tissue difference (%) by group 
 
Table 3.6 Unadjusted observed values for intertwin total brain tissue difference (%) by 
group 
% TBT difference Median Min Max 
DCDA 5 0 21 
uMCDA 5 0 12 
TTTS 5 3 7 
sFGR 13 9 16 
Overall 5 0 21 
 
3.3.2.3 Model adjusted values for predicted intertwin brain volume discordance (%) 
Linear regression analysis was performed as described previously, and the predicted 
values below are after correcting for covariates.  
Exposure variable – category of twin 
Outcome variable – intertwin brain volume discordance (%) 
Covariates – birthweight discordance (ß = 0.3, p 0.028), gender discordance (ß = 7.3, 






Figure 3.8 Graph showing predicted intertwin total brain tissue volume difference (%) 
by group 
 
Table 3.7 Predicted intertwin total brain tissue difference (%) by group 
TBT (cm3) Mean SE CI (lower) CI (upper) 
DCDA 4.0 1.3 1.3 6.7 
uMCDA 5.8 1.0 3.8 7.8 
TTTS 5.5 1.3 2.8 8.3 
sFGR 12.0 2.0 7.9 16.0 
 
When correcting for gestational age at birth, birthweight and all additional 
confounders, monochorionic twins with selective fetal growth restriction had a mean 
intertwin brain volume discordance of 12.0%, whereas dichorionic twins, 
uncomplicated monochorionic twins or those treated for twin-to-twin transfusion 
syndrome had a much smaller mean intertwin brain volume discordance, of between 
4% and 6%. Table 3.8 shows the between group comparisons; monochorionic twins 
with sFGR have an 8% increase in intertwin brain volume discordance compared to 
DCDA twins, and a 6% increase compared to either uncomplicated monochorionic 




increase in intertwin brain volume discordance in monochorionic twins with selective 
growth restriction (p values all < 0.05).  
 
Table 3.8 Between group comparisons for predicted intertwin brain volume 
discordance 
Category Contrast in % 
discordance  
SE p value CI (lower) CI (upper) 
DCDA vs sFGR -8.0 2.5 0.003 -13.0 -2.9 
uMCDA vs sFGR -6.2 2.1 0.007 -10.6 -1.8 
TTTS vs sFGR -6.4 2.3 0.011 -11.20 -1.6 
DCDA vs uMCDA -1.8 1.8 0.334 -5.5 1.9 
TTTS vs uMCDA -0.2 2.1 0.891 -3.5 3.1 
TTTS vs DCDA 1.6 2.1 0.452 -2.6 5.8 
 
3.4 Discussion 
This is the first study comparing brain tissue volumes using MRI scans between 
different categories of twin, and directly comparing brain volumes and intertwin brain 
volume discordance in uncomplicated monochorionic twins and those with pathology. 
The data demonstrate no differences in absolute total brain tissue volume or intertwin 
% brain volume discordance between uncomplicated monochorionic twins and 
dichorionic twins, which is in keeping with previous studies where measures of brain 
volume have been compared between monozygotic and dizygotic twins188,189.  
 
There is clear evidence that neurodevelopmental morbidity is increased in 
monochorionic twins compared to dichorionic twins4,65,100. The prevalence of cerebral 
palsy in monochorionic twins is ten times the background risk (2% vs 0.2), and even in 
uncomplicated monochorionic twins, the rate of neurodevelopmental impairment has 
been shown to be as high as 7%100. The monochorionic twin placenta is characterised 
by multiple anastomoses which can cause transient haemodynamic instability, 





Monochorionic twins are monozygotic, therefore should have less intertwin brain 
volume discordance than dichorionic twins, who are largely dizygotic. Despite this, my 
data show no difference in intertwin brain volume discordance between 
uncomplicated monochorionic twins and dichorionic twins. Previous studies have 
demonstrated no difference in antenatal head circumference discordance, but an 
increased intertwin brain volume discordance at term corrected gestational age in 
dizygotic twins compared to monozygotic twins. This implies a postnatal period of 
“catch-up normalisation” in monozygotic twins, where they revert to their genetic 
potential, rather than being influenced by placental factors188,189. This reflects the 
presence of intrauterine factors that make monochorionic twins more discordant than 
expected, given their identical genetic make-up. However, in these studies 
monozygotic twins were not stratified according to chorionicity, and approximately 
half of the monozygotic group were dichorionic.  
 
Discordance of brain volume in monochorionic twins suggests a disruption in brain 
growth in one of the twin pair, rather than a predetermined genetic difference. My 
data suggest a similar level of discordance in brain volume in apparently 
uncomplicated monochorionic twins and non-identical dichorionic twins. This is in 
agreement with the current literature and evidence that even in the absence of 
diagnoses such as twin-to-twin transfusion syndrome or selective fetal growth 
restriction, interfetal transfusion is still almost always present. Inevitably this will lead 
to temporary episodes of haemodynamic instability, which will have an effect on the 
developing brain and therefore may affect brain volume. This may, therefore, help to 
explain the underlying increased neurological morbidity seen in even apparently 
uncomplicated monochorionic twins.  
 
In addition, there were no differences in absolute total brain tissue volume or 
intertwin % brain volume discordance between uncomplicated monochorionic twins 
and those who had been treated for TTTS. This cohort of TTTS pregnancies were all 
treated using fetoscopic laser photocoagulation and all who underwent an MRI scan 
were twinsets where both fetuses survived to discharge from hospital. FLP was 




five twinsets who underwent FLP, four had a single laser treatment and one required 
a total of three laser treatments due to recurrence. 
 
 My findings suggest that, once successfully treated, twin-to-twin transfusion 
syndrome has no measurable effect on brain volume. Predicted brain volumes are 
similar to uncomplicated monochorionic and dichorionic twins. This implies that if the 
hostile intrauterine environment is corrected and both twins survive, then brain 
volume is not affected. This is in keeping with findings from Taylor-Clarke et al, who 
reported that fetal brain volume in twins treated with laser for twin-to-twin 
transfusion syndrome were comparable to singleton controls, and there were no 
significant differences in brain volume between donors and recipients206. This implies 
that the early hostile placental configuration in TTTS does not affect brain volume if 
the disease is successfully treated.  
 
The accepted incidence of neurodevelopmental impairment in surviving 
monochorionic twins who have undergone laser treatment is 10%207. The timing of 
cerebral injury in TTTS remains unclear, and can occur before, during or after 
fetoscopic laser photocoagulation104. Sudden haemodynamic fluctuations during FLP 
may cause injury to the developing brain208. More recently, studies have published 
lower rates of neurodevelopmental impairment (3-7%) following FLP, 208-210 with low 
birthweight and prematurity being the most significant risk factors for cerebral 
damage. The authors from one study suggested that neurological morbidity following 
FLP for TTTS results primarily from prematurity related complications, contradicting 
earlier studies suggesting that cerebral lesions are predominantly antenatally 
acquired210.  
 
In successful laser treatment, the placenta is effectively dichorionised and therefore 
the interfetal transfusion is stopped, protecting the fetus from further transfusional 
haemodynamic instability. This is in keeping with data from Stirnemann et al who 
showed that incomplete surgery increased the risk of perinatal brain injury due to 
ongoing interfetal transfusion106. This implies that brain volume is affected by the 




corrected then brain volume is preserved. TTTS is recognised to cause cardiovascular 
dysfunction and decompensation which leads to disturbance of brain perfusion. 106 In 
the same way that cardiac dysfunction promptly resolves following successful laser 
FLP, maybe this rapid improvement in cardiac function allows resolution of 
disturbances in brain perfusion, thereby preserving brain growth and therefore brain 
volume. Although monochorionic twins with TTTS have an early hostile intrauterine 
environment with significant haemodynamic instability, they will have significantly 
less interfetal transfusion following successful FLP than uncomplicated monochorionic 
twins, due to the placental dichorionisation. Rapid cessation of transfusion should 
therefore create a less hostile intrauterine environment than in uncomplicated 
monochorionic twins, which may compensate for the early insult of TTTS. 
 
Finally, I showed that monochorionic twins with a diagnosis of selective fetal growth 
restriction have strong evidence of an increase in intertwin % brain volume 
discordance compared to uncomplicated monochorionic twins, and a trend towards a 
reduction in absolute total brain tissue volume. This provides valuable information 
towards understanding the poorer neurodevelopmental outcomes seen in those with 
selective growth restriction. In my next chapter, I look in more detail at the patterns 
of fetal growth and intertwin weight discordance to study their association with 
neonatal brain volume. 
 
3.5 Conclusion 
Monochorionic twins with selective fetal growth restriction have a trend towards a 
reduction in absolute brain tissue volume at term corrected gestational age compared 
to uncomplicated monochorionic twins, those treated for twin-to-twin transfusion 
syndrome, or dichorionic twins. There is strong evidence of an increase in relative 
intertwin brain volume discordance in monochorionic twins with selective growth 
restriction compared to the other groups. Monochorionic twins who undergo 
successful FLP have no differences in brain volume compared to dichorionic or 




Chapter 4 Investigation into the association between growth 
discordance and neonatal brain volume 
 
4.1 Introduction 
In my previous chapter, I demonstrated that monochorionic twins with an antenatal 
diagnosis of selective growth restriction had an increase in intertwin % brain volume 
discordance and a trend towards an overall reduction in total brain tissue volume. 
Discordance in birthweight has been associated with increased neurologic morbidity 
in twins64-66. Studies have shown that, irrespective of chorionicity, the risk of 
neurodevelopmental morbidity is significantly higher in growth discordant twinsets, 
compared to growth concordant twinsets64,67. However the cause of underlying 
neuromorbidity in growth discordant twins is unknown64. 
 
In the UK, the Royal College of Obstetricians and Gynaecologists has adopted a 
threshold of greater than 20% weight discordance being classed as significant and 
warranting closer surveillance72. However, different thresholds for growth 
discordance have been proposed, 63,67,71-73 with evidence of increased neonatal 
morbidity even at weight discordances of less than 20%63. 
 
I aimed to assess whether both absolute brain volume and intertwin % brain volume 
discordance were affected by birthweight discordance. To investigate this association 
further, a 20% birthweight discordance threshold was applied and neonatal brain 
volume was measured in twinsets above and below this threshold. Finally, I aimed to 
assess whether divergent growth had a different effect on brain volume compared to 
a stable weight discordance, therefore I compared the change in weight discordance 
over time.  
 
4.2 Methods 
The same cohort of twins as described in Chapter 3 was used for this study. As 
previously outlined, this was a multicentre prospective study over a 2 year period, 




invited to participate.  Participants had a neonatal MRI scan performed at term 
corrected gestational age. The MRI sequence performed is described in detail in 
Chapter 2. The scan images were processed and volumetric data extracted, as 
described previously.  Regression analyses were performed to assess the association 
between the mean total brain tissue volume and relative intertwin brain volume 
discordance, and: 
 
i) intertwin % birthweight discordance  
ii) twinsets who had <20% birthweight discordance versus those who had 
>20% 
iii) the pattern of birthweight discordance over time 
 
4.3 Results 
4.3.1 Recruitment  
4.3.1.1 Individual twins for analysis of absolute total brain tissue volume 
Figure 4.1 outlines the study recruitment. Of the total number of twins recruited to 
the study (n=162), a total of 96 (59.2%) were scanned. A total of 30 twins (18.5%) did 
not undergo a neonatal MRI scan as the parents/guardians declined, 18 (11.1%) had a 
fetal or neonatal death, 15 (9.3%) were lost to follow up, and 3 (1.9%) were not 
scanned for technical reasons. Of the 96 MRI scans performed, 6 scans (6.3%) were 
unable to be analysed due to poor quality images from movement artefact and 1 scan 
(1.0%) was excluded due to significant structural abnormalities (as per protocol). This 






Figure 4.1 Recruitment flowchart 
 
Pregnancies were separated according to chorionicity, and the baseline characteristics 
of each of these subgroups can be seen in Table 4.1. Two thirds (n = 32, 66.7%) of the 
pregnancies were monochorionic and one third (n = 16, 33.3%) were dichorionic. 
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and approximately three quarters (n = 24, 77.4%) were gender concordant. Zygosity 
testing was not performed, so the gender concordant dichorionic twins were not 
separated into monozygotic and dizygotic. 
 
Table 4.1 Baseline characteristics 
Twin pregnancies (n = 48) MC (n = 32) DC (n=16) 
Age, mean (SD) 32.0 (6.2) 31.8 (4.9) 
BMI, mean (SD) 25.4 (4.6) 23.4 (3.2) 
Ethnicity, n (%)   
White 27 (84.4) 15 (93.8) 
Non white 5 (15.6) 1 (6.2) 
Parity, n (%)   
0 14 (43.8) 11 (68.8) 
1 13 (40.6) 4 (25.0) 
2+ 5 (15.6) 1 (6.2) 
Smoking status, n (%)   
Non-smoker 27 (84.4) 16 (100.0) 
Smoker 1 (3.1) 0 (0.0) 
Missing 4 (12.5)  
Twin fetuses (n = 89) (n = 58) (n = 31) 
GA at delivery, median (range) 35+4 (29+1-36+4) 36+3 (29+1-38+2) 
Birthweight (g), mean (SD) 2123 (454) 2279 (554) 
Gender, n (%)   
Female 28 (48.3) 14 (45.2) 
Male 30 (51.7) 17 (54.8) 
% BWT discordance, mean (SD) 12.3 (9.0) 15.0 (6.7) 
cGA at MRI scan, median (range) 39+0 (37+0-45+3) 37+4 (36+1-40+6) 
Gender disc, n (%) N/A  
Discordant  7 (22.6) 




4.3.1.2 Twinsets for analysis of intertwin brain volume discordance 
Figure 4.2 outlines the study recruitment. Of the total number of twins with MRI scans 
available for analysis (n=89, 48 twinsets), 6 monochorionic twins were excluded and 1 
dichorionic twin was excluded as there were no scans available for their co-twin. This 
resulted in a total of 41 twinsets (85.4%) with paired scan data for analysis.  
 
Figure 4.2 Recruitment flowchart 
 
Table 4.2 Breakdown of twinsets into chorionicity 
Category Frequency Percent 
MCDA 26 63.4 
DCDA 15 36.6 
Gender concordant 12 80.0 
Gender discordant 3 20.0 
Total 41 100.0 
 
Table 4.2 demonstrates the breakdown of twinsets into chorionicity, and the 
breakdown of dichorionic twins into gender discordant and gender concordant 
twinsets. Approximately two thirds of the twinsets were monochorionic (n = 26, 
63.4%) and one third were dichorionic (n = 15, 36.6%). Of the dichorionic twinsets, 




4.3.2 The effect of birthweight discordance on mean total brain tissue volume 
Figure 4.3 and Table 4.3 demonstrate the mean birthweight discordance in 
monochorionic and dichorionic twins. Monochorionic twins had a mean birthweight 
discordance of 12.4%, whereas in dichorionic twins it was 15.6%. Interestingly, the 
range for birthweight discordance was greater in monochorionic compared to 
dichorionic twins, which is in keeping with the literature. 
 
 
Figure 4.3 Birthweight discordance by chorionicity 
The central line in the box represents the median value, the box represents the 
interquartile range (IQR), the whiskers represent the upper and lower adjacent values 
(1.5*the IQR) and the individual dots are data points that are outliers. 
 
Table 4.3 Birthweight discordance by chorionicity  
BW discordance Median Min Max 
MCDA 9 1 34 
DCDA 13 7 28 





4.3.2.1 Observed values for brain volume  
Figures 4.4 and 4.5 show the raw unadjusted observed values for the absolute total 
brain tissue volumes (cm3) against birthweight discordance for each individual twin.  
 
Figure 4.4 Observed values for total brain tissue volume (cm3) by birthweight 
discordance  
 
Figure 4.5 Observed values for total brain tissue volume (cm3) by birth weight 




In Figure 4.4 the twins are separated according to chorionicity, separate marker 
symbols are used for dichorionic and monochorionic twins (green triangles and purple 
circles respectively).  In Figure 4.5 the twins are separated into “heavier” and “lighter” 
twins in each twinset (based on their respective birthweights), separate markers are 
used for heavier and lighter twins (blue and red circles respectively). 
 
4.3.2.2 Model adjusted values for predicted total brain tissue volume 
Mixed multiple regression analysis was performed with the following parameters 
included in the model: 
Exposure variable – intertwin birthweight discordance (%) 
Outcome variable – neonatal total brain tissue volume (cm3) 
Covariates – birth weight (ß = 0.02, p 0.06), birth gestation (ß = -7.9, p 0.003), male 
gender (ß =21.7, p <0.001), corrected gestational age at MRI scan (ß = 19.0, p <0.001), 
ethnicity, (ß = -16.5, p 0.085), heavier twin (ß = 3.1, p 0.58) 
  
Table 4.4 and Figures 4.6, 4.7, 4.8 and 4.9 demonstrate the predicted total brain tissue 
volume by birthweight discordance. 
 
Figure 4.6 Graph showing predicted total brain tissue volume (cm3) by birthweight 




Table 4.4 Predicted values for total brain tissue volume (cm3) for birthweight 
discordance by group 
TBT (cm3) Difference* Robust SE p value CI (lower) CI (upper) 
MCDA -1.0 0.4 0.007 -1.8 -0.3 
DCDA - gender 
concordant -4.8 0.8 0.000 -6.4 -3.1 
DCDA - gender 
discordant -0.4 0.4 0.322 -1.3 0.4 
All twins -1.2 0.4 0.006 -2.0 -0.3 




Figure 4.7 Graph showing predicted total brain tissue volume (cm3) by birthweight 
discordance  in heavier and lighter twins (in whole twin cohort) 
 
When all twins were examined together, there was a negative association between 
birthweight discordance and brain volume. As the birthweight discordance increased, 
the predicted absolute total brain tissue volume decreased. There was a 1.2cm3 
reduction in brain volume for every 1% increase in birthweight discordance (p 0.006 
CI -2.0, -0.3).  When twins were separated into “heavier” and “lighter” twins, there 




heavier and lighter twins (1.2cm3 reduction in brain volume for every 1% increase in 
birthweight discordance (p 0.003 CI -1.9, -0.4). There was no evidence of a difference 
in the relationship between birthweight discordance and brain volume in heavier and 
lighter twins (p 0.582 CI -8.1, 14.3).  
 
In order to investigate this association further, I examined the association between 
birthweight discordance and total brain tissue volume in i) monochorionic twins ii) 
gender concordant dichorionic twins, and iii) gender discordant dichorionic twins. I 
was unable to analyse this in the same model, as there were no gender discordant 
twinsets in the monochorionic group. Therefore, I ran the model separately for each 
subgroup as described above.  
 
 
Figure 4.8 Graph showing predicted total brain tissue volume (cm3) by birthweight 
discordance in monochorionic twin pairs 
 
Figure 4.8 shows the predicted brain volume by birthweight discordance in 
monochorionic twins. There was a negative association between birthweight 




1% increase in birthweight discordance, there was a 1cm3 reduction in total brain 
tissue volume (p 0.007 CI -1.80, -0.29). 
 
 
Figure 4.9 Graph showing predicted total brain tissue volume (cm3) by birthweight 
discordance in gender discordant and concordant dichorionic twin pairs 
 
Figure 4.9, above, shows the predicted brain volume by birthweight discordance in 
dichorionic twins. The dichorionic twin group were split into gender concordant pairs 
(navy blue line) and gender discordant pairs (maroon line). These data demonstrate 
that gender concordant dichorionic twins have a more marked association between 
brain volume and birthweight discordance than gender discordant dichorionic twins. 
In gender concordant pairs, there was a 4.8cm3 reduction in brain volume for every 
1% increase in birthweight discordance (p <0.001 CI -6.4, -3.1). In gender discordant 
pairs there was a 0.4cm3 reduction in brain volume for every 1% increase in 
birthweight discordance (p 0.322 CI -1.3, 0.4). There was strong evidence of a 
difference in the association between brain volume and birthweight discordance in 





4.3.3 The effect of birthweight discordance on brain volume discordance 
4.3.3.1 Observed values for intertwin % brain volume discordance 
Figure 4.10 shows the observed intertwin % brain volume discordance plotted against 
the intertwin % birthweight discordance for each individual twinset. Twinsets are 
separated on the graph into dichorionic (green triangle marker) and monochorionic 
(purple circle marker). The raw data on the graph suggest that a larger brain volume 




Figure 4.10 Observed values for intertwin total brain tissue volume difference (%) by 
birthweight discordance 
 
4.3.3.2 Model adjusted values for intertwin brain volume discordance according to 
birthweight discordance 
Linear regression analysis was performed to calculate predicted values for relative 
intertwin % brain volume discordance.  
Exposure variable – intertwin birthweight discordance (%) 








Figure 4.11 Graph showing predicted intertwin brain volume discordance (%) against 
intertwin birthweight discordance (%) 
 
Table 4.5 Predicted values for intertwin total brain tissue volume % difference for 
birthweight discordance by group 
TBT (cm3) Difference Robust SE p value CI (lower) CI (upper) 
MCDA 0.3 0.1 0.028 0.03 0.50 
DCDA 1.1 0.3 0.010 0.40 1.90 
DCDA - gender 
concordant 0.9 0.19 0.002 0.46 1.36 
DCDA - gender 
discordant 1.26 0.43 0.02 0.24 2.29 
All twins 0.3 0.1 0.028 0.03 0.5 
 
Figure 4.11 and Table 4.5 demonstrate the predicted values for intertwin % brain 
volume discordance, once the model has adjusted for all the confounders described. 




birthweight discordance and brain volume discordance in twin pairs. There was a 0.3% 
increase in brain volume discordance for every 1% increase in birthweight discordance 
(p 0.028, CI 0.03. 0.52).  
 
Again, in order to investigate this association further, I examined the association 
between birthweight discordance and brain volume discordance in i) monochorionic 
twins ii) gender concordant dichorionic twins, and iii) gender discordant dichorionic 
twins. As described previously, I was unable to analyse this in the same model, as there 
were no gender discordant twinsets in the monochorionic group. Therefore, I ran the 
model separately for each subgroup as described above.  
 
 
Figure 4.12 Graph showing predicted intertwin brain volume discordance (%) against 
intertwin birthweight discordance (%) for MCDA twins 
 
When monochorionic twins were assessed as a separate subgroup, as the birthweight 
discordance increased, there was an increase in the intertwin % brain volume 
difference. For every 1% increase in birthweight discordance, there was a 0.3% 





Dichorionic twins were assessed as a separate subgroup using a linear regression 
model, without separating them into gender discordant and concordant pairs. Figure 
4.13 demonstrates that in this subgroup as the birthweight discordance increased, 
there was an increase in intertwin % brain volume discordance. For every 1% increase 
in birthweight discordance, there was a 1.1% increase in brain volume discordance (p 
0.01, CI 0.4,1.9). 
 
 
Figure 4.13 Graph showing predicted intertwin brain volume discordance (%) against 
intertwin birthweight discordance (%) for DCDA twins 
 
When DCDA twins were subdivided into gender discordant and gender concordant 
subgroups, both had an increase in intertwin brain volume % discordance as the 
birthweight increased. In gender discordant twin pairs, for every 1% increase in 
birthweight discordance, there was a 1.3% increase in brain volume discordance (p 
0.02, CI 0.24, 2.29), and in gender concordant pairs for every 1% increase in 
birthweight discordance, there was a 0.9% increase in brain volume discordance (p 






Figure 4.14 Graph showing predicted intertwin brain volume discordance (%) against 
intertwin birthweight discordance (%) for DCDA twins by gender discordance 
 
Figures 4.11, 4.13, and 4.14 illustrate the values for intertwin brain volume 
discordance predicted by the regression model at each level of relative intertwin 
birthweight discordance. The intercepts on the y axis (when the intertwin birthweight 
discordance is 0%) for the whole twin cohort (Figure 4.11), all dichorionic twins (Figure 
4.13) and gender discordant dichorionic twins (Figure 4.14) are negative values, 
however a negative intertwin brain volume discordance is not possible clinically as the 
minimum value is 0%. This reflects an estimation from the regression model for the 
expected mean intertwin brain volume discordance when all predictor variables are 
set to zero, and is produced by extrapolation beyond the observed data. Therefore, 
this can result in implausible predictions outside the observed data when the sample 
size is small.    
 
As expected, gender discordant twin pairs had a greater starting brain volume 




discordance was 9.6% higher in gender discordant pairs. This likely reflects the fact 
that male neonates have larger brain volumes than female neonates195 therefore the 
mean brain volume will be more discordant. Interestingly, as the birthweight 
discordance increased, the gap between intertwin brain volume difference in gender 
concordant and discordant pairs narrowed. At a birthweight discordance of 35%, the 
predicted brain volume discordance was the same in gender discordant and 
concordant dichorionic twin pairs. This implies that at lower birthweight discordances, 
the difference in brain size between male and female neonates has a bigger effect, 
hence the greater brain volume discordance. Whereas at greater birthweight 
discordances, the weight difference has a larger effect on brain volume discordance 
and negates the gender difference. 
 
When contrasting the effect of birthweight discordance on predicted intertwin brain 
volume discordance between the two subgroups of DCDA twins, gender discordance 
had no significant effect on the association between the two (p 0.336, CI -1.16, 0.46). 
 
4.3.4 The effect of a 20% discordance threshold on mean total brain tissue 
volume 
Twins were stratified into those with an intertwin birthweight discordance greater 
than 20%, and those with less than 20%.  Table 4.6 and Figures 4.15, 4.16, and 4.17 
demonstrate the numbers in each subgroup.  
 
Table 4.6 Proportion of twins overall and by subgroup above and below a threshold 
weight discordance cut off of 20% 
Group Discordance Frequency Percent 
Monochorionic 
  
Less than 20% 43 74.14 
More than 20% 15 25.86 
Dichorionic 
  
Less than 20% 21 67.74 
More than 20% 10 32.36 
All twins 
  
Less than 20% 64 71.91 





Overall, 71.9% of twins (n = 64) had a birthweight discordance of less than 20%, and 
28.1% (n = 25) had a discordance greater than 20%. When separated according to 
chorionicity, out of 58 monochorionic twins, three quarters (n = 43, 74.1%) had a 
birthweight discordance of less than 20% and one quarter (n = 15) had greater than 
20%. Whereas out of 31 dichorionic twins, two thirds (n = 21) had a birthweight 
discordance of less than 20%, and one third (n = 10) had greater than 20%.  
 
 
Figure 4.15 Bar chart showing proportion of twinsets above and below a threshold cut 






Figure 4.16 Bar chart showing proportion of cohort above and below a threshold cut 
off of 20% birthweight discordance by chorionicity 
 
Figure 4.17 Bar chart showing proportion of dichorionic twins above and below a 






4.3.4.1 Observed values for total brain tissue volume  
Table 4.7 and Figure 4.18 demonstrate the raw observed values for total brain tissue 
volume for twins with a birthweight discordance above and below a threshold value 
of 20%. In Figures 4.18, 4.19, and 4.20 the central line in the box represents the 
median value, the box represents the interquartile range (IQR), the whiskers represent 
the upper and lower adjacent values (1.5*the IQR) and the individual dots are data 
points that are outliers. 
 
Table 4.7 Observed values for total brain tissue volume (cm3) by weight discordance 
TBT (cm3) Mean SD Min Max 
Under 20% 342.5 46.8 250 450 
Over 20% 326.4 51.3 220 430 
Overall 338 48.4 220 450 
 
The mean brain volume for those with a birthweight discordance of less than 20% was 
343cm3, and for those with a birthweight discordance greater than 20% the mean 
brain volume was 326cm3. The range of total brain tissue volumes in the cohort was 






Figure 4.18 Observed values of total brain tissue volume by weight discordance 
 
In order to further investigate the effect of a 20% threshold for birthweight 
discordance, I separated the twin cohort into monochorionic and dichorionic 
subgroups. Table 4.8 and Figure 4.19 show the raw unadjusted observed values for 
total brain tissue volume in monochorionic twins above and below a threshold 
birthweight discordance of 20%. The mean total brain tissue volume in those with a 
birthweight discordance of less than 20% was 359.5cm3, and in those with a 
discordance of greater than 20% was 336.7cm3. The range of total brain volume 





Figure 4.19 Graph showing observed total brain tissue volume (cm3) by weight 
discordance (>20% or <20%) in monochorionic twin subgroup 
 
Table 4.8 Observed values for total brain tissue volume (cm3) by weight discordance 
in monochorionic twins subgroup 
TBT (cm3) Mean SD Min Max 
Under 20% 359.5 42.8 260 450 
Over 20% 336.7 50.4 270 430 
 
Table 4.9 and Figure 4.20 show the raw unadjusted observed values for total brain 
tissue volume in dichorionic twins above and below a threshold birthweight 
discordance of 20%. The mean total brain tissue volume in those with a birthweight 
discordance of less than 20% was 307.6cm3, and in those with a discordance of greater 
than 20% was 311.0cm3. The range of total brain volume observed was larger in 
dichorionic twins with a birthweight discordance greater than 20%, and the wider 






Figure 4.20 Observed values for total brain tissue volume (cm3) by weight discordance 
in dichorionic twins subgroup 
 
Table 4.9 Observed values for total brain tissue volume (cm3) by weight discordance 
in dichorionic twins subgroup 
TBT (cm3) Mean SD Min Max 
Under 20% 307.6 34.0 250 390 
Over 20% 311.0 51.3 220 410 
 
4.3.4.2 Model adjusted values for predicted total brain tissue volume 
Mixed multiple regression analysis was performed with the following parameters 
included in the model: 
Exposure variable – <20% or >20% birthweight discordance 
Outcome variable – neonatal total brain tissue volume (cm3) 
Covariates – birth weight (ß = 0.03, p 0.02), birth gestation (ß =-9.0, p 0.001), male 





The model predicted mean total brain tissue volume for a twinset with a birthweight 
discordance of less than 20% was 341cm3 (CI 334.7, 348.1), and for a twinset with a 
birthweight discordance of greater than 20% was 331cm3 (CI 319.5, 342.4).  When 
twins were split into those with >20% growth discordance and those with <20% 
growth discordance, there was no significant difference in predicted brain volume 
between the two groups (p 0.136 CI -24.1, 3.27). When looking at the entire twin 
cohort, there was no evidence of a threshold effect of 20% birthweight discordance 
on neonatal brain volume.  
 
Table 4.10 Model adjusted values for total brain tissue volume (cm3) by weight 
discordance 
TBT (cm3) Mean SD CI (lower) CI (upper) 
Under 20% 341.4 3.4 334.7 348.1 
Over 20% 331.0 5.9 319.5 342.4 
 
 
Figure 4.21 Graph showing predicted total brain tissue volume (cm3) by birthweight 





As before, in order to investigate this association further, I stratified the twins 
according to chorionicity and examined the association between a threshold 
birthweight discordance of 20% and total brain tissue volume. 
 
Table 4.11 Model predicted values for total brain tissue volume (cm3) by weight 
discordance in monochorionic twins only 
TBT (cm3) Mean SD CI (lower) CI (upper) 
Under 20% 357.6 4.4 349.1 366.2 
Over 20% 345.3 6.0 333.6 357.0 
 
 
Figure 4.22 Graph showing model adjusted total brain tissue volume (cm3) by 
birthweight discordance (>20% or <20%) in monochorionic twin subgroup 
 
In monochorionic twins with a birthweight discordance less than 20%, the predicted 
mean brain volume was 357.6cm3, whereas in those with a discordance greater than 




monochorionic twins above a threshold growth discordance of 20%, with a 12.3cm3 
reduction in brain volume in twins with greater than 20% birthweight discordance 
compared to those with less than 20% discordance. However, this did not reach 
statistical significance (p 0.095, CI -26.7, 2.2).  
 
Table 4.12 Model predicted values for total brain tissue volume (cm3) by weight 
discordance in dichorionic twins only 
TBT (cm3) Mean SD CI (lower) CI (upper) 
Under 20% 337.8 6.3 325.4 350.2 
Over 20% 327.9 7.3 313.7 342.1 
 
 
Figure 4.23 Graph showing model adjusted total brain tissue volume (cm3) by 
birthweight discordance (>20% or <20%) in dichorionic twin subgroup 
 
The predicted mean total brain tissue volume was 337.8cm3 for dichorionic twins with 
a birthweight discordance of less than 20%, and 327.9cm3 for those with greater than 
20% discordance.  I found no significant effect of a threshold birthweight discordance 




4.3.5 The effect of a 20% discordance threshold on intertwin % brain tissue 
volume discordance 
In order to examine whether a birthweight discordance of 20% has a significant 
threshold effect on intertwin brain volume discordance, I categorised twinsets into 
those with a birthweight discordance of greater than 20% and those with less than 
20%. Table 4.13 and Figures 4.24 and 4.25 show the distribution of the cohort of 
twinsets into these categories. Of the 41 twinsets who had complete data available 
for analysis, three quarters (n = 30, 73.2%) had a birthweight discordance of less than 
20%, and one quarter (n = 11, 26.8%) had a birthweight discordance of greater than 
20%.  Figure 4.25 shows the distribution of twinsets above and below the birthweight 
discordance threshold, when stratified according to chorionicity. Three quarters of 
monochorionic twins (n = 20, 76.9%) had a birthweight discordance of less than 20% 
and one quarter (n = 6, 23.1%) had a discordance greater than 20%. In dichorionic 
twins, two thirds (n = 10, 66.7%) had a birthweight discordance less than 20%, and 
one third (n = 5, 33.3%) had a discordance greater than 20%.  
 
Table 4.13 Proportion of twins overall and by subgroup above and below a threshold 
weight discordance cut off of 20% 
Group Discordance Frequency Percent 
Monochorionic 
  
Less than 20% 20 76.92 
More than 20% 6 23.08 
Dichorionic 
  
Less than 20% 10 66.67 
More than 20% 5 33.33 
All twins 
  
Less than 20% 30 73.17 






Figure 4.24 Bar chart showing proportion of twinsets above and below a threshold cut 
off of 20% weight discordancy for the whole twin cohort 
 
 
Figure 4.25 Bar chart showing proportion of cohort above and below a threshold cut 




4.3.5.1 Observed intertwin % brain volume discordance 
Table 4.14 Observed values for intertwin relative brain volume discordance (%) by 
weight discordance 
TBT % difference Mean SD Min Max 
Under 20% 4.4 4.0 0 14 
Over 20% 10.5 7.7 0 21 
Overall 6.07 5.81 0 21 
 
Table 4.14 (above) and Figure 4.26 (below) show the observed values for relative 
interwin % brain volume discordance when twins were categorised into those above 
and below a birthweight discordance of 20%. In twinsets with a birthweight 
discordance of less than 20%, the mean relative brain volume discordance within the 
twinset was 4.4%. In those with a birthweight discordance of greater than 20%, the 
mean relative brain volume discordance was 10.5%.  
 
 
Figure 4.26 Graph of observed intertwin relative brain volume discordance (%) by 





In Figures 4.26, 4.27, and 4.28 the central line in the box represents the median value, 
the box represents the interquartile range (IQR), the whiskers represent the upper 
and lower adjacent values (1.5*the IQR) and the individual dots are data points that 
are outliers. Tables 4.15 and 4.16, and Figures 4.27 and 4.28 show the observed values 
for relative intertwin % brain volume discordance, when the twin cohort is stratified 
by chorionicity. In monochorionic twin pairs (Table 4.14 and Figure 4.25) with a 
birthweight discordance less than 20%, the mean relative brain volume discordance 
within the twinset was 4.6%; whereas in those pairs with a birthweight discordance 
greater than 20%, the mean brain volume discordance was 8.2%. In dichorionic twin 
pairs (Table 4.15 and Figure 4.26), when the birthweight discordance was less than 
20%, the mean observed relative brain volume discordance was 4.1% and when it was 
greater than 20%, the relative brain volume discordance was 13.4%. 
 
Table 4.15 Observed values for intertwin relative brain volume discordance (%) by 
weight discordance in monochorionic twins 
TBT (cm3) Mean SD Min Max 
Under 20% 4.6 3.7 0 12 
Over 20% 8.2 5.3 3 16 






Figure 4.27 Graph of observed values for intertwin relative brain volume discordance 
(%) by weight discordance in monochorionic twins  
 
Table 4.16 Observed values for intertwin relative brain volume discordance (%) by 
weight discordance in dichorionic twins 
TBT % difference Mean SD Min Max 
Under 20% 4.1 4.7 0 14 
Over 20% 13.4 9.7 0 21 






Figure 4.28 Graph of observed values for intertwin relative brain volume discordance 
(%) by weight discordance in dichorionic twins  
 
4.3.5.2 Model adjusted values for intertwin brain volume discordance above and 
below a threshold birthweight discordance of 20% 
 
Linear regression analysis was performed with the following parameters included in 
the model: 
Exposure variable – <20% or >20% birthweight discordance 
Outcome variable – relative intertwin brain volume discordance (%) 
Covariates – gender discordance (ß = 6.5, p 0.015) 
When all twinsets in the cohort were included in the same model without stratifying 
for chorionicity, there was an increase in intertwin brain volume discordance in those 
who had a birthweight discordance of greater than 20% compared to those with less 
than 20%. Table 4.17 and Figure 4.29 show the predicted values for intertwin brain 
volume discordance above and below a threshold birthweight discordance of 20%. 
There was a 6% increase in brain volume discordance in those above a 20% threshold 





Table 4.17 Model adjusted intertwin total brain volume % difference by weight 
discordance 
TBT % difference Mean SD CI (lower) CI (upper) 
Under 20% 4.5 0.7 3.0 5.9 
Over 20% 10.4 2.2 6.0 15.0 
 
Figure 4.29 Model adjusted intertwin total brain volume % difference by weight 
discordance for whole twin cohort (with 95% CI) 
 
In order to further investigate the effect of a threshold of 20% for birthweight 
discordance, I repeated the model and stratified the twinsets according to 
chorionicity.  
 
Table 4.18 Model adjusted values for intertwin relative brain volume discordance (%) 
by weight discordance in monochorionic twins 
TBT (cm3) Mean SD CI (lower) CI (upper) 
Under 20% 4.6 0.9 2.8 6.5 






Figure 4.30 Graph of predicted values for intertwin relative brain volume discordance 
(%) by weight discordance in monochorionic twins  
 
The predicted relative brain volume discordance in monochorionic twin pairs with a 
birthweight discordance less than 20% was 4.6%, and for those with a birthweight 
discordance greater than 20% was 8.0%. The predicted intertwin relative brain volume 
discordance was 3.4% higher in those pairs with over 20% birthweight discordance (p 
0.171 CI -1.8,8.3) compared to those with a birthweight discordance less than 20%. 
Therefore, my data showed no significant difference in brain volume discordance in 
monochorionic twinsets with a birthweight discordance less than 20% compared to 
those with greater than 20%.  
 
Table 4.19 Predicted values for intertwin relative brain volume discordance (%) by 
weight discordance in dichorionic twins 
TBT % difference Mean SD CI (lower) CI (upper) 
Under 20% 3.8 1.1 1.3 6.4 






Figure 4.31 Graph of predicted values for intertwin relative brain volume discordance 
(%) in dichorionic twins above and below a threshold birthweight discordance of 20%  
 
In dichorionic twin pairs with a birthweight discordance less than 20%, the predicted 
relative brain volume discordance was 3.8%, and for those with a birthweight 
discordance greater than 20% was 13.9%. There was an increase of 9.6% in the 
predicted intertwin relative brain volume discordance in those pairs with over 20% 
birthweight discordance (p 0.150 CI -4.3, 23.5) compared to those with a birthweight 
discordance less than 20%. Therefore, my data showed no significant difference in 
brain volume discordance in dichorionic twinsets with a birthweight discordance less 
than 20% compared to those with greater than 20%.  
 
4.3.6 The effect of the pattern of growth discordance on mean total brain tissue 
volume 
Figure 4.32 and Table 4.20 (below) demonstrate the mean change in weight 
discordance over time in monochorionic and dichorionic twin pairs. In Figure 4.32 the 
central line in the box represents the median value, the box represents the 
interquartile range (IQR), the whiskers represent the upper and lower adjacent values 




monochorionic twins, the mean change was 0.2% per week, meaning that the mean 
weight discordance within the twin pair increases by an average of 0.2% every week. 
In dichorionic twins, the mean change in weight discordance was 0.5% per week, 
meaning that in dichorionic twins the growth patterns are more divergent than in 
monochorionic twins.  
 
 
Figure 4.32 Change in discordance over time by chorionicity  
 
Table 4.20 Change in weight discordance over time (% per week) by chorionicity  
Change in discordance Mean SD Min Max 
MCDA 0.2 0.5 -1.4 1.1 
DCDA 0.5 0.5 -0.1 1.7 
Overall 0.3 0.5 -1.4 1.7 
 
 
4.3.6.1 Observed values for total brain tissue volume 
Figure 4.32 shows each individual twin’s observed brain volume plotted against their 
change in weight discordance over time. The brain volume values plotted are raw 








Figure 4.32 Observed values for total brain tissue volume (cm3) by change in 
discordance  
 
4.3.6.2 Model adjusted values for predicted total brain tissue volume 
Mixed multiple regression analysis was performed with the following parameters 
included in the model: 
Exposure variable – change in weight discordance over time (% per week) 
Outcome variable – total brain tissue volume (cm3) 
Covariates – male gender (ß = 21.7, p <0.001), corrected gestational age at MRI scan 
(ß = 19.0, p <0.001), birth weight (ß =0.01, p 0.06), birth gestation (ß =-7.9, p 0.003), 
ethnicity, gender discordance (for dichorionic twins only) (ß = 20.2, p 0.28) 
 
Table 4.21 shows the values for the association between change in weight discordance 
over time and predicted total brain tissue volume in i) the whole twin cohort ii) 




total brain tissue volume by change in weight discordance over time when the whole 
twin cohort was assessed together. There was no evidence of an association between 
change in weight discordance over time and predicted brain volume: for every 1% 
increase in weight discordance per week, there was a 1.4cm3 increase in predicted 
brain volume (p 0.829 CI -13.7, 16.4). 
 
Table 4.21 Predicted values for total brain tissue volume (cm3) for change in 
discordance by group 
TBT (cm3) Difference Robust SE p value CI (lower) CI (upper) 
MCDA -6.0 10.9 0.581 -27.5 15.4 
DCDA 49.8 7.8 0.000 34.5 65.2 
All twins 1.4 7.7 0.861 -13.7 16.4 
 
 
Figure 4.33 Graph showing predicted total brain tissue volume (cm3) against change 
in discordance (% per week) for whole twin cohort  
 
Next I separated the twins by chorionicity, to see whether there was an association 




subgroup (monochorionic or dichorionic twins). Figure 4.34 shows the predicted total 
brain tissue volume according to the change in weight discordance per week, for 
monochorionic twins. As with the whole twin cohort, there was no association 
between change in discordance over time and predicted brain volume. For every 1% 
increase in weight discordance per week, there was a 6cm3 reduction in brain volume 
(p 0.581, CI -27.49, 15.42).  
 
 
Figure 4.34 Graph showing predicted total brain tissue volume (cm3) against change 
in discordance (% per week) for subgroup of monochorionic twins 
 
When only dichorionic twins were selected, there was an association between the 
change in weight discordance over time and the predicted brain volume. Figure 4.35 
shows the predicted brain volume against the change in discordance (% per week). As 
the change in discordance increased (i.e. the growth diverged), the predicted total 
brain tissue volume (cm3) increased. For every 1% increase in weight discordance per 
week, there was a 49.9cm3 increase in brain volume (p 0.00, CI 34.5, 65.2).  In order 
to assess the effect of gender discordance on this association, I repeated the model 





Figure 4.35 Graph showing predicted total brain tissue volume (cm3) against change 
in discordance (% per week) for dichorionic twins 
 
 
Figure 4.36 Graph showing predicted total brain tissue volume (cm3) against change 





Figure 4.36 shows the predicted brain volume against the change in discordance (% 
per week) when dichorionic twins were stratified according to gender discordance. In 
both gender discordant and gender concordant dichorionic twin pairs, there was 
evidence of an association between the change in weight discordance over time and 
predicted total brain tissue volume. As the growth within the twinset diverged, the 
predicted brain volume increased. In gender discordant twin pairs, for every 1% 
increase in intertwin weight discordance per week, there was a 67.3cm3 increase in 
predicted brain volume (p <0.001 CI 42.0,92.5), and in gender concordant pairs an 
increase of 47.0cm3 (p <0.001 CI 28.3 – 65.8). There was no significant difference 
between gender discordant and gender concordant twinsets and their relationship 
between change in weight discordance and brain volume (p 0.280). 
 
This finding is surprising and the clinical significance of this is uncertain, as there is no 
plausible mechanism to explain why divergent growth in dichorionic twins appears to 
be associated with an increase in total brain tissue volume. As discussed in Section 
2.5.3, the measure of the pattern of growth discordance is artificial and does not 
adequately reflect the complexities surrounding patterns of growth and therefore the 
conclusions that can be drawn are limited.  
 
4.3.7 The effect of the pattern of growth discordance on intertwin % brain tissue 
volume discordance 
4.3.7.1 Observed values for brain volume discordance 
Figure 4.37 shows each the relative % brain volume discordance in each twinset 
plotted against their change in weight discordance over time (% per week). The brain 
volume discordance values plotted are raw data and are therefore unadjusted for 
confounders. Monochorionic twins are represented by purple marker symbols and 






Figure 4.37 Observed values for intertwin total brain tissue volume % difference by 
change in discordance  
 
4.3.7.2 Model adjusted values brain volume discordance 
Linear regression analysis was performed with the following parameters included in 
the model: 
Exposure variable – change in weight discordance over time (% per week) 
Outcome variable – relative intertwin brain volume discordance (%) 
Covariates – gender discordance (ß = 6.8, p 0.008), presence of pre-eclampsia (ß =7.8, 
p 0.001) 
 
Table 4.22 and Figures 4.38, 4.39 and 4.40 show the predicted values for relative brain 
volume discordance within the twinset for i) the whole twin cohort ii) monochorionic 







Table 4.22 Predicted values for intertwin total brain tissue volume % difference by 
change in discordance 
TBT % difference Difference Robust SE p value CI (lower) CI (upper) 
MCDA -3.5 2.3 0.149 -8.4 1.4 
DCDA -2.5 3.9 0.531 -11.4 6.4 




Figure 4.38 Graph of predicted values for intertwin relative brain volume discordance 






Figure 4.39 Graph of predicted values for intertwin relative brain volume discordance 
(%) by change in discordance in monochorionic twins 
 
Figure 4.40 Graph of predicted values for intertwin relative brain volume discordance 





There was no evidence of an association between predicted relative intertwin brain 
volume discordance and the pattern of weight discordance over time in either the 
whole cohort, or when twinsets were stratified according to chorionicity. In the whole 
twin cohort, for every 1% increase in intertwin weight discordance per week there was 
a 3.2% reduction in predicted intertwin brain volume discordance (p 0.128 CI -7.5, 
1.0). In monochorionic twins there was a 3.5% reduction in brain volume discordance 
for every 1% increase in intertwin weight discordance per week (p 0.149 CI -8.4, 1.4), 
and in dichorionic twins there was a 2.5% reduction in brain volume discordance (p 
0.531 p -11.4, 6.4). Therefore, I found no evidence of a change in intertwin brain 
volume discordance when the growth of the twinset diverges with advancing 
gestation.   
 
4.4 Discussion 
This is the first study to directly look at the association between growth discordance 
and neonatal brain volume in monochorionic and dichorionic twinsets. I found strong 
evidence of an association between birthweight discordance and neonatal brain 
volume. I stratified the twins according to chorionicity to investigate whether there 
was a difference in the association between birthweight discordance and brain 
volume in monochorionic and dichorionic twins. Previous analysis (in Chapter 3) 
demonstrated no effect of treated TTTS on brain volume in monochorionic twins, 
therefore the monochorionic subgroup included those with a diagnosis of TTTS. 
 
My data demonstrate a linear relationship between birthweight discordance and brain 
volume, rather than a threshold relationship. In both monochorionic and dichorionic 
twins, as the birthweight discordance increases, the predicted absolute brain volume 
decreases. The birthweight discordance in a twinset also affects the relative intertwin 
brain volume discordance as well as the absolute brain volume. There is evidence that 
as the birthweight discordance increases, so does the intertwin brain volume 
discordance. There is no evidence of a difference in either absolute brain volume or 
relative intertwin brain volume discordance when twins are classified as having a 
relative birthweight discordance above or below 20%. This is in keeping with there 




birthweight discordance. There is no strong evidence of an association between the 
pattern of growth discordance and predicted neonatal brain volume in monochorionic 
twins, however there is evidence of an association in dichorionic twins. There is no 
evidence of an association between the pattern of growth discordance and intertwin 
relative brain volume discordance. 
 
Current evidence has shown that there is increased neurodevelopmental morbidity 
above a threshold of growth discordance in twins. However, the accepted threshold 
varies widely,63,67,71-73 with a 20% discordance threshold adopted by the Royal College 
of Obstetricians and Gynaecologists72 for monochorionic twins. The idea of a 
threshold suggests that growth discordance is tolerated up to a certain level, but once 
that threshold is breached, morbidity increases. In contrast to this, my data clearly 
demonstrate a linear relationship between growth discordance and brain volume. My 
data demonstrate that with any degree of growth discordance, there is a loss of brain 
volume and an increase in intertwin brain volume discordance. When heavier and 
lighter twins were compared, as birthweight discordance increased, the predicted 
brain volume in both the heavier and the lighter twin decreased. In addition, group 
comparison showed no difference in association between birthweight discordance 
and predicted brain volume (after correcting for birthweight) between heavier and 
lighter twins in each twinset. This suggests that birthweight discordance has a 
negative effect on the brain volume in both the larger and the smaller twin.   
 
The fact that increased birthweight discordance is associated with a reduction in brain 
volume in both the larger and smaller twin implies an intrauterine pathophysiological 
process that affects both twins. A growth restricted fetus diverts blood preferentially 
to essential organs, in particular the brain and the heart, to protect brain growth. 
However, this brain sparing mechanism does not spare brain development168. If 
growth restriction in the smaller twin causes a stress response, then this may have a 
corresponding biochemical effect in the larger twin, therefore resulting in reduced 





The finding that increasing birthweight discordance causes both an increased 
intertwin brain volume discordance and a reduction in absolute total brain tissue 
volume implies that whilst there is a reduction in the brain volume of both twins, this 
reduction is not equal in both. It is not clear at present whether the overall reduction 
in brain volume is driven by the heavier or lighter twin, and this may depend on the 
underlying pathological mechanism behind the growth discordance. 
 
The implication of this finding that increasing birthweight discordance has a negative 
effect on brain volume is of unknown significance in terms of brain function and 
neurodevelopmental outcomes. The evidence in the literature supports a threshold 
effect for birthweight discordance on neurodevelopmental outcomes63,67,86,116. 
However, there is no data as yet on the clinical implications of brain volume 
discordance in twins. Therefore, it may be that there is a threshold effect in the 
association between brain volume and neurodevelopmental outcome, and below a 
certain brain volume, there may be an increase in neurodevelopmental morbidity. 
This cohort of twins was followed up to enable assessment of neurodevelopmental 
outcomes. Every parent was invited to complete a questionnaire to assess their 
children's cognitive and language development at 24 months of age. This will enable 
assessment of the clinical significance of brain volume discordance in twins.  
 
4.5 Conclusion  
There is evidence of a linear relationship rather than a threshold relationship between 
birthweight discordance and both absolute brain tissue volume and intertwin brain 
volume discordance. There is no evidence of an effect of the pattern of growth 





Chapter 5 The use of speckle tracking to assess the impact of 




Approximately 15% of monochorionic twin pregnancies will be complicated by twin-
to-twin transfusion syndrome,211 and a further 10-15% by selective fetal growth 
restriction212. The two conditions can present with a very similar clinical picture in the 
early stages, and it is often hard to differentiate whether the amniotic fluid 
discordance present is due to twin-to-twin transfusion syndrome or selective fetal 
growth restriction. In addition, prediction of whether, and how rapidly, early pre-stage 
twin-to-twin transfusion syndrome will develop into more advanced disease is 
complex, and various studies have looked at assessment of cardiac function to aid 
prediction and risk stratification in early disease52,58,147,151. Twin-to-twin transfusion 
syndrome is associated with cardiac dysfunction especially in the recipient twin, and 
there is emerging evidence that altered left ventricular strain may be an earlier 
indicator of twin-to-twin transfusion syndrome, before the traditional and 
cumbersome diagnostic criteria have been met151. Studies have shown that there is 
reduced left ventricular strain the recipient twin in TTTS pairs, and that there is 
increased intertwin strain discordance in TTTS pairs compared to uncomplicated 
monochorionic twins151.  
 
However, although speckle tracking has been shown to be feasible in healthy singleton 
fetuses,162-166 there have been varying rates of success and reproducibility in 
performing speckle tracking in fetuses with twin-to-twin transfusion syndrome151,158. 
In addition, there are no published studies that compare uncomplicated 
monochorionic twins to: those with selective fetal growth restriction, those with twin-






The aims of my study were to assess: 
(iii) The feasibility of performing speckle tracking in twin pregnancies 
(iv) Whether there is a change in left ventricular strain over gestation  
(v) Whether there are group differences in left ventricular strain between:  
(a) dichorionic twins  
(b) uncomplicated monochorionic twins (uMCDA) 
(c) monochorionic twins with twin-to-twin transfusion syndrome (TTTS), 
and  
(d) monochorionic twins with selective fetal growth restriction (sFGR). 
(vi) Whether there are within twinset differences in left ventricular strain in 
each of the four groups as above. 
 
5.3 Methods 
I ran a prospective cohort study enrolling consecutive referrals of women with 
monochorionic diamniotic (MCDA) and dichorionic diamniotic (DCDA) twin 
pregnancies, over an 18 month period.  
 
Each fetus was scanned by one of two operators (JJ and SDN) and the same 
assessment process was performed at each visit, as previously described.  The clips 
were exported from the ultrasound machine in DICOM format for offline analysis. The 
clips were analysed offline on a desktop computer running TomTec® 2D Cardiac 
Performance Analysis (CPA) software (Tomtec® Imaging Systems GMBH Munich, 
Germany).  
 
Participants were divided into four subgroups, as detailed in Chapter 2. Regression 
analyses were performed to compare left ventricular strain and correct for potential 
confounders, to assess: 
 
i) The change in left ventricular strain over gestation  
ii) Intergroup differences in left ventricular strain between the four subgroups 




The intra-observer and inter-observer variability of the strain measurements were 
assessed in a subset of 30 clips from randomly selected patients at various gestations. 
The intraclass correlation coefficient was used for intra- and inter-observer variability. 
5.4 Results 
5.4.1 Recruitment 
Figure 5.1 shows outlines the recruitment this study. There were 160 twins recruited, 



































A total of 16 (10%) participants did not have speckle tracking performed. This was 
either due to equipment issues (4.3%, n = 7), intrauterine fetal death (1.9%, n = 3), 
discharge to local hospital prior to second trimester (2.5%, n = 4), or failure to attend 
for assessment (1.3%, n = 2). This resulted in a total of 144 twins who had serial 
calculation of left ventricular strain using speckle tracking. Of the 144 twins, 27.8% 
were dichorionic and 72.7% were monochorionic. Of the monochorionic twins, 59.6% 
were uncomplicated, 23.1% had twin-to-twin transfusion syndrome, and 17.3% had a 
diagnosis of selective fetal growth restriction. Table 5.1 shows the baseline 
characteristics in each of the four subgroups.  
 






  DCDA twins  
(n = 40) 
uMCDA twins 
 (n = 62)  
TTTS twins 
 (n = 24) 
sFGR twins 
 (n = 18) 
Maternal age 32.3 (4.7) 30.3 (6.4) 31.1 (3.7) 34.7 (6.7) 
mean (SD) 
BMI 24.4 (3.6) 26.7 (6.2) 26.3 (4.7) 24.2 (3.0) 
mean (SD) 
Ethnicity White 18 (29) 27 (43) 11 (17) 7 (11) 
n (%) Non-
white 
2 (22) 4 (44) 1 (11)  2 (22) 
Parity P0 15 (39) 11 (29) 7 (18) 5 (13) 
P1 4 (17) 14 (61) 2 (9) 3 (13) 
P2+ 1 (9) 6 (55) 3 (27) 1 (9) 
Smoking 0 1 1 1 
Diabetes 2 1 0 0 





Table 5.2 Success of left ventricular speckle tracking 
Category Successful Unsuccessful % success 
Whole cohort 451/550 99/550 82% 
DCDA 137/154 17/154 89% 
uMCDA 190/238 48/238 80% 
TTTS 78/96 18/96 81% 
sFGR 46/62 16/62 74% 
 
The 144 fetuses enrolled in the study were scanned longitudinally throughout 
gestation, which generated a total of 550 clips for analysis (see Table 5.2, above). Left 
ventricular speckle tracking was performed successfully in 451/550 clips (82%) which 
is in keeping with previous reports in the literature.158,165,200 When the cohort was split 
into the four categories: speckle tracking was performed successfully in 89% of 
dichorionic twins, 80% of uncomplicated monochorionic twins, 81% of monochorionic 
twins with twin-to-twin transfusion syndrome, and 74% of monochorionic twins with 
selective fetal growth restriction. 
 
There was variation in the measurement of global longitudinal strain for the same 
fetus measured on different occasions by the same observer (see Table 5.3, below). 
The agreement between those measurements was rated as “moderate to good” for 
observer 1 (ICC 0.74), and “good to excellent” for observer 2 (ICC 0.89), based on 
accepted threshold values204. Whereas, there was “excellent” agreement between the 
mean strain values from two observers (ICC 0.85). These values for success rates for 
speckle tracking, and intra- or inter-observer variability are in keeping with previous 













Observer 1 0.74 0.59,0.86 <0.001 Moderate to good 
Observer 2 0.89 0.79,0.93 <0.001 Good to excellent 
Inter-observer variability 
Observer 1 (mean) and 
Observer 2 (mean) 
0.85 0.69,0.93 <0.001 Excellent 
*extent to which values are equal to each other 
 
5.4.3 Assessment of peak global left ventricular systolic strain by gestation 
5.4.3.1 Observed values for global left ventricular strain 
Table 5.4 and Figure 5.2 show the values for mean global left ventricular peak systolic 
strain (with standard deviations) for each category of twins.  These are overall raw 
unadjusted mean strain values across all gestational ages.  
 






Figure 5.2 Observed values for strain over gestation by category 
Mean values DCDA uMCDA TTTS sFGR 













Figure 5.2 (above) shows the raw unadjusted values for global left ventricular peak 
systolic strain when the cohort is stratified into different categories of twin. These are 
raw unadjusted values, and each scan for each twin in the cohort is plotted against 
the gestational age at the time of the scan. The red line represents dichorionic twins, 
the green line is uncomplicated monochorionic twins, the blue line is monochorionic 
twins with twin-to-twin transfusion syndrome and the purple line is monochorionic 
twins with selective fetal growth restriction.  
 
5.4.3.2 Model adjusted values for global left ventricular strain 
Mixed multiple regression analysis was performed with the following parameters 
included in the model: 
Exposure variable – (i) gestational age (ii) category 
Outcome variable – global longitudinal left ventricular strain (%) 
Covariates – maternal age, ethnicity, BMI, smoking status, presence of pre-eclampsia 
or diabetes mellitus.  
 
The model was used to assess the association between global peak left ventricular 





Figure 5.3 Model adjusted values for global peak left ventricular systolic strain over 















Figure 5.3 and Table 5.5 show the predicted values for global peak left ventricular 
systolic strain in each category of twin. There was no evidence of an association 
between strain and gestational age in dichorionic twins (p 0.295) or monochorionic 
twin with either TTTS (p 0.489) or selective fetal growth restriction (p 0.708). However, 
there was evidence of an association in uncomplicated monochorionic twins with a 
reduction in left ventricular strain with advancing gestation. There was a 0.29% 
reduction in left ventricular strain for every advancing week of gestation (p 0.001 CI -
0.47, 0.11).  
 
Table 5.5 Model adjusted values for global peak left ventricular systolic strain over 
gestation by category 
Group Estimate CI (lower) CI (upper) P-value 
uMCDA -0.29 -0.47 -0.11 0.001 
DCDA -0.01 -0.28 0.08 0.295 
TTTS -0.07 -0.28 0.14 0.489 
sFGR -0.06 -0.35 0.24 0.708 
 
 
5.4.4 Assessment of group differences in left ventricular strain at different 
gestations 
Due to the evidence of an association between gestational age and strain in 
uncomplicated monochorionic twins, it was not possible to compare the mean strain 
throughout gestation. Therefore, in order to assess whether there were group 
differences in strain, I identified three clinically important time points (16, 21 and 26 
weeks (based on cut offs for “early” and “late” TTTS)), and compared the predicted 
values for strain across the categories at these time points. 
 
Figure 5.4 and Table 5.6 show the predicted values for peak left ventricular strain at 
three clinically significant time points, for each subgroup of twins. Left ventricular 
strain was not measured in all participants at 16 weeks, therefore in order to generate 
predicted values for all groups at this gestation, values were extrapolated from the 




comparison of left ventricular strain between groups at different gestational ages, 
although it must be acknowledged that the values for some groups are extrapolated 
rather than based on measured data. Table 5.7 shows pairwise comparison of 
predicted left ventricular strain between each subgroup at different time points. 
There were significant differences in predicted strain values between uncomplicated 
monochorionic twins and those with TTTS at both 16 weeks (3.1% lower in TTTS, p 
0.01) and 21 weeks (2.0% lower in TTTS, p <0.001). In addition, there were significant 
differences between DCDA twins and monochorionic twins with TTTS at 21 weeks 
(2.3% lower in TTTS, p <0.001) and at 26 weeks (2.2% lower in TTTS, p 0.04). There 
were no significant differences in predicted strain values between monochorionic 
twins with selective growth restriction and uncomplicated monochorionic twins, nor 





Figure 5.4 Model adjusted values for global peak left ventricular systolic strain at (a) 






Table 5.6 Model adjusted values for strain at different gestations by category 
Category Weeks Estimate  CI (lower) CI (upper) p value 
uMCDA 16 25.8 24.5 27.1 
0.02 
DCDA 16 25.1 23.8 26.4 
TTTS 16 22.7 21.3 24.1 
sFGR 16 24.4 22.2 26.6 
uMCDA 21 24.3 23.7 24.9 
0.0003 
DCDA 21 24.6 24 25.3 
TTTS 21 22.3 21.5 23.2 
sFGR 21 24.1 23 25.2 
uMCDA 26 22.8 22.1 23.6 
0.04 
DCDA 26 24.1 23.2 25.1 
TTTS 26 22 20.7 23.2 






Table 5.7 Pairwise comparison of predicted global peak left ventricular systolic strain 
at different time points 
Groups compared Estimate SE P value 
uMCDA,16 - DCDA,16 0.69 0.93 0.88 
uMCDA,16 - TTTS,16 3.08 0.97 0.01 
uMCDA,16 - sFGR,16 1.43 1.29 0.69 
DCDA,16 - TTTS,16 2.39 0.95 0.07 
DCDA,16 - sFGR,16 0.74 1.28 0.94 
TTTS,16 - sFGR,16 -1.65 1.3 0.58 
uMCDA,21 - DCDA,21 -0.31 0.45 0.91 
uMCDA,21 - TTTS,21 1.98 0.51 <0.001 
uMCDA,21 - sFGR,21 0.24 0.62 0.98 
DCDA,21 - TTTS,21 2.28 0.52 <0.001 
DCDA,21 - sFGR,21 0.54 0.63 0.83 
TTTS,21 - sFGR,21 -1.74 0.68 0.06 
uMCDA,26 - DCDA,26 -1.3 0.61 0.16 
uMCDA,26 - TTTS,26 0.87 0.75 0.65 
uMCDA,26 - sFGR,26 -0.95 0.82 0.65 
DCDA,26 - TTTS,26 2.17 0.79 0.04 
DCDA,26 - sFGR,26 0.34 0.85 0.98 
TTTS,26 - sFGR,26 -1.82 0.96 0.23 
 
5.4.5 Assessment of intertwin discordance in strain by category at different 
gestations 
Twins were classified as “donor” or “recipient” in TTTS pairs, or whether they were 
“heavier” or “lighter” in DCDA, sFGR and uMCDA pairs. Regression analysis was 
performed to assess the relationship of strain and gestational age in normal and 
abnormal twins. The slopes for normal and abnormal twins were compared to assess 
whether there were intertwin differences in strain across gestation. 
 
Table 5.8 and Figure 5.5 show the predicted global peak left ventricular systolic strain, 




twins over gestation for each category. The line represents the estimated values at 
each gestation, and the shaded area represents the 95% confidence intervals.  
 
Figure 5.5 Model adjusted predicted global peak left ventricular systolic strain by 
normal and abnormal twins in a twinset 
 
There was evidence of an intertwin discordance in left ventricular strain between 
donor and recipient twins in monochorionic twinsets with TTTS (p = 0.05). Donor 
fetuses had decreasing strain with advancing gestation whereas recipient fetuses had 
increasing strain with advancing gestation. There was no evidence of an intertwin 
discordance in strain across gestation in dichorionic twins, uncomplicated 
monochorionic twins or those with selective fetal growth restriction. 
 
Table 5.8 Model adjusted predicted global peak left ventricular systolic strain by 
normal and abnormal twins in a twinset 
Group Twin Estimate 
LV strain 
CI (lower) CI (upper) Difference SE P-value 
uMCDA heavier -0.3 -0.5 0.0    
uMCDA lighter -0.3 -0.6 -0.1 0.1 0.2 0.70 
DCDA heavier -0.1 -0.4 0.1    
DCDA lighter -0.1 -0.3 0.2 -0.1 0.2 0.73 
TTTS donor -0.3 -0.6 0.0    
TTTS recipient 0.1 -0.2 0.4 -0.4 0.2 0.05 
sFGR heavier -0.1 -0.5 0.3    
sFGR lighter 0.0 -0.4 0.4 0.3 0.3 0.68 
 





The traditional diagnostic criteria for TTTS are cumbersome and do not reflect the 
natural progression of the disease, nor do they correlate with the clinical outcomes. 
Therefore, there is a need for additional assessment tools which provide a better set 
of diagnostic criteria for the disease. Early research examining left ventricular strain 
has produced mixed results, and therefore this technique remains a research tool 
rather than being accepted for use in clinical practice. My data showed that using 
speckle tracking to calculate global left ventricular strain was feasible, even in 
challenging conditions such as the polyhydramnios seen in twin-to-twin transfusion 
syndrome. Successful speckle tracking was achieved in 82% of cases, and the intra- 
and inter-observer variability varied from “moderate” to “excellent”, although a 
previous study looking at fetal speckle tracking deemed any ICC value > 0.6 as 
“good”202. The Intraclass Correlation Coefficient was noticeably higher in Observer 2 
(0.89) compared to Observer 1 (0.74), and this may reflect the fact that Observer 1 
performed the repeated measurements on different days, whereas Observer 2 
performed them on the same day. If Observer 1 had also performed the repeated 
measurements in the same day, the ICC may have been higher, therefore this may 
explain the different values between the two observers.   Overall, the intra- and inter-
observer variability is in keeping with previously reported figures7-12 and is 
encouraging for its potential as an adjunct to routine ultrasound assessment, although 
it is constrained by the same technical limitations that affect all methods of functional 
fetal cardiac assessment (for example fetal movement, fetal position and angle of 
acquisition).  
 
I demonstrated a reduction in global left ventricular strain in monochorionic twins 
with TTTS compared to uncomplicated monochorionic twins, whereas there was no 
difference in left ventricular strain between those with selective growth restriction 
compared to uncomplicated monochorionic twins. I also demonstrated a significant 
within pair strain discordance in those with twin-to-twin transfusion syndrome, which 
was not replicated in uncomplicated monochorionic twins, those with selective 
growth restriction or dichorionic twins. Interestingly, the significant reduction in left 




21 weeks, but when examined at 26 weeks, there were no significant differences in 
strain. In addition, the within twin pair strain discordance present in those treated for 
TTTS resolved by 26 weeks. All of the participants with TTTS underwent successful 
laser treatment prior to 26 weeks. Therefore, these data suggest that successful laser 
treatment allows prompt resolution of cardiac dysfunction, which is in keeping with 
published data159,213,214. Laser treatment has been established as the preferred 
treatment modality for twin-to-twin transfusion syndrome and has been shown to 
improve outcomes. This may be, in part, due to improvement in the cardiovascular 
dysfunction seen in the recipient twin. Despite often severe fetal cardiac dysfunction, 
long term follow up has shown that there are few cardiac sequelae in children who 
have been successfully treated for twin-to-twin transfusion syndrome, reflecting 
prompt resolution following successful laser treatment215,216. This is an important 
finding and useful for future counselling, as it implies a more optimistic prognosis in 
these patients. 
 
Currently, little is known about the effects of interfetal transfusion on cardiac function 
in normal monochorionic pregnancies and those developing twin-to-twin transfusion 
syndrome, before they satisfy the Quintero criteria. Previous work has demonstrated 
that pre-stage twin-to-twin transfusion syndrome is associated with early 
cardiovascular responses and alteration in left ventricular strain145. My data support 
the theory that quantification of left ventricular strain may be useful in differentiating 
early twin-to-twin transfusion syndrome from discordant growth in monochorionic 
twin pregnancies.  
 
However further research is needed to obtain normal reference values for fetal strain 
throughout gestation as currently there are no established normal values even for 
uncomplicated singletons. In addition, different studies have shown contradictory 
results for the development of strain over gestation, highlighted in a recent 






It may be feasible to use speckle tracking to measure left ventricular strain in fetuses, 
in both uncomplicated twin pregnancies, and in monochorionic twins with pathology. 
There is a reduction in left ventricular strain in twinsets affected by twin-to-twin 
transfusion syndrome, and an increase in intertwin discordance, with recipients 
having lower strain values than donor twins. Within twin pair differences in left 
ventricular strain between may help to distinguish early twin-to-twin transfusion 




Chapter 6 Is there an association between fetal cardiac 
function and neonatal brain volume? 
 
6.1 Introduction 
In my previous chapters I demonstrated that: (i) birthweight discordance in twin 
pregnancies is associated with a reduction in brain volume and an increase in intertwin 
brain volume % discordance, (ii) there is no difference in predicted brain volume in 
monochorionic twins complicated by treated twin-to-twin transfusion syndrome 
compared to uncomplicated monochorionic or dichorionic twins, and (iii) 
monochorionic twins complicated by twin-to-twin transfusion syndrome have a 
reduction in cardiac function (as measured by left ventricular strain) and an increase 
in intertwin strain discordance, with the recipient twin having a significant reduction 
in left ventricular strain.  
 
It is well known that twin-to-twin transfusion syndrome is associated with poorer 
neurodevelopmental outcomes and an increased rate of cerebral palsy.64,104,218 
Advanced Quintero stages are associated with poorer cardiac function and reduced 
left ventricular strain,151 and are linked to poorer outcomes59. Intrauterine growth 
restriction in both singleton and twin pregnancies is strongly linked to increased 
neurological morbidity64-67,168. In singleton pregnancies, intrauterine growth 
restriction has been shown to result in subclinical cardiac dysfunction even in early 
stages; and the cardiac dysfunction gets progressively worse as the fetal condition 
deteriorates. 219-221 In addition, there is increasing evidence that congenital heart 
disease is associated with abnormal fetal brain development222-224. The left ventricle 
is responsible for cerebral perfusion, therefore cardiac dysfunction in utero may be 
linked to poorer neurological outcome. Therefore, the aim of my study was to assess 






As previously outlined, this was a multicentre prospective study over a 2 year period, 
where consecutive referrals of monochorionic and dichorionic twin pregnancies were 
invited to participate.  Each fetus was scanned at 21 weeks’ gestation by one of two 
operators (JJ and SDN) and the same assessment process was performed as previously 
described.  The clips were exported and analysed offline on a desktop computer 
running TomTec® 2D Cardiac Performance Analysis (CPA) software (Tomtec® Imaging 
Systems GMBH Munich, Germany) to enable calculation of global left ventricular 
strain.  After birth, participants had a neonatal MRI scan performed at term corrected 
gestational age. The MRI sequence performed is described in detail in Chapter 2. The 
scan images were processed and volumetric data extracted, as described previously.   
 
The twin cohort was split into four categories, as previously described, based on their 
antenatal diagnosis: 
 
(i) dichorionic twins (DCDA) 
(ii) uncomplicated monochorionic twins (uMCDA) 
(iii) monochorionic twins with twin-to-twin transfusion syndrome (TTTS) 
(iv) monochorionic twins with selective fetal growth restriction (sFGR) 
 
Regression analyses were performed to correct for potential confounders and to 
assess the relationship between the mean total brain tissue volume and left 




Table 6.1 shows the baseline characteristics and Figure 6.1 shows the recruitment and 
the participants who underwent both functional cardiac assessment and neonatal MRI 
scan. Out of 162 twins recruited, 62 had complete data for both functional cardiac 
assessment and neonatal MRI scan. There was approximately an even split between 




29) dichorionic. Of the monochorionic twins, 51.5% (n = 17) were uncomplicated, 
27.3% (n = 9) had twin-to-twin transfusion syndrome and 21.2% (n = 7) had selective 
fetal growth restriction.  
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Table 6.1 Baseline characteristics 
Maternal Characteristics 
Twin pregnancies (n = 36) DCDA (n=16) NMT (n=10) TTTS (n = 5) DFGR (n = 5) 
Age, mean (SD) 31.9 (4.9) 31.7 (5.6) 31.4 (1.8) 34.2 (8.9) 
BMI, mean (SD) 23.4 (3.15) 26.4 (4.4) 23.9 (3.2) 24.4 (2.5) 
Ethnicity, n (%)     
White 15 (93.8) 9 (90.0) 4 (80.0) 4 (80.0) 
Non white 1 (6.2) 1 (10.0) 1 (20.0) 1 (20.0) 
Parity, n (%)     
0 11 (68.8) 3 (30.0) 3 (60.0) 3 (60.0) 
1 4 (25.0) 5 (50.0) 2 (40.0) 2 (40.0) 
2+ 1 (6.2) 2 (20.0) 0 (0.0) 0 (0.0) 
Smoking status, n (%)     
Non-smoker 16 (100.0) 10 (100.0) 5 (100.0) 5 (100.0) 
Smoker 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Infant Characteristics  









GA at delivery, median 
(range) 
36+3  
(29+1 – 38+2) 
36+2  
(33+2 – 36+4) 
33+3  
(29+1 – 35+1) 
33+3  
(29+2 – 34+2) 
Birthweight (g), mean (SD) 2240 (551) 2291 (355) 1782 (544) 1895 (391) 
Gender, n (%)     
Female 13 (44.8) 12 (70.6) 5 (55.6) 4 (57.1) 
Male 16 (55.2) 5 (29.4) 4 (44.4) 3 (42.9) 
% BWT discordance, mean 
(SD) 15.9 (6.8) 10.9 (7.3) 14.0 (9.6) 22.7 (8.1) 
cGA at MRI scan, median 
(range) 
37+4  
(36+1 – 40+6) 
38+1  
(37+0 – 45+3) 
41+2  
(38+5 – 44+2) 
38+1  
(37+4 - 44+2) 
Gender disc, n (%)  N/A N/A N/A 
Discordant 7 (24.1)    
Concordant 22 (75.9)    
 
6.3.2 Observed values for global peak left ventricular systolic strain (measured at 
21 weeks’ gestation) by group 
Table 6.2 and Figure 6.2 show the observed values for left ventricular systolic strain at 
21 weeks’ gestation in each category of twin. The overall mean left ventricular strain 
for the whole cohort at 21 weeks’ gestation was -24.9%. The mean strain in dichorionic 
twins was -25.8%, in uncomplicated monochorionic twins: -24.7%, in monochorionic 
twins with twin-to-twin transfusion syndrome: -22.1% and in monochorionic twins 




represents the median value, the box represents the interquartile range (IQR), the 
whiskers represent the upper and lower adjacent values (1.5*the IQR) and the 
individual dots are data points that are outliers. 
 
 
Figure 6.2 Observed values for global peak left ventricular systolic strain by group 
 
Table 6.2 Observed strain by group  
LV strain Mean SD Min Max 
DCDA - 25.8 2.7 - 20.3 - 32.0 
uMCDA - 24.7 3.1 - 17.6 - 29.0 
TTTS - 22.1 3.0 - 16.0 - 25.2 
sFGR - 25.0 3.1 - 21.9 - 30.0 
Overall - 24.9 3.1 - 16.0 - 32.0 
 
6.3.3 Predicted values for global peak left ventricular systolic strain (measured at 
21 weeks’ gestation) by group 
Mixed multiple regression analysis was performed with the following parameters 
included in the model: 




Outcome variable – total brain tissue volume (cm3) 
Covariates – male gender (ß =22.9, p 0.004), corrected gestational age at MRI scan (ß 
=17.3, p <0.001), birth gestation (ß =3.8, p 0.404), birth weight (ß =0.2, p 0.101), 
ethnicity (ß =-14.2, 0.062) 
 
Table 6.3 and Figure 6.3 show the predicted values for total brain tissue volume (cm3) 
against global peak left ventricular systolic strain (measured at 21 weeks’ gestation) 
by group.  
 
Figure 6.3 Graph of predicted total brain tissue volume (cm3) against LV strain by group 
 
Table 6.3 Model adjusted values for total brain tissue volume (cm3) for strain by group  
TBT (cm3) Difference SE p value CI (lower) CI (upper) 
DCDA -0.1 1.1 0.945 -2.2 2.1 
uMCDA -2.2 1.3 0.101 -4.8 0.4 
TTTS -1.0 1.3 0.470 -3.6 1.6 
sFGR 2.5 2.2 0.259 -1.8 6.8 
Overall -2.2 1.3 0.101 -4.8 0.4 
*Difference refers to the change in predicted neonatal brain volume for every 1% 





There was no evidence of an association between left ventricular strain at 21 weeks 
and predicted neonatal brain volume in any subgroups: dichorionic twins (p 0.945 CI -
2.2, 2.1), uncomplicated monochorionic twins (p 0.101 CI –4.8, 0.4), monochorionic 
twins with TTTS (p 0.470 CI -3.6, 1.6) or monochorionic twins with sFGR (p 0.259 CI -
1.8, 6.8). Table 6.4 shows a pairwise comparison for each group of twins against the 
others, to compare the group differences in the relationship between left ventricle 
strain at 21 weeks and predicted neonatal brain volume. Interestingly, although there 
was no evidence of an association between left ventricular strain and brain volume in 
any subgroup, there was some evidence of a difference in this association between 
subgroups. When slopes were compared between all categories of twin, there was 
some evidence of group differences between uncomplicated monochorionic twins 
and those with selective fetal growth restriction; with a trend towards increased strain 
resulting in a decrease in predicted brain volume in uncomplicated monochorionic 
twins and an increase in predicted brain volume in those with sFGR, but this does not 
reach statistical significance (p 0.06 CI -0.2, 9.5).   
 
Table 6.4 Pairwise comparison of slopes between different categories of twin and the 
association between LV strain and total brain tissue volume (cm3). 
Pair compared Difference SE CI (lower) CI (upper) P value 
uMCDA vs DCDA 2.1 1.9 -1.6 5.8 0.27 
uMCDA vs TTTS 1.2 1.8 -2.3 4.7 0.50 
uMCDA vs sFGR 4.7 2.5 -0.2 9.5 0.06 
DCDA vs TTTS -0.9 1.9 -4.5 2.8 0.64 
DCDA vs sFGR 2.6 2.7 -2.7 7.8 0.34 




This is the first study to look at the association between fetal cardiac function and 
neonatal brain volume in twin pregnancies. The analysis was exploratory, and limited 
by the small sample size, and due to these constraints left ventricular strain was 




gestation. I found no association between left ventricular strain and predicted brain 
volume in any subgroup of twins. However, I found some evidence of a difference in 
the relationship between left ventricular strain and neonatal brain volume in 
uncomplicated monochorionic twins compared to those with selective fetal growth 
restriction. In uncomplicated monochorionic twins, there was a trend towards 
increased left ventricular strain being associated with a decrease in predicted brain 
volume, whereas in monochorionic twins with sFGR, there was a trend towards 
increasing left ventricular strain being associated with an increase in predicted brain 
volume. Although neither subgroup showed a significant association individually, 
when margins contrast was used to compare the associations, there was evidence of 
a difference in the association between cardiac function and neonatal brain volume 
between these two subgroups. 
 
Little is known about the effect of selective fetal growth restriction on cardiac function 
in monochorionic twins. In my previous study, I found no differences in left ventricular 
strain values between monochorionic twins with selective fetal growth restriction and 
uncomplicated monochorionic twins. Interestingly, in a recently published study, 
monochorionic twins with selective fetal growth restriction were found to have higher 
(augmented) strain values compared to uncomplicated monochorionic twins.145 
However, the authors were uncertain of the significance or basis for the augmented 
LV strain seen in twins with sFGR. 
 
In singleton pregnancies, placental insufficiency leads to intrauterine growth 
restriction (IUGR) and this results in fetal cardiac remodelling and dysfunction.219 
There is growing evidence that even in the early stages of IUGR with normal umbilical 
artery Doppler readings, the fetus develops subclinical cardiac dysfunction.219-221 As 
the intrauterine growth restriction becomes more severe, the cardiac dysfunction 
increases. Studies have shown that the more severe the intrauterine growth 
restriction, the poorer the outcome. 225,226 
 
I previously showed that increasing birthweight discordance and selective fetal 




studies have suggested that subtle cardiac dysfunction may distinguish between a 
constitutionally small fetus versus a growth restricted fetus. Growth restriction is 
strongly associated with neonatal brain volume and neurodevelopmental outcome; 
therefore, it may be that growth restricted fetuses who have evidence of cardiac 
dysfunction are at higher risk of neurodevelopmental impairment. This is a very small 
sample of fetuses, but the potential implications of this finding support further 
research into the association between cardiac function, brain volume and 
neurodevelopmental outcomes.   
6.5 Conclusion 
There may be an association between fetal cardiac function and neonatal brain 
volume in monochorionic twinsets with selective fetal growth restriction. However, 
this was an exploratory study and the numbers were small, therefore further research 
is needed to investigate this relationship further and examine the association between 





Chapter 7 Investigation into the relationship between growth 
discordance and brain growth 
 
7.1 Introduction 
A number of studies have shown a relationship between intrauterine growth 
restriction, brain volume and neurodevelopmental impairment169,178. In my previous 
chapters, I demonstrated that monochorionic twins with an antenatal diagnosis of 
selective growth restriction had an increase in intertwin brain volume discordance and 
a trend towards an overall reduction in total brain tissue volume. I also demonstrated 
a linear relationship between birthweight discordance and brain volume. As the 
birthweight discordance increased, there was a corresponding reduction in predicted 
brain volume and increase in brain volume discordance.  
 
Severe brain pathology is increased in the larger of the monochorionic twin 
pair,63,68,69,117 which can partly be attributed to increased postnatal pathology. 
However, approximately half of brain injuries in monochorionic twins are antenatally 
acquired, which means that the neurological morbidity cannot completely be 
explained by postnatal complications183.   Studies have used fetal MRI to investigate 
brain volumes in monochorionic twinsets treated for twin-to-twin transfusion 
syndrome, and showed no difference in brain volume between  ex-donors and ex-
recipients206,227. In addition, they found that fetal brain growth was maintained in 
survivors of co-twin demise in TTTS, and brain volumes were similar to recipients in 
twin pairs with two survivors227. In singleton fetuses with growth restriction, there is 
evidence of a reduction in third trimester fetal brain volume compared to normally 
grown control fetuses186. To date there have been no studies looking at fetal brain 
volumes in twins with discordant fetal growth. Therefore, the aim of this chapter was 







As previously outlined, this was a multicentre prospective study over a 2 year period, 
where consecutive referrals of monochorionic and dichorionic twin pregnancies were 
invited to participate.  Participants had a fetal MRI scan at 30-32 weeks’ gestation and 
a neonatal MRI scan performed at term corrected gestational age. The MRI sequence 
performed is described in detail in Chapter 2. Automatic segmentation was performed 
to enable quantification of total brain tissue volume and third trimester brain growth, 
as described previously.  Mixed multiple regression analyses were performed to assess 
the association between third trimester brain growth (cm3 per week) and fetal growth. 
 
Exposure variables – (i) intertwin % birthweight discordance, (ii) twinsets who had 
<20% birthweight discordance versus those who had >20%, and (iii) the pattern of 
birthweight discordance over time 
Outcome variable – total brain tissue volume (cm3) 
Covariates – male gender (ß =4.2, p 0.107), birth gestation (ß =-2.0, p 0.004), birth 




Figure 7.1 outlines the recruitment and the breakdown of participants by chorionicity. 
162 twins were recruited into the study, of whom 64 (39.5%) did not undergo a fetal 
MRI scan, resulting in 98 fetal MRI scans being performed. A total of 20 (12.3%) twins 
did not undergo a fetal scan as the parents declined, 22 twins were (13.6%) born prior 
to the gestation at which the fetal MRI was performed, 14 twins (8.6%) had a fetal 
death, 6 twins (3.7%) were lost to follow up / did not attend and 2 twins (1.2%) were 
not scanned due to technical reasons. Quality of segmentation was too poor to allow 
quantification of brain volume in 70 scans (71.4%) and therefore fetal brain volume 
was calculated in 28 scans (28.6%). Of these 28 scans, 7 twins did not have neonatal 
scans available for comparison, resulting in paired fetal and neonatal brain volumes in 




Of the 21 paired fetal and neonatal brain volumes, 15 were monochorionic twins 
(71.4%) and 6 were dichorionic twins (28.6%).   
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7.3.2 Effect of intertwin birthweight discordance on brain growth 
Pregnancies were stratified according to chorionicity and Table 7.1 and Figure 7.2 
demonstrate the mean birthweight discordance by chorionicity. The mean 
birthweight discordance in MCDA twins was 11.2% and in DCDA twins 15.3%. 
 
Table 7.1 Birthweight discordance by chorionicity 
BW discordance Median Min Max 
MCDA 7 1 34 




Figure 7.2 Birthweight discordance by chorionicity 
 
The central line in the box represents the median value, the box represents the 
interquartile range (IQR), the whiskers represent the upper and lower adjacent values 






7.3.2.1 Observed values for brain growth by intertwin birthweight discordance 
Figure 7.3 demonstrates the raw unadjusted observed values for brain growth (cm3 
per week between 32 weeks and 40 weeks gestational age) separated by chorionicity. 
MCDA twins are represented by purple circles, and the DCDA twins by green triangles. 
 
Figure 7.3 Observed values for total brain tissue growth (cm3/week) by birthweight 
discordance 
 
As described previously, mixed multiple regression analysis was used to adjust for 
confounders and assess the relationship between brain growth and: 
(i) intertwin % birthweight discordance 
a. As a continuous variable 
b. Above and below a threshold of 20% birthweight discordance 
(ii) Change in intertwin weight discordance over time 
 
7.3.2.2 Adjusted values for brain growth by intertwin birthweight discordance 
Table 7.2 and Figures 7.4 and 7.5 show the model adjusted values for brain growth 
(cm3 per week) by % birthweight discordance for the cohort. Due to extremely small 
numbers, it was not possible to assess DCDA twins as a separate subgroup, therefore 
the table and graphs show the entire twin cohort, and MCDA twins assessed as a 





Figure 7.4 Graph showing predicted brain tissue volume growth (cm3 per week) by 
birthweight discordance for whole twin cohort 
 
 
Figure 7.5 Graph showing predicted brain tissue volume growth (cm3 per week) by 





Table 7.2 Predicted values for brain tissue volume growth (cm3 per week) for 
birthweight discordance by group 
TBT growth/wk Difference Robust SE p value CI (lower) CI (upper) 
MCDA 0.3 0.2 0.217 -0.15 0.66 
All twins 0.2 0.2 0.303 -0.19 0.64 
 
There was no evidence of an association between birthweight discordance and brain 
growth (cm3 per week) either in the whole twin cohort (p 0.303 CI -0.19, 0.64), or 
when monochorionic twins were assessed as a subgroup (p 0.217 CI -0.15, 0.66). 
 
7.3.3 The effect of a 20% discordance threshold on brain growth 
As described previously, twins were stratified into those with an intertwin birthweight 
discordance greater than 20%, and those with less than 20% and then stratified 
according to chorionicity.  Table 7.3 and Figures 7.6 and 7.7 demonstrate the numbers 
in each subgroup.  
 
 
Figure 7.6 Bar chart showing number of twins above and below a threshold cut off of 






Figure 7.7 Bar chart showing number of cohort above and below a threshold cut off of 
20% birthweight discordance by chorionicity 
 
Table 7.3 proportion of twins above and below 20% discordance threshold  
Group Discordance Frequency Percent 
Monochorionic 
  
Less than 20% 11 73.3 
More than 20% 4 26.7 
Dichorionic 
  
Less than 20% 5 83.3 
More than 20% 1 16.7 
All twins 
  
Less than 20% 16 76.2 
More than 20% 5 23.8 
 
Overall, 76.2% of twins (n = 16) had a birthweight discordance of less than 20%, and 
23.8% (n = 5) had a discordance greater than 20%. When separated according to 
chorionicity, out of 15 monochorionic twins, 73.3% (n = 11) had a birthweight 
discordance of less than 20% and 26.7% (n = 4) had greater than 20%. Out of 6 
dichorionic twins, 83.3% (n = 5) had a birthweight discordance of less than 20%, and 





7.3.3.1 Observed values for brain growth above and below a 20% discordance 
threshold 
Table 7.4 and Figures 7.8 and 7.9 show the observed values for brain growth when 
twins were categorised into those above and below a threshold birthweight 
discordance of 20%, and when monochorionic twins were assessed as a separate 
subgroup. In Figures 7.8 and 7.9 the central line in the box represents the median 
value, the box represents the interquartile range (IQR), the whiskers represent the 
upper and lower adjacent values (1.5*the IQR) and the individual dots are data points 
that are outliers. 
 
Table 7.4 Observed values for brain growth (cm3 per week) by weight discordance 
TBT growth/wk Mean SD Min Max 
< 20% discordance 15.7 6.7 2.5 24.6 
> 20% discordance 17.2 2.2 14.0 19.2 
Overall 16.0 5.9 2.5 24.6 
MONOCHORIONIC only     
< 20% discordance 17.2 5.8 5.7 24.6 
> 20% discordance 16.7 2.2 14.0 18.5 
Overall 17.0 5.0 5.7 24.6 
 
In twinsets with a birthweight discordance of less than 20%, the mean brain growth 
was 15.7cm3 per week. In those with a birthweight discordance of greater than 20%, 
the mean brain growth was 17.2cm3 per week. When monochorionic twins were 
assessed separately, the mean brain growth was 17.2cm3 per week and 16.7cm3 per 
week for those with below and above a 20% threshold for birthweight discordance 






Figure 7.8 Observed values for brain growth (cm3 per week) by weight discordance  
 
 
Figure 7.9 Graph of observed values for brain growth (cm3 per week) by weight 




7.3.3.2 Adjusted values for brain growth above and below a 20% discordance 
threshold 
Tables 7.5 and 7.6, and Figures 7.10 and 7.11 show the values for brain growth (cm3 
per week) above and below a threshold of 20% birthweight discordance, after 
regression analysis has been performed to adjust for confounding factors.  
 
Table 7.5 Model adjusted values for brain growth (cm3 per week) by weight 
discordance 
TBT growth/wk Mean SD CI (Lower) CI (upper) 
< 20% discordance 14.6 1.0 12.7 16.6 
> 20% discordance 20.5 2.2 16.3 24.8 
 
 
Figure 7.10 Graph showing predicted brain growth (cm3 per week) difference by 
weight discordance  
 
When the whole twin cohort is assessed together, there is some evidence that twins 
with a weight discordancy of over 20% have an increase in brain growth compared to 
those with a weight discordancy of less than 20%. There was a 6% increase in brain 
growth in twins with >20% discordance compared to those with <20% (p 0.02 CI 0.95, 




no significant association between brain growth per week and a weight discordancy 
above or below a threshold of 20% (p 0.22 CI -1.88, 8.05). 
 
Table 7.6 Model adjusted values for brain growth (cm3 per week) by weight 
discordance in monochorionic twins 
TBT growth/wk Mean SD CI (Lower) CI (upper) 
< 20% discordance 16.3 1.5 13.4 19.1 




Figure 7.11 Graph of model adjusted values for brain growth (cm3 per week) by weight 





7.3.4 The effect of pattern of weight discordance on brain growth 
Finally, I examined the relationship between the pattern of weight discordance (% 
change per week throughout gestation) and brain growth between 32 weeks and 40 
weeks of gestation.  
 
7.3.4.1 Observed values for brain growth by pattern of weight discordance 
Figure 7.12 shows each individual twin’s observed brain growth plotted against their 
change in weight discordance over time. The brain growth values plotted are raw 
values and are therefore unadjusted for confounders. Monochorionic twins are 




Figure 7.12 Observed values for brain tissue volume growth (cm3 per week) by change 
in weight discordance for monochorionic and dichorionic twins  
 
7.3.4.2 Adjusted values for brain growth by pattern of weight discordance 
As described previously, mixed regression was used to adjust for confounders and 
assess the relationship between brain growth and change in intertwin weight 




Table 7.7 shows the values for the relationship between change in weight discordance 
over time and predicted brain growth in i) the whole twin cohort and ii) 
monochorionic twins. Figure 7.13 demonstrates the predicted brain growth by change 
in weight discordance over time when the whole twin cohort is assessed together, and 
Figure 7.14 when monochorionic twins are examined separately. 
 
 
Figure 7.13 Predicted values for brain tissue volume growth (cm3 per week) by change 
in weight discordance  
 
Table 7.7 Predicted values for total brain tissue volume (cm3) for change in 
discordance by group 
TBT growth/wk Difference Robust SE p value CI (lower) CI (upper) 
MCDA -5.9 2.2 0.008 -10.3 -1.5 
All twins -4.5 2.3 0.049 -8.9 -0.1 
 
There was evidence of an association between the pattern of birthweight discordance 
and brain growth in both the whole twin cohort (p 0.049), and in the monochorionic 
twin subgroup (p 0.008). There was evidence of a reduction brain growth as the 




became more divergent). In the whole twin cohort, there was a 4.5cm3 per week 
reduction in brain growth for every 1% increase in growth discordance per week (p 
0.049 CI -8.9, -0.1). This association was more marked in monochorionic twins, with a 
5.9cm3 per week reduction in brain growth for every 1% increase in weight 
discordance per week (p 0.008 CI -10.3, -1.5). It was not possible to assess dichorionic 
twins as a separate subgroup due to the small sample size (n = 6). 
 
 
Figure 7.14 Predicted values for brain tissue volume growth (cm3 per week) by change 
in weight discordance in monochorionic twin subgroup  
 
7.4 Discussion 
This is the first study to assess the association between third trimester brain growth 
and growth discordance in twins. The sample size was small due to issues in 
acquisition of fetal MRI scans of sufficient quality for segmentation and quantification 
of brain growth. Despite this, I found some evidence that brain growth was affected 
by the pattern of intrauterine growth discordance. As the growth discordance within 
the twinset increased (i.e. their weights diverged), there was an associated reduction 
in third trimester brain growth. However, I found no association between the actual 




difference in brain growth above and below a threshold of 20% birthweight 
discordance. In Chapter 4, I demonstrated that there was no association between 
pattern of growth discordance and absolute neonatal brain volume. Therefore, these 
data imply that the pattern of growth discordance affects the growth velocity of the 
brain but not the final neonatal brain volume. 
 
In contrast, my previous data (in Chapter 4) investigating the effect of growth 
discordance on neonatal brain volume, demonstrated no association between the 
pattern of growth discordance and the absolute neonatal brain tissue volume, but 
strong evidence of an association between relative intertwin % birthweight 
discordance and neonatal brain volume.  
 
My data suggest that brain growth depends on the pattern and timing of growth 
discordance, whereas absolute brain volume depends on the degree of growth 
discordance. If the growth discordance is stable (for example the discordance stays at 
20% throughout pregnancy and at birth) then the baseline brain volume is smaller, 
but grows at a faster rate. However, if the growth discordance increases (for example 
starts at 0%, increases throughout the pregnancy and ends up with a birthweight 
discordance of 20%), then the baseline brain volume is larger but the brain growth 
plateaus, meaning that the end brain volumes are the same, but with different routes 
to that end volume.  
 
This may be explained by the different pathophysiologies for discordant growth in 
twins. There are different causative mechanisms for growth restriction in 
monochorionic and dichorionic twins, and even within monochorionic twins. The 
majority of dichorionic twins are dizygotic and therefore growth discordance 
represents either constitutional genetic differences or uteroplacental insufficiency. If 
the growth discordance in dichorionic twins is due to genetic differences, then they 
are likely to have genetically different sized brains but a normal brain growth 
trajectory. However, if the growth discordance is due to uteroplacental insufficiency 




an altered growth trajectory, resulting in the same brain volume discordance seen in 
the twin sets with genetically determined growth discordance.  
 
Monochorionic twins are genetically identical and the growth discordance seen in 
these twinsets is far more complex. It is due to a combination of the vascular 
architecture of the shared placenta (in terms of the number and type of anastomoses), 
sites of cord insertion (peripheral or central), and placental territory share. However, 
there is also a theory that unbalanced early cytoplasmic division of the egg, which 
happens early on during the twinning process, may be responsible for early onset 
discordant growth.228 This means that although the monochorionic twin pair are 
identical, due to unequal allocation of cells they each have a different predestined 
growth potential. These different pathophysiologies may be reflected in the different 
patterns of growth restriction seen in monochorionic twins, and whether any weight 
discordance is stable or divergent. A different predestined genetic growth potential 
would be more likely to present as a significant but stable weight discordance, 
whereas placental causes may result in increasing discordance and divergent growth. 
As with the dichorionic twins, a stable discordance from the start may result in 
different sized brains early in pregnancy, whereas diverging fetal growth results in 
diverging brain volumes. As previously discussed, numbers in the selective growth 
restriction group were not sufficient to allow stratification according to type I, II and 
III; but it may be that these subtypes reflect a different pathophysiology underlying 
the growth restriction and therefore this may affect brain volume and brain growth.  
 
7.5 Conclusion  
The pattern of fetal growth discordance in a twinset affects the third trimester brain 
growth velocity. As the growth becomes more divergent, there is a reduction in brain 
growth, although as demonstrated in Chapter 4, this has no effect on the final total 
brain tissue volume at term corrected gestational age.  Further investigation into third 
trimester brain growth may provide valuable information to improve management in 
these high risk pregnancies, and if fetal brain growth is shown to be significantly 




Chapter 8 General discussion 
 
8.1 Background 
I conducted a longitudinal cohort study to investigate the association between relative 
intertwin growth discordance and brain volume. In this thesis I have explored the 
association between relative intertwin growth discordance and neonatal brain 
volume, third trimester brain growth, and fetal cardiac function in monochorionic and 
dichorionic twins. I also studied the effect of fetal cardiac function on neonatal brain 
volume. In this chapter; I will reflect on the main findings of my work and the 
interpretation with the current literature, I will discuss the limitations of my work, and 
implications for future research within this field. 
 
Overall my study findings showed a number of important novel observations, which 
are discussed below. 
 
8.2 Key Findings 
1. Chorionicity does not affect neonatal brain volume – uncomplicated 
monochorionic and dichorionic twins have no significant differences in either 
absolute brain volume or relative intertwin brain volume discordance. 
2. Monochorionic twins with selective fetal growth restriction have increased brain 
volume discordance and a reduction in brain volume compared to dichorionic 
twins, uncomplicated monochorionic twins or those who have been treated for 
twin-to-twin transfusion syndrome 
3. Regardless of chorionicity, increased intertwin growth discordance is associated 
with a reduction in neonatal brain volume and an increase in neonatal brain 
volume discordance. This relationship appears to be a linear, rather than a 
threshold relationship. 
4. Monochorionic twins who have undergone successful fetoscopic laser 
photocoagulation for twin-to-twin transfusion syndrome do not have differences 




5. Divergent fetal growth is associated with a reduction in third trimester brain 
growth compared to stable growth discordance. 
6. Left ventricular strain is reduced in monochorionic twins with twin-to-twin 
transfusion syndrome at 16 weeks and 21 weeks’ gestation compared to 
uncomplicated monochorionic twins and those with selective fetal growth 
restriction, but this difference disappears by 26 weeks following successful laser 
treatment. 
 
8.3 Implications of Key Findings 
8.3.1 The effect of monochorionicity and interfetal transfusion on brain 
development  
Fetal brain growth and development is genetically programmed but environmentally 
influenced and results from a complex interplay between these two factors229. 
However, the degree to which variation in brain structure is genetically or 
environmentally determined is not fully established230. Twin studies have shown high 
levels of heritability, with data suggesting that the main genetic factors determining 
overall brain size are those controlling cell division in early development230,231. 
However, adverse prenatal environments experienced by monochorionic twins may 
result in discordant growth and unequal blood supply, and therefore violate this 
“equal environment” assumption in twin studies. The pathophysiology behind how 
this affects brain growth and development is not fully understood. 
 
Twin studies from Mukherjee et al188 and Gilmore et al189 have demonstrated an 
increased intertwin brain volume discordance at term corrected gestational age in 
dizygotic twins compared to monozygotic twins. Gilmore et al recruited 217 twins and 
performed neonatal MRI scans to compare regional brain volumes between 
monozygotic and dizygotic twins. They found no significant differences in total brain 
tissue volume, or regional brain volumes between monozygotic and dizygotic twins. 
In addition, they showed that monozygotic twin brain sizes became much less 






Mukherjee et al examined 88 same sex twin pairs, and performed neonatal scans at 
term corrected gestational age to calculate intracranial volume. Participants were 
divided into groups based on chorionicity and zygosity. Comparisons were made 
between discordance in biometry and brain volume in monozygotic-monochorionic, 
monozygotic-dichorionic and dizygotic-dichorionic subgroups. There were no 
significant differences in absolute or relative discordance of birth weight or head 
circumference at birth between groups, and no significant correlation between birth 
weight discordance and birth head circumference discordance in any group. When 
placed in zygosity groups (without stratifying according to chorionicity), the dizygotic 
group had significantly greater head circumference discordance at the time of the 
neonatal MRI scan, and significantly higher intracranial volume discordance than the 
monozygotic group188. Both studies concluded that the reduction in head 
circumference discordance postnatally, reflected a postnatal period of “catch-up 
normalisation” in monozygotic twins, where they revert to their genetic potential, 
rather than being influenced by placental factors188,189.  
 
Monochorionic twins are genetically identical, therefore should have less intertwin 
brain volume discordance than dichorionic twins, which are largely dizygotic and 
therefore genetically non-identical. However, both these studies and my data 
demonstrate that monochorionic twins are more discordant than expected 
antenatally, given their identical genetic make-up. Both studies demonstrated a 
significantly higher intracranial volume discordance in their dizygotic group compared 
to their monozygotic group, whereas my data demonstrate no difference in total brain 
tissue volume discordance between uncomplicated monochorionic twin and 
dichorionic twins. However, in both Mukherjee et al and Gilmore et al’s studies 
monozygotic twins were not stratified according to chorionicity, and approximately 
half of the monozygotic group were dichorionic. This means that whilst they are 
genetically identical, they were not exposed to the potentially hostile intrauterine 
environment associated with a shared placenta. This may account for the differences 
between their findings and my data. The group with the lowest predicted brain 
volume discordance should be the monozygotic-dichorionic twins, and in my study, 




Gilmore et al, they were in the monozygotic group. In addition, I separated 
monochorionic twins with pathology (twin-to-twin transfusion syndrome or selective 
fetal growth restriction into separate groups) so my monochorionic twin group were 
only uncomplicated monochorionic twins.  
 
In successful laser treatment, the placental anastomoses are divided and therefore 
monochorionic twins are essentially dichorionised. My data showed no difference in 
brain volume in twins who undergo successful laser treatment for twin-to-twin 
transfusion syndrome. Predicted brain volumes are similar to uncomplicated 
monochorionic and dichorionic twins. This suggests that if the hostile placental 
configuration is corrected, the fetus is protected from ongoing haemodynamic 
instability and therefore cerebral injury. This implies that brain volume is affected by 
ongoing interfetal transfusion later in the pregnancy, but if interfetal transfusion is 
corrected then brain volume is preserved, in the same way that cardiac function 
rapidly improves with successful laser treatment. These data are in keeping with 
findings from Taylor-Clarke et al, who reported that fetal brain volume in twins treated 
with laser for twin-to-twin transfusion syndrome were comparable to singleton 
control,206 and also with Stirnemann et al who showed that incomplete surgery 
increased the risk of perinatal brain injury106. 
 
In summary, uncomplicated monochorionic twins have similar levels of intertwin brain 
volume discordance to dichorionic twins. When monochorionic twins with twin-to-
twin transfusion syndrome are “dichorionised” they exhibit the same level of 
discordance as uncomplicated monochorionic twins or dichorionic twins, and show no 
differences in predicted brain volume. 
 
8.3.2 The effect of growth discordance on brain volume 
It is well recognised that fetal growth restriction is associated with increased 
neurological morbidity and poorer outcomes, and there is evidence that intrauterine 
growth restriction is associated with a reduction in total brain volume,168,169 and a 




demonstrated effects of intertwin growth discordance on both third trimester brain 
growth and neonatal brain volume. My data suggest that brain growth depends on 
the pattern and timing of growth discordance, whereas absolute brain volume 
depends on the degree of growth discordance. 
 
Growth discordance is associated with an increase in intertwin brain volume 
discordance and a reduction in brain volume after correcting for gestational age at 
birth and birthweight, and this relationship is linear. Importantly, although the brain 
volume discordance is increased, this loss of brain volume is present in both twins, not 
just the smaller twin. This provides evidence that birthweight discordance has a 
negative effect on the brain volume in both the larger and the smaller twin, and that 
the increased brain volume discordance is not purely driven by a reduction in brain 
volume in the smaller twin. This supports the current literature that poorer outcomes 
are seen in both twins and the fetal response to growth restriction is harmful in both 
the larger and the smaller twin.  
 
The Barker Hypothesis is well established, and describes the fetal cardiovascular and 
metabolic adaptations to placental insufficiency232. A reduction in fetal cardiac 
function has been linked to increased neurodevelopmental morbidity233. Further 
research has examined the fetal response to growth restriction and has shown that 
there is dysregulation of the hypothalamic pituitary axis which leads to increased 
cortisol. The stress response in the fetus leads to alterations in cerebral perfusion 
which impair brain maturation and development234,235.  In the same way that the 
adaptive response to twin-to-twin transfusion syndrome is harmful to both twins, the 
adaptive response to selective growth restriction in a twin pregnancy may also be 
harmful to both. In twin-to-twin transfusion syndrome, there is activation of the renin-
angiotensin system (RAS) in the donor fetus in response to decreased circulating blood 
volume. Downregulation of the RAS would be the expected response in the recipient, 
however high levels of renin and angiotensin have also been demonstrated in the 
recipient. Therefore, it has been hypothesised that renin and angiotensin are 
transferred from the donor to the recipient through the placental anastomoses, 





The mechanism behind cerebral injury and loss of brain volume in both the larger and 
smaller twin in growth discordant monochorionic twin pairs remains unclear. It may 
represent two different pathologies: an effect of chronic underperfusion and growth 
restriction in the smaller twin, and haemodynamic instability due to interfetal 
transfusion leading to transient underperfusion in the larger twin. Alternatively, it may 
be due to a similar adaptive response, as is seen in twin-to-twin transfusion syndrome 
with the smaller twin’s physiology having an impact on the larger twin. Interestingly, 
within the subgroup of monochorionic twins with selective fetal growth restriction, 
there was evidence that there was a corresponding reduction in predicted neonatal 
brain volume as the left ventricular strain reduced. 
 
As discussed previously, the aetiology of selective growth restriction in monochorionic 
twins is a complex interplay between early cell division, placental share and the 
placental angioarchitecture. Different pathophysiologies may be reflected in the 
different patterns of growth restriction seen in monochorionic twins, the umbilical 
artery Doppler waveforms and whether any weight discordance is stable or divergent.  
 
In summary, whatever the aetiology of the intertwin growth discordance, it is evident 
that growth discordance has a negative effect on brain volume in both the larger and 
smaller twin, even after correcting for weight. Whilst it is clear there is a linear 
relationship between birthweight discordance and brain volume, the relationship 
between brain volume and neurological impairment is uncertain. The link between 
brain volume and neurodevelopmental outcome is established, with a reduced brain 
volume associated with increased neurological morbidity. The question remains 
whether any association is linear or whether there is a threshold effect of loss of brain 
volume, with poorer neurological outcomes only occurring above a certain threshold. 






8.3.3 Cardiac function in monochorionic twins 
Discordance in amniotic fluid volume in monochorionic twins is commonly seen, and 
can represent normal variation, pre-stage twin-to-twin transfusion syndrome or early 
selective fetal growth restriction. Differentiating between these diagnoses is 
problematic and inevitably leads to increased ultrasound surveillance and a period of 
uncertainty for both patient and clinician. Left ventricular strain measurement has 
emerged as a potentially promising assessment tool to differentiate between these 
pathologies. My data demonstrated a clear increase in intertwin strain discordance 
and a reduction in left ventricular strain, driven by reduced strain in the recipient, in 
twins with twin-to-twin transfusion syndrome. This was not seen in uncomplicated 
monochorionic twins or those with selective growth restriction. This is in keeping with 
published data which show that left ventricular strain is reduced in early stage twin-
to-twin transfusion syndrome and intertwin strain discordance is increased, whereas 
this difference is not seen in monochorionic twins with selective growth restriction. 
151 Therefore, within pair strain discordance may be a useful marker in distinguishing 
early twin-to-twin transfusion syndrome from growth discordance. In addition, I 
demonstrated that this reduction in strain in the recipient twin resolves promptly 
following successful laser treatment reflecting resolution of cardiac dysfunction. This 
is an important finding and useful for future counselling, as it implies a more optimistic 
prognosis in these patients.  
 
8.4 Clinical Implications 
If normal reference values for fetal left ventricular strain were available, then 
quantification of strain using speckle tracking may be a useful adjunct in the routine 
assessment of monochorionic twins in the future. Further research could enable this 
measure to be helpful in differentiating between monochorionic twins who have early 
pre-stage TTTS and those who have early sFGR.  Acquisition of a cineloop sequence is 
quick and does not require significant cardiology expertise and, in this respect, could 
easily be introduced into routine monochorionic twin surveillance. However, as 
discussed in Sections 2.7.4.2, 5.1, and 5.5, there are significant issues which require 




My findings provide evidence of prompt resolution of cardiac dysfunction and no 
evidence of an effect on brain volume in cases of TTTS treated with FLP where both 
fetuses survive. These findings are helpful when counselling patients in this situation, 
and may also be useful in aiding decision making regarding management. There is still 
uncertainty regarding the optimal management of Stage 1 TTTS. The North American 
Fetal Therapy Network multicentre study concluded that early intervention with FLP 
was associated with significantly higher rates of dual fetal survival, 236 however a  
recent large meta-analysis concluded that the optimal initial management for Stage 1 
TTTS remains in equipoise211. My findings of comparable brain volumes in treated 
TTTS twins compared to uncomplicated monochorionic and dichorionic twins fit with 
the current literature206,227 and may support FLP rather than expectant management 
in Stage 1 TTTS. 
 
Finally, I demonstrated clear evidence of a relationship between birthweight 
discordance and neonatal brain volume. However, the timing of the effect on brain 
volume is not yet established. Additional research into fetal brain growth to further 
assess the relationship between third trimester brain growth and fetal growth 
discordance in twins may clarify when the effect on brain growth occurs. This may 
provide extra information when considering timing of delivery, and potentially 
evidence for earlier intervention in selected high risk twin pregnancies.  
 
8.5 Limitations  
The cohort of monochorionic twins with twin-to-twin transfusion syndrome in these 
studies were all pairs with double survivors following successful treatment with 
fetoscopic laser coagulation. Therefore, they were not truly representative of the 
twin-to-twin transfusion syndrome population where, in approximately half of cases, 
there is an intrauterine death. This was due to the clinical nature of the study; 
participants who had sadly lost a fetus were grieving and therefore it was not 
appropriate to ask them to come for additional non-clinical visits. This was 
compounded by the fact that many of the twin-to-twin transfusion syndrome cases 





There was inevitably some sample bias, whereby motivated individuals were more 
likely to participate. This was especially true of the dichorionic twinsets, as they 
underwent additional scans and study visits compared to routine antenatal care, 
whereas there were fewer additional visits for monochorionic twins. 
 
The sample size was limited due to time constraints: (i) the study recruitment period 
was limited by the length of my research post, and (ii) the time-consuming nature of 
the data collection (significant time taken to perform ultrasound scans (n = 550) and 
MRI scans (n = 292). The sample size limited the statistical analyses that could be 
performed and therefore the conclusions that could be drawn from my studies. In 
particular, there numbers in the gender discordant dichorionic twin group were very 
small (n = 3 twinsets) limiting the conclusions that could be drawn. However, despite 
the sample size, I demonstrated a number of significant and novel findings.  The only 
way to have increased the numbers in these studies would have been to extend the 
data collection period, or have additional staff to perform data collection to enable 
recruitment from additional sites. 
 
Neonatal MRI scans were performed at term corrected gestational age as brain 
volume at this time has been shown to correlate with neurodevelopmental outcomes. 
However, due to the varying gestations at birth (a median gestational age of 33+3 
weeks in the TTTS group compared to a median of 36+4 in the DCDA group), 
participants were of varying postnatal ages when they underwent neonatal MRI scan. 
Therefore, there were undoubtedly postnatal factors (for example mechanical 
ventilation, parenteral nutrition) that could have affected brain growth in the period 
between birth and the MRI scan and therefore had an impact on the brain volume at 
term corrected gestational age. However, in a recent study by Wang et al looking at 
neonatal brain volumes at different postmenstrual and postnatal ages between 30 
and 43 weeks, the biggest predictor of total brain tissue volume was postmenstrual 
(corrected gestational) age. Postnatal age was found to be an important predictor of 





Birthweight and birthweight discordance were included as covariates, to assess the 
association between fetal growth restriction and brain volume. However, a head 
circumference measurement was not included. This would have enabled 
differentiation between symmetrical and asymmetrical growth restriction to see 
whether “brain sparing” had any effect on the total brain tissue volume at term 
corrected gestational age. Although a recent review article concluded that asymmetric 
FGR and “brain sparing” does not necessarily result in normal brain development168. 
 
Paired fetal and neonatal MRI scans were only available for 21 out of 162 (13%) twins 
to calculate brain growth. This was largely due to poor fetal scan quality making it 
impossible to extract volumetric data. Whilst fetal MRI has been established for use 
in singleton pregnancies, it is significantly more challenging in twin gestations where 
there is more likely to be unfavourable lie and increased amniotic fluid leading to 
suboptimal imaging. In addition, 18.5% of the cohort declined neonatal MRI scan due 
to concerns about the invasive nature of having this done to their children. This is 
understandable and is part of the nature of a clinical study. 6 out of the 96 neonatal 
MRI scans (6.3%) were excluded as the data were too noisy due to movement artefact. 
This is impressive as these were unsedated well neonates, therefore scan acquisition 
was challenging and frequently took a long time due to movement and needing to 
delay or resettle the babies. Other studies have used sedation in order to be able to 
acquire MRI data. 
 
Manual segmentation has traditionally been considered superior to automatic 
segmentation for examination of neonatal brain volumes237. However, a recent study 
demonstrated that measurements of total brain tissue volume using automatic 
segmentation in SPM12, were as accurate as manual segmentation238. The 
segmentation tool in SPM12 uses a combination of tissue classification, bias correction 
and image registration in the same algorithm to try and improve precision. In addition, 
the use of automatic segmentation avoided some of the pitfalls associated with 
manual segmentation including operator subjectivity, increased inter- and intra-






The limitations of fetal speckle tracking have been described extensively in the 
literature239,240. Artefact from maternal breathing and fetal movement is 
recognised pitfall that may lead to inaccurate tracking, which is especially true in 
twin pregnancies. In this study, multiple clips were taken at each visit for each 
participant to enable the fetal heart to be captured while it was quiescent, 
therefore minimising artefact. Offline analysis to enable quantification of left 
ventricular strain requires manual correction of the endocardial border which 
creates a risk of bias and subjectivity. Inter- and intra-observer variability were 
calculated and were in keeping with accepted values in the literature. In addition, 
members of the study team received training sessions by an applications specialist 
from TomTec® to perfect the technique and minimise subjectivity. Finally, speckle 
tracking is subject to the same technical limitations that compromise all methods 
for fetal cardiac assessment. Despite this, successful speckle tracking was achieved 






8.6 Future research 
8.6.1 Neurodevelopmental outcomes  
As previously discussed, it is imperative to correlate brain volume and birthweight 
discordance with neurodevelopmental outcomes in this cohort, in order to 
understand the significance of altered brain volume. This will enable us to provide 
better information for patients and improve counselling. 
 
8.6.2 Selective fetal growth restriction 
Further investigation into the effect of selective fetal growth restriction in 
monochorionic twins on brain growth and neonatal brain volume is warranted. This 
could be achieved by recruitment of a larger cohort, to allow stratification into 
Gratacos subtypes. In addition, it would be interesting to assess the impact of fetal 
cardiac function on neonatal brain volume in these subgroups, to investigate this 
association further.  
 
8.6.3 Brain growth 
The finding that brain growth is affected by different patterns of growth discordance 
certainly warrants further investigation. It would be beneficial to collaborate with 
centres who have established successful MRI protocols for fetal imaging in twin 
pregnancies, to optimise our protocol and allow further investigation into brain 
growth in monochorionic twins. 
 
8.6.4 Left ventricular strain to predict twin-to-twin transfusion syndrome 
Left ventricular strain is emerging as a promising early marker to differentiate twin-
to-twin transfusion syndrome from selective growth restriction. In order to investigate 
this further, a study with a large group of monochorionic twins with liquor volume 






Understanding the aetiology of and being able to predict complications in 
monochorionic twins remains one of the biggest challenges in their management. The 
interfetal transfusion associated with monochorionic placentation creates a unique 
set of complications necessitating intensive surveillance. My data provide evidence 
for the potential benefit of using left ventricular strain quantification to differentiate 
between and predict monochorionic pathologies, and evidence of a negative impact 
of intertwin growth discordance on brain growth and development. These findings 
improve our understanding of why poorer outcomes are seen in these twins and may 
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Appendix 4: Methodology 
 





















Appendix 5: Outcomes 
 















































































Table S5.3 Indications for Preterm Delivery (TTTS and sFGR cases) 
 
Participant ID Diagnosis Gestation at birth Indication for delivery 
BRITP7 TTTS 33+5 PROM 
BRITP19 TTTS 35+1 Elective LSCS  
BRITP28 TTTS 32+5 Spontaneous preterm labour 
BRITP38 TTTS 29+1 PROM 
BRITP62 TTTS 33+4 PROM 
BRITP14 sFGR 33+4 Elective LSCS (periodic AEDF) 
BRITP17 sFGR 29+2 Static growth, REDF, cerebral redistribution 
BRITP20 sFGR 33+1 Static growth, oligohydramnios, raised 
UAPI, cerebral redistribution, reduced FM 
BRITP41 sFGR 33+3 Elective LSCS (periodic AEDF) 
BRITP50 sFGR 34+1 Elective LSCS 






Table S5.4 White Matter Lesions on Neonatal MRI 
 
 
MRI files Participant WM lesion
P1 Twin 1 n
Twin 2 n
P2 Twin 1 yes tiny punctate WM lesions in peritrigonal WM on T1 
Twin 2 n
P5 Twin 1 n
Twin 2 yes Single PWML in left peritrigonal region 
P6 Twin 1 n
Twin 2 n
P7 Twin 1 n
Twin 2 n
P8 Twin 2 n
P9 Twin 1 n
Twin 2 n
P10 Twin 1 n
Twin 2 n
P11 Twin 1 n
Twin 2 n
P14 Twin 2 n
P16 Twin 1 n
Twin 2 n
P17 Twin 1 n
P19 Twin 1 n
Twin 2 n
P20 Twin 1 n
Twin 2 n
P21 Twin 1 n
Twin 2 yes Single punctate focus of high T1 intensity in left frontal WM
P23 Twin 1 n
Twin 2 n
P24 Twin 1 yes 2 tiny punctate foci of high T1 intensity in WM (1 in right peritrigonal and 1 in left corona radiata)
Twin 2 n
P28 Twin 1 n
Twin 2 n
P29 Twin 1 n
Twin 2 n
P35 Twin 1 n
Twin 2 n
P38 Twin 1 n
Twin 2 yes Structurally abnormal - EXCLUDED FROM ANALYSIS
P39 Twin 1 n
Twin 2 n
P41 Twin 1 n
P45 Twin 1 n
Twin 2 n
P47 Twin 2 n
P48 Twin 1 n
Twin 2 n
P49 Twin 1 n
Twin 2 n
P50 Twin 1 n
Twin 2 n
P51 Twin 1 n
Twin 2 n
P58 Twin 1 n
Twin 2 yes right frontal lobe transmantle cortical dysplasia (linear focus of high T1 intensity and low T2 intensity)
P59 Twin 1 n
Twin 2 n
P62 Twin 1 n
Twin 2 yes left parieto-occipital polymicrogyric cleft and left cerebellar heterotopia grey matter
C1 Twin 1 yes tiny focal acute infarct in right precentral gyrus
Twin 2 n
C6 Twin 1 n
Twin 2 n
C7 Twin 1 n
Twin 2 n
C8 Twin 1 yes tiny foci of old blood products in high medial frontal lobes bilaterally
Twin 2 n
C9 Twin 1 n
Twin 2 n
C10 Twin 1 n
Twin 2 n
C11 Twin 1 n
Twin 2 n
C12 Twin 1 n
Twin 2 n
C13 Twin 1 n
Twin 2 n
C14 Twin 1 n
Twin 2 n
C15 Twin 1 n
Twin 2 n
C16 Twin 1 n
Twin 2 n
C17 Twin 1 n
C18 Twin 1 n
Twin 2 n
C19 Twin 1 n
Twin 2 n







Appendix 6: Statistical Models
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